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Abstract
O steom yelitis  is a d e b ilita tin g  infectious disease o f th e  bone. It is m ain ly  caused  
by Staphylococcus aureus and Staphylococcus epidermidis, being th e  second one, 
th e  m a jo r cause o f im p la n t-re la te d  osteom yelitis . O steom yelitis  is associated  
w ith  significant m o rb id ity  and m o rta lity  and it is m ain ly  characterised  by 
w ea k e n e d  bones due to  progressive bone loss and in fla m m a tio n . H ow ever, 
cu rren tly  th e  m echan ism  th ro u gh  w hich e ith e r bone d estruction  o r in flam m atio n  
occurs in o s teo m yelitis  patien ts  is poorly  understood .
The  data  presen ted  in th is  thesis shows th a t S. aureus and S. epidermidis bind  
d iffe re n tly  to  bone and fo llo w  distinct pathw ays in th e  in itia tio n  and progression  
o f disease. W h ile  S. epidermidis in teracts  w ith  o s teo b last via SdrG binding to  
fib rinogen  w hich in tu rn  binds to  an in tegrin  re c e p to r on th e  osteoblast surface,
S. aureus uses a very  specific in te rac tio n  m e d ia ted  by S. aureus pro te in  A (SpA) 
and T u m o r Necrosis fa c to r  recep to r 1 (TN FR -1) to  bind osteoblast. A study o f th e  
in te rac tio n  b e tw e e n  S. epidermidis and o s teo b last d e m o n stra ted  th a t S. 
epidermidis SdrG p ro te in  is involved in th e  inh ib ition  o f osteoblast g row th  but 
n o t in osteoblast d e a th  fo llo w in g  in fection . On th e  o th e r hand, investigation  o f  
th e  e ffe c t fo llo w in g  SpA binding to  TN FR -1 revea led  th is  to  be crucial in th e  
activation  o f th e  re c e p to r p a th w ay  m ed ia tin g  m u ltip le  signals u ltim a te ly  leading  
to  suppression o f bone g row th  to g e th e r w ith  bone destruction  and  
in flam m atio n . H ere , it  is show n th a t upon in fection  w ith  S. aureus, osteoblasts  
undergo  apoptosis, th ro u g h  caspase 3 c leavage, and th e  activation  o f 
in fla m m a to ry  processes occurs via NFkB ac tiva tio n  associated w ith  IkB 
degradatio n  and th e  release o f IL6. All o f these events  w e re  p reven ted  w hen  
blocking SpA o r TN FR -1 o r both, confirm ing  th e  im po rtance  o f th is in te rac tio n  in 
th e  onset and d e v e lo p m e n t o f disease
T he findings p resen ted  in th is thesis describe fo r  th e  firs t tim e  in teractions  
b e tw e e n  Staphylococci and osteoblast and th e ir  role in th e  progression o f 
Staphylococcal induced osteom yelitis . F u rth e rm o re , th is study m ay also highly  
c o n trib u te  fo r  th e  d e v e lo p m e n t o f a novel o r im proved  th e ra p y  fo r osteom yelitis  
p atien ts  using th e  TNFR -1.
V . A B ST R A C T
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Chapter 1- General Introduction
The skeleton  plays a cen tra l ro le  In th e  life o f a h um an  being. It gives every  body  
an individual fo rm , a rch itec tu re  and it also d e te rm in a te s  its size. Bone is a highly  
specialized tissue e m b e d d e d  w ith in  soft tissues w ith  tw o  m ain  d iffe re n t  
functions: support and storage (A d ler 2 0 0 0 ). This com plex  tissue is com posed o f 
extrace llu la r m atrix  th a t m ineralizes, conferring  streng th  and rig id ity  to  th e  
skeleton  but also som e e lastic ity . In ad d ition , bone is a m a jo r source o f inorganic  
ions, actively  partic ip ating  in calcium  hom eostasis in th e  body (Ducy 2 0 0 0 ). Bone 
is m ain ly  com posed o f ty p e  I collagen, im p reg n a ted  w ith  crystals o f calcium  
h ydroxyap atite , accounting  fo r a p p ro x im ate ly  95  % o f th e  organic m atrix; th e  
rem ain in g  5 % a re  proteoglycans (h ighly glycosylated pro te ins) and num erous  
non-co llagenous p ro te ins.
M orpho log ica lly , th e re  are  
tw o  distinct types o f bone: 
com pact (o r cortica l) bone  
w hich constitu tes 85 % o f 
th e  to ta l bone in th e  body, 
and spongy (o r tra b e c u la r or 
cancellous) bone constitu ting  
th e  rem ain ing  15 % (F igure 1- 
1) (llvesaro 2 0 0 1 ). The  
m ed u lla ry  cavity  in th e  
cen tre  o f th e  bone is 
com posed o f bone m a rro w , responsible fo r  th e  production  o f th e  m a jo rity  o f  
blood cells. C ortical bone is th e  dense, rigid o u te r layer th a t provides s trength  
and structura l in teg rity  w h ile  th e  cancellous bone is a loosely organized  porous  
m atrix  th a t m akes up m uch o f th e  en larged ends o f th e  long bones and ribs 
(Rogers 2 0 1 0 ). D ifferences  in th e  structura l a rran g em en ts  o f these tw o  bone  
types are re la ted  to  th e ir  p rim ary  functions: com pact bone provides m echanical 
and p ro tec tive  fu nctions  w hereas  spongy bone provides m etabo lic  functions  
(B ilezikian, Raisz et al. 2 0 0 8 ).
1.1 . B one
Spongy
Bone
Yellow
Marrow
Compact
Bone
\
Figure 1-1 - Schematic representation of compact and 
spongy bone
(http://www.teachpe.com/anatomy/bone_structure.php)
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Chapter 1- General Introduction
During the first 20 to 30 years of life, there is more bone being formed than 
resorbed, resulting in an increase in bone mass (Matkovic et al. 1994, Mundy
1995). Following the growth period the adult skeleton is remodelled every year 
with equal ratio of localized bone resorption and formation (Parfitt 1994). Later 
in life, the remodeling activity starts to fail, deregulating the capacity of 
maintaining the skeletal mass. Therefore skeletal strength is reduced and the risk 
of fracture increases over time, depending on the magnitude by which 
resorption and formation are uncoupled.
Bone is composed of three main cell types: osteoclasts, osteoblasts and 
osteocytes. While osteoclasts are bone resorbing cells, osteoblasts are bone 
forming cells, and finally osteocytes are mature bone cells that permeate the 
interior mineralized matrix and account for 90 % of all cells in the adult skeleton 
(Figure 1-2). Osteoclasts are hematopoietic descent and their precursors are 
located in the monocytic fraction of the bone marrow (Fujikawa, Quinn et al.
1996). On the other side, osteoblasts and osteocytes share the same origin both 
deriving from pluripotent mesenchymal stem cells (Aubin 1998).
14
O steoclast Multinucleate 
cell that secretes acids and 
enzymes to dissolve bone 
matrix
Osteocyte: Mature bone 
cell that maintains the 
bone matrix
Osteoblast Immature bone 
cell that secretes organic 
components of matrix
Osteoclast Matrix
Marrow
cavity
Canaiiculi Osteocyte Matrix Osteoid Osteoblast
Figure 1-2 -  D iffe ren t types o f bone cells, th e ir orig in and location (M artin i and Bartholom ew 2003)
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1.2.1. Osteoclasts
Derived from hematopoietic stem cells, osteoclasts are defined as specialized 
macrophages, highly migratory and multinucleated with a life span reasonably 
short, varying among species from days to weeks (Teitelbaum 2000; Tanaka, 
Miyazaki et al. 2006). The cross sectional diameter of an osteoclast ranges from 
twenty to hundred microns, being several times the size of a robust osteoblast 
(Tanaka, Miyazaki et al. 2006). Osteoclasts are also called bone resorbing cells as 
their main function is to resorb bone by destroying the extracellular bone matrix 
through dissolution of hydroxyapatite and degradation of the organic matrix 
components (Teitelbaum 2007; Pietrzak 2008). The number of osteoclast must 
be balanced to maintain normal bone remodeling and to prevent excess of bone 
resorption that would lead to pathological bone loss (Bruzzaniti and Baron 2006).
1.2.2. Osteoblasts
Osteoblasts are fully 
differentiated cells responsible 
for the production of bone 
(Bilezikian, Raisz et al. 2008).
Osteoblasts arise from the 
same pluripotent stem cell 
with chondroblasts,
adipocytes, myoblasts and 
fibroblasts (Grigoriadis,
Heersche et al. 1988; Bennett,
Joyner et al. 1991; Yamaguchi 
and Kahn 1991). These bone 
forming cells are located at the 
bone surface and are morphologically mono-nucleated and cuboid in shape. 
They maturate from osteoprogenitor cells into pre-osteoblasts and some
1.2. Bone cells
(forms matrix of bone tissue)
Osleocyte 
(maintains matrix of bone tissue)
Figure 1-3 - Osteoblasts lineage (adapted from  
w w w .h ighered.m cgraw -h ill.com )
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differentiate into osteocytes (Figure 1-3) (Sommerfeldt and Rubin 2001; 
Bilezikian, Raisz et at. 2008). Osteoblasts are strongly alkaline-phosphatase 
positive cells and synthesise bone matrix proteins, hormones receptors, 
cytokines and growth factors, with the ultimate aim of making a tissue 
recognizable as bone (Bilezikian, Raisz eta/. 2008).
1.2.3. Osteocytes
Considered the most differentiated cells from the osteoblast lineage, osteocytes 
are highly specialized and fully differentiated osteoblasts incorporated within the 
extracellular matrix. Only 10 to 20 % of the osteoblasts differentiate into 
osteocytes, however osteocytes end up being the most abundant cells in bone 
(Parfitt 1977; Bilezikian, Raisz et al. 2008). Despite sharing the same lineage, 
osteoblasts and osteocytes are very distinct in morphology, location and 
function. Osteocytes are smaller star shaped cells with an increased nucleus to 
cytoplasm ratio, contain less organelles and have decreased alkaline 
phosphatase activity than osteoblasts (Sommerfeldt and Rubin 2001). They 
reside in a regular spacing within lacunas in the mineralized bone matrix and 
newly formed osteoid (un-mineralized bone matrix) (Kogianni and Noble 2007) 
and are functionally responsible for the mechanical sensing on bone which 
initiates bone matrix turnover or bone remodeling (Burger and Klein-Nulend 
1999; Mikuni-Takagaki 1999; Petersen 2007). This mechanical sensing is initiated 
via the osteocytes through their long cytoplasmic extensions denominated 
canaliculi, which allow them to contact neighbouring osteocytes, osteoblasts, 
internal and external surfaces of bone, and blood vessels traversing the matrix 
(Doty 1981; Menton, Simmons etal. 1984; Bonewald 1999).
1.3. Bone cells surface receptors
Osteoblasts, osteocytes and osteoclast express a wide range of surface 
molecules such as cadherins and integrins that mediate binding and signaling
17
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pathways that are involved in maintaining normal functioning of bone. The 
processes of cell to cell and cell to matrix communication play a central role in 
the physical and mechanical changes that lead to bone remodeling. The bone 
cells surface receptors are complex and diverse and this is easily explained by the 
number of functions that they exercise. Beyond adhesive functions, surface 
receptors have been increasingly identified to mediate signaling pathways in 
immune response regulation. Conversely, intracellular events can also lead to 
receptor affinity and activity changes. For example, in platelet -  fibrinogen 
interaction, the platelet integrin gpllbllla only binds the extracellular matrix 
protein after alteration on integrin conformation, following its activation via 
ligand binding such as the thrombin receptor.
1.3.1. Cadherins
Cadherins are a large family of binding molecules that play 
a major role in intercellular binding and signaling (Takeichi 
1991; Geiger and Ayalon 1992), tissue morphogenesis and 
tumor suppression (Takeichi 1993). These calcium 
dependent proteins share a common primary structure 
composed of an amino-terminal extracellular domain, a 
single trans-membrane domain and a conserved carboxyl-
Cadherins
terminal cytoplasmic region (Figure 1-4). The extracellular Fjgure 1-4 . classic
domain can be divided into highly homologous regions cadherin s tructure
whereas the calcium cations articulate with the ligand (v iem inckx 2011)).
binding site, the conserved HAV motif (Ac-Cys-His-Ala-Val- 
Cys-NH2) located in the first extracellular repeat, rigidifying the extracellular 
domain into a rod like conformation. The cytoplasmic region binds to catenins 
which are important in gene transcription and binding regulation. Cells often 
express a repertoire of different cadherins simultaneously, and they tend to be 
concentrated at cell-cell junctions on the cell surface (Siegel and Agranoff 1999; 
Bilezikian, Raisz et al. 2008). The known cadherins of bone cells, their respective 
ligand and function are summarized below in Table 1-1. On osteoclasts, blocking
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antibodies to E- cadherin have been demonstrated to inhibit osteoclast 
formation and fusion in vitro, as well as resorption by mature osteoclasts 
(Mbalaviele, Chen et al. 1995; llvesaro, Lakkakorpi et al. 1998). While on 
osteoblasts, intercellular binding is likely to be mediated by cadherins such as N- 
cadherin, cadherin -4, -6 and -11 (Babich and Foti 1994; Okazaki, Takeshita et al. 
1994; Cheng, Lecanda et al. 1998; Mbalaviele, Nishimura et al. 1998; Ferrari, 
Traianedes et al. 2000), however the knowledge about their role in osteoblast 
function is limited (Babich and Foti 1994).
Table 1-1 -  Bone cells cadherins, respective ligand and function
N- an o th e r cadherins Osteoblast 
E- cadherin Osteoclast
N- cadherin O steoblast developm ent 
E- cadherin Osteoclast d iffe re n tia tion
A
w
j,
5!
1.3.2. Immunoglobulin superfamily
The human genome encodes 765 distinct Ig 
domains, making it the most abundant domain in 
human proteins. Within the immunoglobulin 
superfamily most of the members are well known 
for their involvement in immune functions, 
however some of these proteins also mediate cell 
to cell binding (Karp 2008). Structurally the 
immunoglobulin family of receptors are 
characterized by an Ig-like domain in their 
extracellular domain and by one or more Ig fold 
copies organized into two anti-parallel (3 sheets 
held together by hydrophobic bonds (Figure 1-5)
(Juliano 2002; Belkin, Gu et al. 2010). Members of this family such as VCAM 
(vascular cell binding molecule) or NCAM (neural cell binding molecule) play an 
important role in nerve outgrowth, synapse formation, and other events during 
the development of the nervous system (Karp 2008). Their ligands include 
members of the Ig family such as NCAM binding to itself, but also members of
Ig-like
Figure 1-5 -  Im m unoglobulin 
superfam ily  structure
(adapted from  ((Vleminckx 
2011)).
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the integrin family such as for the ICAMs (Intercellular binding molecules), which 
bind (32 integrins and components of the extracellular matrix (e.g. collagen 
binding for myelin-associated glycoprotein). Signaling pathways activated by Ig 
family members include MAP (Microtubule-Associated Protein) kinase pathways 
(Isacke and Horton, 2000; Hubbard and Rothlein, 2000). Ig superfamily of 
receptors in bone cells and their specific role in bone cell functioning is 
summarized in Table 1-2 below. Osteoblasts express ICAM-1 and VCAM-1 on 
their surface and some studies showed that these receptors are involved in 
osteoblasts interactions with T-lymphocytes followed by cytokine release 
(Tanaka, Morimoto et al. 1995) which may be important in the regulation of 
skeletal turnover during inflammation.
Table 1-2 - Ig superfamily of receptors in bone cells, respective ligand and function.
r ~
I CAM-1 O steoblast
LFA-1 (lym phocyte 
function - associated 
antigen) on leukocytes
VCAM-1 O steoblast cu Integrins on leukocytes
Function
Osteoblast d iffe ren tia tion  
Production o f cytokines
O steoblast d iffe ren tia tion  
Production o f cytokines
1.3.3. Integrins
Integrins are heterodimeric transmembrane molecules important in a variety of 
cellular functions such as growth, development, immune response, and wound 
repair (Juliano 2002). These receptors are composed of two subunits, alpha and 
beta, linked non-covalently whereas both subunits are amino-glycosylated 
glycoproteins with a large extracellular domain, a single hydrophobic 
transmembrane region, and a short intracellular cytoplasmic tail (Figure 1-6). 
Several isoforms of the alpha and beta subunits have been identified to date; 18 
different mammalian a subunits and 8 P subunits, forming 24 distinct 
heterodimers dictating their integrin-binding specificity (Zamir and Geiger 2001). 
a subunits vary in size from 120 to 180 KDa, while p subunits are 90 to 110 KDa, 
apart from the 210 KDa p4 chain. Most integrins can bind different types of 
ligands such as extracellular matrix molecules or signal molecules, such as
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growth factors. Many of those ligands are recognized by multiple integrins and 
this is often through recognition of a common sequence. In many extracellular 
matrix molecules this is an RGD peptide sequence, although other proteins can 
recognize other sequences, such as collagen, recognizing DGEA (Asp-Gly-Glu-Ala) 
or fibronectin that recognizes LDV (Leu-Asp-Val) sequences (Plow et al, 2000; 
Humphries etal., 2006).
Figure 1-6 -  Basic s tructure  o f an in tegrin . (h ttp ://w w w .scq .ubc .ca /the -ro le -o f-in teg rins-in - 
w ound-healing /)
Osteoclast integrins
Binding of osteoclasts to the bone surface is mediated by the interaction 
between integrins and extracellular matrix proteins within the bone matrix. 
Phenotypic and biochemical analyses demonstrated that osteoclasts express 
integrins avP3 and avpi, receptors for vitronectin; and ot2Pi, a collagen/laminin 
receptor on their surface (Helfrich, Nesbitt et al. 1996; Horton and Rodan 1996). 
The av3s vitronectin receptor mediates RGD peptide-dependent binding to a 
wide variety of proteins containing the RGD sequence, including bone 
sialoproteins and several extracellular matrix and plasma proteins. This 
interaction is involved in inducing a change on integrin conformation which in 
turn leads to a number of outside-in signaling events including cytoskeletal
ligand-b ind ing  sue 
binds extracellular m atrix
a  p
cytosolic dom ain  
binds cytoskeletor
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remodeling (Teltelbaum 2007). Moreover, studies on osteoclasts a2Pi integrln 
blockade suggest a role for this integrin in osteoclast fusion (Helfrich, Nesbitt et 
al. 1996). Although the downstream effects of integrin-mediated signaling in 
osteoclasts have not been clearly investigated, osteoclasts seem to respond to 
integrin ligands, in a number of ways indicative of direct signal transduction 
(Duong, Lakkakorpi et al. 2000). These include the release of intracellular calcium 
stores, induction of protein tyrosine phosphorylation, and as mentioned before 
reorganization of the structural and signaling components of the cytoskeleton 
(Paniccia, Colucci et al. 1993; Shankar, Davison et al. 1993; Zimolo, Wesolowski 
et al. 1994). Additional downstream effects of osteoclast integrin-mediated 
signaling are transcytosis, regulation of cell motility and induction of binding- 
related apoptosis (Ruoslahti and Reed 1994). Osteoclasts use transcytosis to 
remove degraded matrix from active sites of bone resorption, enabling the 
osteoclast to maintain the integrity of the enclosed resorption site and facilitate 
cell migration and penetration into bone (Nesbitt and Horton 1997; Salo, 
Lehenkari et al. 1997). Reports have suggested that the integrins a2Pi and avP3 
may also be involved in the uptake of the bone matrix at the ruffled border area 
(Nesbitt, Nesbit et al. 1993; Helfrich, Nesbitt et al. 1996). Some of the known 
osteoclast integrins, their ligands and potential functions are summarized below 
in Table 1-3.
Table 1-3 -  Osteoclast integrins, their ligands and respective function
Known/potential function
avP3
a2Pj
avPi
V itronec tin , osteopontin , 
bone sia loprote in , 
fib ro ne c tin , fibrinogen, 
dena tu red collagen 
Native collagens 
V itronec tin
M a trix  b ind ing 
Signal transduction  
Osteoclast po larization 
Cessation o f  reso rp tion* 
M a trix  b ind ing 
M a trix  b ind ing
* Potential function
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A diverse range of integrins have been shown to be expressed by osteoblasts 
(Table 1-4) particularly of the Pi class (Brighton and Albelda 1992; Clover, Dodds 
et al. 1992; Grzesik and Robey 1994; Ganta, McCarthy et al. 1997). However 
there is some contradiction between different studies which may reflect the 
heterogeneity of osteoblast-like populations that might show different pattern of 
integrin expression along the different stages of osteoblast differentiation. 
Functional studies have demonstrated that a2Pi binding to collagen leads to 
expression or up-regulation of markers of osteoblastic differentiation (Xiao, 
Wang et al. 1998). Others have shown that ligand binding by the a2 integrin 
modulates cell motility and contraction of collagen gels in vitro (Riikonen, 
Westermarck et al. 1995). Moreover, the osteoblast integrin a3Pi binds collagen, 
fibronectin and function-perturbing antibodies inhibiting the formation of 
mineralized nodules in rat calvarial osteoblast cultures (Moursi, Globus et al. 
1997). Finally, in vitro studies have shown that the selective fibronectin receptor, 
dspi, is expressed by osteoblasts, and it seems to be important in both cell 
survival (Globus, Doty et al. 1998) and mechanical sensing (Salter, Robb et al.
1997) for bone maintenance.
Osteoblast integrins
Table 1 -4 - Osteoblast integrins, their ligands and respective function
Osteoblast
Receptor
Ligand Function
0t2ßl Native cotlagens Matrix binding
aaßi Collagen, fibronectin Osteoblast mineralization
Osteoblast differentiation
Olsßl Fibronectin (RGD) Mechanical sensing
Osteocyte integrins
The ability of osteocytes to adhere and communicate within bone is crucial for 
the translation of biomechanical signals into chemical signals during bone 
mechanical sensing. Although there is a lack of knowledge in osteocytes 
integrins, some studies reported their ability to bind collagen type I, osteopontin, 
vitronectin, fibronectin and thrombospondin, however the exact integrin
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receptor for each ligand have not been yet identified (Table 1-5) (Aarden, 
Nijweide et al. 1996). Furthermore, expression of integrins avp3 and p3 by 
osteocytes has been suggested to be involved in their differentiation from 
osteoblasts and binding to bone matrix molecules (Bennett, Carter et al. 2001).
Table 1-5 - Osteocyte integrins and respective function
avp3, P3 Unknown
Function
Matrix binding 
Osteoblasts differentiation
1.3.4. Other important receptors in bone: RANK/RANKL, OPG, TNFR-1
Along with numerous cytokines and colony stimulating factors, the members of 
the Tumor necrosis factor (TNF) superfamily of ligands and receptors have a 
pivotal role in both the immune system and bone regulation (Hofbauer, Khosla et 
al. 2000; Lorenzo 2000).
RANKL/RANK
The receptor activator of NF-kB (RANK) ligand (RANKL) is a member of the TNF 
superfamily (Yasuda, Shima eta l. 1998) produced by osteoblasts in response to a 
variety of stimuli. This receptor is most commonly found as a membrane 
receptor, however a soluble form also exists (Simonet, Lacey et al. 1997; 
Teitelbaum 2000). RANKL plays an important role in osteoclasts development by 
interacting with its receptor RANK in osteoclast precursors (Nakagawa et al.,
1998). RANKL induces differentiation, formation, survival, and fusion of pre­
osteoclasts (Hsu, Lacey et al. 1999). In addition, RANKL has also been shown to 
mediate the actin ring formation during cytoskeleton rearrangement before 
resorption, and to activate mature osteoclasts to resorb bone (Lacey, Timms et 
al. 1998). In vivo studies revealed an increase in osteoclast formation and 
activation following administration of soluble RANKL to mice, leading to 
osteoporosis and hypercalcemia (Simonet, Lacey e ta l. 1997). On the other hand,
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RANKL knockout mice showed an increased in bone mass and impaired tooth 
eruption because of a lack of mature osteoclasts (Giuliani, Bataille et al. 2001).
OPG
Osteoprotegerin (OPG), also a member of the TNF superfamily, is a soluble 
receptor produced by osteoblasts and acts as an inhibitor of the RANK/RANKL 
interaction. Once released by osteoblasts OPG competes with RANK in binding 
RANKL, leading to the inhibition of osteoclast differentiation and activation 
(Simonet, Lacey et al. 1997). In addition, OPG has also been shown to neutralize 
the apoptosis inducing factor TNF-related apoptosis-inducing ligand (TRAIL) 
(Lacey, Timms et al. 1998; Khosla 2001). Studies in mice have revealed that OPG 
knockout mice develop severe osteoporosis, whereas the over-expression of 
OPG in transgenic mouse models and OPG treatment of normal mice leads to 
osteopetrosis (increased bone density) (Hsu, Lacey et al. 1999; Roodman 2001).
TNFR-1
The tumor necrosis factor receptor 1 (TNFR-1) is another member of the TNF 
superfamily and one of the major receptors for the tumor necrosis factor alpha 
(TNF-a). In bone TNFR-1 is expressed by both osteoblasts and osteoclasts (Bu, 
Borysenko et al. 2003). TNF-a signaling via interaction with the TNFR-1 plays an 
important role in the bone system as a potent osteoresorptive cytokine, 
stimulating the differentiation and activity of osteoclasts (Abu-Amer, Erdmann et 
al. 2000; Azuma, Kaji et al. 2000) and inhibiting osteoblast differentiation 
(Gilbert, He et al. 2000; Abbas, Zhang et al. 2003). TNFR-1 can also activate the 
transcription factor NF-kB, mediating apoptotic events, and function as a 
regulator of inflammation.
The signalling pathway following TNFR-1 engagement leads to the recruitment of 
several cytosolic molecules triggering two different pathways: cell survival via the 
activation of Nuclear factor Kappa B (NFkB) and cell death through caspase
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activation (Figure 1-7). NFkB represents a group of transcriptional factors 
controlling different biological processes such as immune and inflammatory 
responses, cellular growth and apoptosis (Ghosh and Karin 2002; Kalthoff 2009). 
On the other hand, Inhibitory kinase 3 (IkP) belongs to a family of cytoplasmic 
inhibitory proteins that regulate the translocation of NFkB from the cytoplasm to 
the nucleus. In resting cells, lk(3 binds to NFkB sequestering it on the cytosol, 
however when the TNFR-1 signalling pathway is activated, the complex TNFR-1- 
Tumor necrosis factor Receptor type 1-Associated Death Domain (TRADD) 
induces the degradation of Ikp allowing the translocation of NFkB to the nucleus 
where it will mediate the expression of genes ultimately involved in 
inflammatory responses, such as cytokines or chemokynes (May and Ghosh 
1997; Kalthoff 2009; Panzer, Steinmetz et al. 2009). TNFR-1 activation can also 
induce the binding of the adaptor Fas-Associated protein with Death Domain 
(FADD) in the cytosol, which is necessary for the cleavage of pro-caspases leading 
to the activation of executioner caspases that will sentence cell death (Srivastava
2007).
In 2004, Gomez et al showed that SpA from S. aureus has affinity to bind the 
TNFR-1 receptor triggering a signalling pathway that leads to inflammation, 
including cytokine release (Gomez et al., 2004). On the other hand, the release of 
cytokines such as IL-6 by osteoblasts has been shown to modulate bone 
resorption and osteoclastogenesis (Udagawa, Takahashi et al. 1995; Kwan Tat, 
Padrines et al. 2004).
Linking this together it is likely that bacterial bone infection may be involved in 
the stimulation of the TNFR-1 pathway leading to cytokine release and 
osteoclastogenesis and at the same time reducing osteoblast-mediated bone 
matrix production and mineralisation, characteristic of bone inflammation and 
bone destruction (Wright and Nair 2010).
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Stimuli followed by TNFR-1 
engagment
TNFR-1 
I  TRADD
V I
U
Pro caspases 
FADD
A
M
NFkB
Ikp
Gene expression 
Cytokine
Figure 1-7 - TNFR-1 signaling pathway. Engagement of cell surface receptor TNFR-1 triggers 
the recruitment of several cytosolic molecules leading to two different pathways: the 
apoptotic pathway, through the activation of executioner caspases or the NFkB signaling 
pathway triggering inflammation processes.
27
Chapter 1- General Introduction
Bone remodeling involves the coordinated effort of osteoblasts, osteocytes and 
osteoclasts. Together these cells ensure localized removal of old bone followed 
by replacement with newly formed bone (Figure 1-8). Normal bone remodeling is 
initiated by local events that lead to an increase in osteoclastic activity. This is 
followed by pre-osteoblast recruitment and differentiation into mature cells, 
which lay down new bone and repair the resorption defects caused by the 
resorbing osteoclasts. Formation follows resorption at the resorption site, and 
the amount of bone formed is almost equal to the amount of bone removed. 
Bone remodeling occurs to enable the bones to adapt to mechanical stress and 
to repair micro-damage maintaining its strength. Alterations in the remodeling 
process will result in metabolic bone disease (Bilezikian, Raisz et al. 2008). In 
adults, osteocytes are continuously replacing the surrounding calcium salts. 
While osteoclasts and osteoblasts activities are balanced: as quickly as 
osteoblasts form osteon, osteoclasts remove bone by osteolysis. In young adults, 
almost one-fifth of the adult skeleton is recycled and replaced each year. 
However not every part of every bone is affected equally: the rate of turnover 
differs regionally and locally, depending on the external forces or stimuli that 
bone senses in each area (Martini and Bartholomew 2003). Bone adjusts to 
different environments, and an inability to do so results in disease. The 
knowledge of bone remodeling physiology is important so that it can be 
manipulated to treat or prevent bone disease (Bilezikian, Raisz et al. 2008).
1.4. Bone re m o d e lin g
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Figure 1-8 -  Bone remodeling. Old bone is resorbed by osteoclasts, macrophages can be found at the remodeling site to remove the dead cells and debris. Finally 
osteoblasts precursors are recruited and after differentiating into mature osteoblasts secrete bone matrix that mineralizes and generates new bone (adapted 
from © Biomedical Tissue Research, University of York).
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Osteoclastogenesis is the 
process by which osteoclasts 
fully differentiate and become 
activated. In the earliest step of 
osteoclastogenesis, osteoclasts 
progenitors are recruited from 
hematopoietic tissues such as 
bone marrow to bone via 
circulating blood (Bilezikian, 
Raisz et al. 2008). The 
macrophage colony stimulating 
factor (M-CSF), and RANK are 
sequentially expressed as a 
requirement for the 
development of the mature 
osteoclast (Arai, Miyamoto et al. 
1999). Osteoclasts undergo 
proliferation in response to 
stimulation by the M-CSF 
(Takeshita, Namba et al. 2002) 
and following recruitment of 
RANK (Figure 1-9(B)). RANK then 
binds to its ligand RANKL
1.4.1. Osteoclastogenesis
A RANKL
YV opfi
C V . 5
Osteoblast precursor
RANK L/'OPG ratio 
high
Differentiation
Mature osleoblust
RANKL/OPCj 
ratio low
Osteoclast
precursor
Inhibition of
atteocJcnfformation Mature osteoclast
Figure 1-9 -  (A) RANK/OPG ratio during osteoblast 
differentiation; (B) RANKL - RANK interaction 
induces osteoclast differentiation and maturation; 
(C) OPG acts as an osteoclastogenesis inhibitor, by 
binding to RANKL and thus blocking the 
RANKL/RANK pathway (adapted from (Rogers and 
Eastell 2005)
expressed on the osteoblast surface (also called osteoclast differentiation 
factor). Finally the RANK-RANKL interaction promotes pre-osteoclasts 
differentiation and fusion, and formation of mature osteoclast, enabling 
osteoclasts to resorb bone (Petersen 2007).
At the end of the process of bone resorption, osteoclastogenesis is inhibited by 
the presence of OPG. As osteoblasts differentiate, the relative production of OPG 
compared with RANKL increases (Figure 1-9(A)). Therefore, OPG binds and
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neutralizes RANKL, inhibiting osteoclastogenesis (Figure 1-9(C)) and leading to 
osteoclast apoptosis which in turn allows the mature osteoblast to form new 
bone in the remodeling space following osteoclast resorption, completing the 
process of bone remodeling (Gori, Hofbauer et al. 2000).
1.4.2. Bone resorption
Once fully differentiated, osteoclasts undergo a series of morphological changes 
that compartmentalize the cell into a clear sealing zone and a ruffled border area 
(Figure 1-10). The sealing zone is rich in actin filaments and free of organelles 
and juxtaposed to the bone surface mediating the process of cell attachment 
(Holtrop and King 1977). The attachment mechanism is thought to be mediated 
via osteoclast integrins interaction with bone matrix proteins, such as the 
interactions between avp3 and avPi with vitronectin or between a2pi and native 
collagens (Vaananen and Horton 1995; Nakamura, Takahashi et al. 1996). The 
ventral membrane coming from the sealing zone is characterized by a highly 
folded membrane, the ruffled border area that harbours the secretory activity. 
From the sealing zone, osteoclasts pump an arsenal of lysosomal vesicles, 
protons and proteases and acid across the ruffled border into the resorption 
lacuna causing collagen destruction and mineral bone dissolution and a marked 
decrease of pH (Silver, Murrills et al. 1988; Horne 1995; Pietrzak 2008). 
Subsequently a secretory domain can be distinguished on the opposite side of 
the ruffled border, from where the resorbed material is released (Baron, Neff et 
al. 1990; Salo, Lehenkari et al. 1997; llvesaro 2001; Bilezikian, Raisz et al. 2008).
Sealing zone
Nuclei Ruffled border
Secretory domain
Resorption
lacuna
Figure 1-10 -  Model of bone resorption by osteodasts( adapted from (Bilezikian, Raisz et al. 
20081).
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1.4.3. Bone formation
Osteoblasts main function is to form bone. In this well-regulated process, 
osteoblasts regulate bone matrix maturation and mineralization by secreting 
membrane-associated alkaline phosphatase, bone matrix molecules such as, type 
I collagen and other non-collagenous proteins such as osteocalcin, osteopontin 
and bone sialoprotein (Bilezikian, Raisz et al, 2008). Also called osteogenesis, 
bone formation is initiated and propagated via the deposition of calcium 
phosphate crystals and the establishment of cytoplasmic connections between 
osteocytes and adjacent cells, which, respectively, make the matrix impermeable 
and ensure metabolic survival (Figure 1-11). During bone matrix formation the 
un-mineralized matrix defined as osteoid is converted into bone (Martini and 
Bartholomew 2003; Bilezikian, Raisz et al. 2008). Osteocytes are responsible for 
the bone matrix maintenance (Buckwalter, Glimcher et a i  1996).
Figure  1-11- Bone formation (adapted from www.hlghered.mcgraw-hill.com).
1.5. Bone disease
Disruption or impairment in the normal functioning of bone growth and 
maintenance results in a variety of bone diseases and disorders.
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Osteoporosis is a bone disease characterized by low bone mass and consequent 
increase in bone fragility and susceptibility to fractures (Meunier 1998; 
Klotzbuecher, Ross et at. 2000; Bilezikian, Raisz et at. 2008). Osteoporosis 
prevalence and incidence worldwide is difficult to establish as there are still 
uncertainties with its definition and diagnosis. However a 2007 World Health 
Organization (WHO) report states that osteoporosis is estimated to affect 200 
million women worldwide, approximately one-tenth of women aged 60, one-fifth 
of women aged 70, two-fifths of women aged 80 and two-thirds of women aged 
90 (Kanis 2007). Although the pathogenesis of osteoporosis is not fully 
understood, the characteristic bone loss is a direct consequence of an increase in 
the osteoclastic activity, whereby bone resorption raises thus weakening bone 
and leading to an augmented risk of fractures (Odell et at. 1993, Takano- 
Yamamoto et at. 1990, Tuukkanen et at. 1991). Therefore, a useful way to 
estimate osteoporosis prevalence is to use the fracture rates. The WHO 
estimates that one in three women and one in eight men over age 50 risk having 
an osteoporotic fracture during their lifetime. These fractures cause disability, 
loss of independence and loss of quality of life. Osteoporotic fractures are a 
major contributor to medical care costs around the world (Hardman and Stensel 
2009).
Osteoporosis is diagnosed by measurement of the bone mass density by X-ray. 
With age, the human skeleton loses bone density, therefore age is a risk factor 
for osteoporosis and prevention is very important mostly in elderly people. In 
women, estrogen is an important hormone for bone density maintenance, after 
menopause the levels of estrogen drop and may induce bone loss. Other strong 
risk factors for osteoporosis are family history of osteoporosis, medical 
conditions such as thyroid disease, rheumatoid arthritis and blocked calcium 
absorption (Weinstein and Buckwalter 2005; Qaseem, Snow etal. 2008). 
Osteoporosis can be classified according to different situations: appearing late in 
life, or due to hormonal insufficiency, disease of the bone marrow or reduced 
osteogenesis. All these forms of osteoporosis share an identical histological
1.5.1. Osteoporosis
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pattern, and only further clinical radiological tests allows the correct 
classification and further treatment administration (Adler 2000).
Treatment focuses on agents that reduce bone loss such as bisphosphonates 
which are potent inhibitors of bone turnover, together with calcium and vitamin 
D as supplements for the maintenance of bone strength. Hormone therapy has 
also been administrated for osteoporosis patients, however, several adverse 
effects have been observed. As inhibitors of osteoclast activity denosumab and 
calcitonin have also been administrated in osteoporotic patients acting by 
reducing bone resorption and consequently bone fractures (Hardman and 
Stensel 2009).
1.5.2. Septic arthritis
Septic arthritis is an infection of the joints accompanied by inflammatory 
destruction. The incidence of this disease ranges from 2 to 10 in 100,000. 
However, in rheumatoid arthritis patients or patients with prosthetic joints it 
may be as high as 30 to 70 per 100,000 (Goldenberg, 1998; Nade, 2003; Stott,
2001). It is more common in children than adults, and in males rather than 
females (Levine and Siegel, 2003). Moreover irreversible loss of joint function 
develops in 25 to 50 % of the patients (Yu, Bradley et al. 1992; Kaandorp, Van 
Schaardenburg et al. 1995; Kaandorp, Krijnen et al. 1997).
Septic arthritis is mainly caused by bacteria such as Staphylococcus aureus (Le 
Dantec, Maury et al. 1996; Ryan, Kavanagh et al. 1997), Streptococcus 
pneumoniae (Morgan, Fisher et al. 1996) or Streptococcus pyogenous (Schattner 
and Vosti 1998). The incidence of Haemophilus influenza as a cause is 
significantly decreasing (De Jonghe and Glaesener 1995). In addition, although 
relatively rare in Western Europe, the Grom-negative bacterial Neisseria 
gonorrhoeae is the most common cause of septic arthritis in the United States 
(Le Dantec, Maury et al. 1996; Ryan, Kavanagh et al. 1997). The infecting 
microorganisms infiltrate and proliferate within the joints triggering
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inflammation through the release of cytokines including IL-ip and IL-6 into the 
joint fluid (Koch, Lemmermeier et al. 1996) and by the recruitment of leukocytes 
(Goldenberg 1998; Nade 2003).
Most of the septic arthritis infections develop as result of haematogenous 
seeding of the vascular synovial membrane (Klein 1988; Morgan, Fisher et al.
1996). Bacteria can also gain entry secondary to penetrating trauma or after 
trauma to a joint. Moreover, direct introduction of bacteria in association with 
knee and hip replacement has increasingly been a source of infection (Nelson 
and Koontz 1966; Barton, Dunkle et al. 1987). Bacterial superantigens such as 
staphylococcal TSST-1 and the staphylococcal enterotoxins A contribute to the 
collagen breakdown and can lead to destruction of intra-articular cartilage and 
subchondral bone loss within days of infection (Goldenberg, 1998; Nade, 2003; 
Shirtliff and Mader, 2002; Stott, 2001(Bremell and Tarkowski 1995). The 
infectious process within the joint will result in increased pressure, which 
impedes blood and nutrient supply to the joint worsening joint damage and 
destruction (Shirtliff and Mader, 2002).
Treatment of septic arthritis requires appropriate antibiotic therapy together 
with drainage of the infected joint. Antibiotic therapy should be adjusted 
following identification of the causative microorganism by synovial fluid or blood 
culture isolation. Antibiotic administration can be oral or intravenous for 
duration of 2 days to 4 weeks. Drainage can be done by needle aspiration (Ho
1993), however an arthroscope (flexible tool fitted with a mini-camera and 
source light) is often used in knee or shoulders infections for better visualization 
and joint irrigation (Le Dantec, Maury et al. 1996; Morgan, Fisher et al. 1996). 
Open surgical drainage should be performed when conservative treatment fails. 
Early active motion exercises within the limits of tolerance will hasten recovery 
(Mathews, Kingsley et al. 2008; Garcia-Lechuz and Bouza 2009).
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1.6.1. Osteomyelitis definition
The word osteomyelitis derives from the ancient Greek words osteon -  bone, 
myelo - marrow and itis meaning 
inflammation (Sax and Lew 1999;
Baltensperger and Eyrich 2009).
The term osteomyelitis was first 
used by the French surgeon 
Edouard Chassaignac in 1852, who 
defined the disease as an 
inflammatory process
accompanied by bone destruction 
and caused by a pyogenic 
microorganism (Chassaignac 1852;
Mader, Mohan et al. 1997).
Infection is established when 
pathogenic microorganisms reach 
the bone, forming pus and 
oedema that compromise or obstruct the local blood supply (Figure 1-12). 
Following this, the infected bone forms an agglomerate of necrotic bone cells, 
defined as sequestrum, which is considered a classical sign of osteomyelitis 
(Topazian and Goldberg 1994). Infection can be limited to a single portion of the 
bone or it may involve several regions, such as marrow, cortex, periosteum, and 
the surrounding soft tissue. Infection takes place as a result of a large inoculation 
of pathogenic microorganisms from the blood stream, following trauma or in the 
presence of implanted devices with subsequent bone damage (Lew and 
Waldvogel 2004).
1.6.2. Different types of Osteomyelitis
Osteomyelitis can be classified according to the source of the infection. The 
infecting microorganisms can reach the bone by haematogenous delivery 
resulting from bacteraemia (bacterial infection of the blood stream); via local
1.6. O s te o m y e litis
Figure 1-12 -  Diagram of osteomyelitis infection 
bone caused by S. aureus infection.
(Illustration © Lydia V. Kibiuk, CMI 2010)
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invasion from a contiguous focus of infection when the infection is spread from 
local tissue (for example cellulitis); or by direct inoculation often following injury, 
surgery or implantation of a foreign body or secondary to vascular insufficiency 
(diabetic patients) (Berendt and Byren, 2004; Simon and Koenigsknecht 2001; 
Ciampolini and Harding, 2000; Goldenberg, 1998; Lazzarini et al., 2004; Lew and 
Waldvogel, 2004).
Haematogenous osteomyelitis
Haematogenous osteomyelitis is caused by direct seeding of bacteria from the 
bloodstream into the bone. It accounts for 20 % of all cases of osteomyelitis from 
which 85 % are diagnosed in children between 1 and 15 years of age. In which 
cases a minor trauma may cause a small hematoma followed by vessel 
obstruction ending in bone necrosis (Lew and Waldvogel 2004). In teenagers and 
in young adults it may be seen in those who play contact sports, and often 
associated with sickle cell anaemia (genetic blood disorder where the red blood 
cells assume abnormal and rigid shape). In adults, predisposing factors include 
advanced age, immunodeficiency, chronic bacteraemia, intravenous drug abuse, 
long-term indwelling catheters, and also sickle cell anaemia (Gentry 1997). In 
most cases it is usually originated by secondary infection where the bacteria 
gains access to the bloodstream subsequently seeding the bone. Infections can 
also reactivate from an inactive focus of haematogenous osteomyelitis 
developed during childhood (Brady, Leid eta l. 2008).
Depending on the site of infection, two types of haematogenous osteomyelitis 
can occur: long bone and vertebral osteomyelitis. Haematogenous osteomyelitis 
of the long bone is mainly diagnosed in children occurring as a single focus in the 
area of the long bones, while vertebral osteomyelitis is most common in older 
persons (Greenwood 2007). In haematogenous osteomyelitis of the long bone, 
the infection begins in the metaphysis (wider portion of the long bone adjacent 
to the bone edges) where the blood supply is denser. The tibia, femur and 
humerus are frequently involved; from where the infection may spread involving
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a larger part of the bone (Chan 1999). The blood flow in these areas is reduced 
allowing the bacteria to settle and colonize, further inducing an inflammatory 
response. However, because bone is a rigid structure, it does not allow swelling 
which greatly compromises the body immune defences. Therefore, following 
trauma a small hematoma is produced in the bone accompanied with vascular 
obstruction and consequent bone necrosis. As previously mentioned, the 
sequestrum is a group of necrotic bone cells formed after trauma. The scheme in 
Figure 1-13 is representative of a bone sequestrum formation; where (A) is 
healthy and (B) newly formed bone surrounded by (C) a contiguous layer of 
newly formed bone, the involucrum that delimits the (E) sequestrum. Abscess 
formation also takes place and it eventually ruptures into the surrounding soft 
tissues reaching the surface forming a sinus (D) (Morrissy and Haynes 1989). 
Finally sequestrum may detach from the surrounding tissues and migrate settling 
in another part of the bone.
B
D
Figure 1-13- Bone sequestrum  fo rm a tio n . Healthy bone (A); New bone (B); Involucrum (C); 
Sinus (D); Sequestrum (E) (adapted from Darland's Medical Dictionary for Health Consumers 
© 2007 by Saunders)
■  Clinical Features
In haematogenous osteomyelitis symptoms can present as fever, lethargy, 
tenderness over the infection site and decreased movement (Carek, Dickerson et 
al. 2001). In children sinus formation is not usually seen, but blood cultures are 
positive in more than half of patients (Lew and Waldvogel 1997). Symptoms are 
usually present for 3 weeks or less, but in some cases may persist for 1 to 3 
months duration. In adults vertebral osteomyelitis is most commonly seen, and
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most patients present with a constant pain that progress slowly. For reasons not 
fully understood, the cervical spine is often the site of infection in long-standing 
intravenous drugs abusers (Endress, Guyot et al. 1990).
Osteomyelitis secondary to a contiguous focus of infection
Osteomyelitis secondary to a contiguous focus of infection usually develops after 
trauma, bone surgery, or joint replacement. It can occur at any age and can 
involve any bone. However, in children, it occurs mainly as result of trauma or 
related surgery (Stott 2001), while in adults is more secondary to nosocomial 
contamination during surgical procedures (Wallace, Cinat et al. 1999). This is due 
to the fact that techniques for joint replacement have improved in the past 
number of years, and so the number of artificial joints implanted into patients 
inserted has increased dramatically. As a result of this the number of infections 
associated with prosthetic joints has also increased. Although the term 
contiguous focus implies that the infection stems from an adjacent soft tissue 
infection, chronic contiguous focus osteomyelitis can also begin as an acute 
infection, with the microorganisms being directly inoculated into the bone at the 
time of trauma (Healy and Freedman 2006)..
■  Clinical Features
In the initial stages osteomyelitis secondary to a contiguous focus of infection, 
patients usually present with pain, fever, swelling, and skin redness. However, 
during persistent chronic infection, fever drops, and pain and drainage from a 
sinus tract are often seen. Acute contiguous osteomyelitis infections after hip 
joint replacement may occur within the first few days or weeks after surgery, 
resulting directly from infected skin, subcutaneous tissue, or muscle. Chronic 
contiguous infections are usually diagnosed 6 to 24 months after surgery. 
Although most infections are probably introduced during surgery but remain 
quiescent, within sequestrum, for a long time (Laughlin, Armstrong et al. 1997).
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Osteomyelitis secondary to vascular insufficiency occurs most frequently in older 
patients with diabetes or severe vascular impairment (Lew and Waldvogel 2004) 
accounting for 30 % of all osteomyelitis cases (Brown and Neumann 2004). In 
almost all cases, infection follows a soft tissue infection that spreads to bone; 
often, in the small bones of the feet in patients in whom soft tissue breaks down 
over weight-bearing or pressure-bearing areas (Southwick 2003). Contributing 
factors for osteomyelitis development involve the metabolic consequences of 
diabetes such as bone and soft-tissue ischemia (blood supply restriction); and a 
combination of neuropathy, atherosclerotic peripheral vascular disease, and 
repetitive trauma (Brady, Leid et al. 2008). Limb ischemia, combined with 
restricted blood circulation, impairs wound healing in foot ulcers and allows for 
the contiguous spread of infection which consequently may contribute to the 
development of gangrenous scenarios and anaerobic infections. In addition, 
peripheral vascular disease may compromise the efficacy of antibiotic therapy by 
preventing the accumulation of adequate drug levels in the infected tissues.
Osteomyelitis should be considered in all diabetic patients with deep or chronic 
foot ulcers or infections. Twenty-five percent of diabetic patients with superficial 
mild to moderate foot infections develop bone infections, from which over 50 % 
will have osteomyelitis (Lipsky 1997). Moreover, debridement of the infected 
area is necessary, whereas two thirds of cases require bone resection or partial 
amputation (Ramsey, Newton eta l. 1999).
Osteomyelitis secondary to vascular insufficiency
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Figure 1-14- Foot X-rays films of an osteomyelitis patient. (A) March 1998 no obvious 
osteomyelitis; (B) September 1999, 5th toe is absent, destruction of the end of the 5th metatarsal, 
resorption of the end of the 4th metatarsal, destructive changes in the 4th proximal phalanx, and 
lack of cortical definition at the base of the proximal phalanx of the 2nd toe and the head of the 2nd 
metatarsal; (C) May 2000, shows demineralization and loss of bone mass with obvious 
inflammatory skin disintegration.
(http://www.circulatorboot.com/casehistory/casel98.html)
■ Clinical Features
Patients with generalized vascular insufficiency may present with an ingrown 
toenail, a perforating foot ulcer, cellulitis, or a superficial or deep wound 
infection. Fever and systemic signs of infection are not usually present (Brady, 
Leid et al. 2006). Diabetic patients present with either no pain (with advanced 
neuropathy) or excruciating pain (if bone destruction has been acute) (Southwick 
2008).
1.6.3. Acute and Chronic Osteomyelitis
Upon bacterial colonization when active bone infection takes place, there are 
three possible outcomes. The infection may resolve, may become an inactive 
recurrent infection, or may become a chronic infection with associated 
progressive bone destruction. Osteomyelitis can be therefore classified according
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to the clinical status related to the length of infection as acute, developing over 
days or weeks of disease onset, or chronic a long-standing infection that can last 
for months or even years.
Acute osteomyelitis
Acute osteomyelitis normally evolves over several days or weeks of disease onset 
(Jauregui 1995), presenting as a suppurative, or pus-forming infection 
accompanied by inflammation at the site of microbial colonisation (Dwivedi, Soni 
et al. 2011). Damage to bone matrix and compression and destruction of 
vasculature is also observed as the infection spreads to surrounding soft tissues, 
which can further exacerbate bone necrosis. Sequestrum may form and detach 
to form a separate infectious focus which, due to the lack of vasculature, is 
protected from immune cells and antibiotics (Lazzarini, Mader et al. 2004; Lew 
and Waldvogel 2004). Such areas of dead, infected tissues that are inaccessible 
to antimicrobials or the immune response can lead to a chronic persistence of 
the infection (Lazzarini, Mader etal. 2004).
Chronic osteomyelitis
Chronic osteomyelitis as opposed to acute is defined as long-standing infection 
that evolves over months or even years. In patients with acute haematogenous 
osteomyelitis, about 10 % will progress to a chronic condition characterised by 
the persistence of microorganisms, low-grade inflammation, and the presence of 
sequestrum (Norden, Nelson et al. 1992; Caputo, Cavanagh et al. 1994; Jauregui 
1995). Patients who are more susceptible to chronic osteomyelitis include those 
with relapses in the same area accompanied with fever (Norden, Nelson et al. 
1992), patients with open fractures and those for whom therapy was delayed. 
The presence of an implant is also associated with chronic osteomyelitis, 
whereby antibiotic treatment is frequently ineffective, and removal of the 
implant and debridement is often required (Ciampolini and Harding 2000). 
Relapsing cases of osteomyelitis episodes have been documented with
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reactivation fifty or even eighty years after the initial infection (Gallie 1951; 
Korovessis, Fortis et al. 1991; Greer 1993; Ciampolini and Harding 2000).
1.6.4. Osteomyelitis prevalence
Despite continued progress toward understanding its pathology and optimal 
management, osteomyelitis causes substantial morbidity and mortality 
worldwide (Haas and McAndrew 1996; Dwivedi, Soni et al. 2011). The overall 
incidence of osteomyelitis ranges between 1 in 5000 and 1 in 10,000 (Weichert, 
Sharland et al. 2008) and in the United States, neonatal prevalence is 
approximately of 1 case per 1,000. The prevalence of osteomyelitis after foot 
puncture can be as high as 16 % increasing between 30 and 40 % in diabetic 
patients (Zimmerli 2010).
Moreover the incidence of implant related osteomyelitis has increased over the 
past decade (Bozic and Ries 2005; Kurtz, Lau et al. 2008) with post-surgery 
infections occurring in approximately 1.2 % of primary surgery and 3 to 5 % 
following revisions (Kurtz, Lau et al. 2008; Bozic, Kurtz et al. 2009; Bozic, Kurtz et 
al. 2010; Urquhart, Hanna et al. 2010). As medical care improves also the aging 
population increases with increased demand for joint replacements. Therefore 
the total number of implanted related infections is estimated to rise from 17,000 
to 266,000 per year by 2030 (Bozic and Ries 2005; Kurtz, Ong et al. 2007; Kurtz, 
Ong etal. 2007; Kurtz, Lau etal. 2008).
1.6.5. Osteomyelitis diagnosis 
Histological examination
Diagnosis of osteomyelitis can be very difficult. The most important step in 
osteomyelitis diagnosis is to isolate the offending organisms so that the 
appropriate antimicrobial therapy can be chosen (Carek, Dickerson et al. 2001). 
The causative agent of osteomyelitis can be identified by histological 
examination, obtained from blood cultures, synovial fluid or by direct biopsy of
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bone (Jacobson and Sieling 1987; Howard, Einhorn et al. 1994). Histological 
examination can be carried by needle biopsy where a hollow needle is used to 
draw tissue from the infected area; or through an open biopsy, a small surgical 
procedure in which an incision is made through the skin in order to expose the 
infected area from where a sample will be taken (Pollard, McCracken et al. 
2004). However, material taken from an open infected area can give misleading 
results as the isolates may include non-pathogenic microorganisms that are 
colonising the site.
Laboratories studies
Although no laboratory test specifically indicates the diagnosis of osteomyelitis, 
standard laboratory indicators of inflammation such as the total white blood cell 
count, Erythrocyte Sedimentation Rate (ESR), and C-reactive protein, are all 
generally elevated (Kaplan 2005). Although it can be of clinical significance to 
monitor disease, ESR is considered of little value in the diagnosis of 
osteomyelitis, because increased results do not identify where the inflammation 
is in the body nor what is causing it, and also because it can be affected by other 
conditions besides inflammation (Perry 1996; Saadeh 1998; Lovell, Winter et al.
2006). C-reactive protein is synthesised by the liver in response to infection, and 
even tough testing for C-reactive protein is also non-specific, this test appears to 
be more reliable for follow-up of the response to treatment than ESR, as the 
concentration of C-reactive protein increases within hours of infection and 
returns to normal within a week after adequate treatment have begun in most 
cases (Unkila-Kallio, Kallio ef al. 1994; (Lovell, Winter etal. 2006).
Imaging procedures
Plain film radiographs or X-rays are the simplest and most common diagnostic 
tool used for diagnosis and follow-up of the bone-skeletal disease (Figure 1-15). 
X-rays pass radiation through the body onto a film. The radiation is absorbed by 
bones but not by soft-tissue like muscle and fat. So despite its limitations this
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m ethod  is used to  check fo r  narrow ing o r w idening o f jo in t spaces, bone 
destruction , and periosteal reaction (fo rm ation  o f new bone in response to  
in fection ). X-rays are also used to  measure bone mass o r the  w e igh t o f the  
skeleton (bone densitom etry) as the  am oun t o f bone in it determ ines its 
strength.
Figure 1-15 - X-ray images of healthy and infected bone with osteomyelitis. Tibia and fibula of 
an osteomyelitis patient, before infection (left side) and after infection (right side) (source: 
Encyclopaedia Britannica Online. Web. 20 Sep. 2011. Credit: Goran C.H. Bauer).
Com puted tom ography (CT) scan and M agnetic Resonance Imaging (MRI) 
are the  m ost com m on ultrasound im aging m ethods. They are useful fo r  the  early 
diagnosis o f osteom yelitis  and a llow  sim ultaneous evaluation o f bone and 
surround ing so ft tissues (Kaiser and Rosenborg 1994; Mah, LeQuesne et al.
1994). Both CT and M RI have excellent resolution pow er and can reveal bone  
destruction  as well as periosteal reaction, cortical destruction , articu la r damage, 
and soft-tissue involvem ent, even when conventional X-rays are norm al.
CT produces cross-sectional views o f parts o f the  body whereas the  x-ray 
beam  rotates around th e  patien t w ho has been injected w ith  a special dye to  
help the area o f the body to  re flect th e  x-ray beam. CT provides excellent 
d e fin itio n  o f cortical bone and a fa ir  assessment o f the  surrounding soft tissues. 
It is especially useful in iden tifica tion  o f sequestrum  and devitalized bone. 
H ow ever CT is prone to  image degradation, ow ing to  artefacts caused by the
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presence of bone or metal, but is nevertheless useful for guiding needle biopsy 
(Santiago Restrepo, Gimenez etal. 2003).
An MRI scan uses radio waves and a magnet to produce cross-sectional 
views of specific parts of the body and provides detailed information about soft 
tissue, bone marrow and bone marrow tumors. Furthermore, MRI is particularly 
reliable in distinguishing normal from abnormal areas when surgery is being 
planned for diabetic patients with osteomyelitis (Sammak, Abd El Bagi et al.
1999). However, the expense of MRI precludes its use on a routine basis.
MRI is more useful than CT for soft-tissue assessment and so, more 
effective to use for early detection of infection. Although MRI it is not helpful in 
assessing the response to therapy, given the persistence of oedema despite 
microbiological cure (Berendt and Byren 2004).
Positron Emission Tomography (PET) is a nuclear imaging technique that 
produces a three-dimensional image in the body by detecting pairs of gamma 
rays emitted indirectly by a positron-emitting radio-nucleotide which is 
introduced into the body on a biologically active molecule. PET has been used as 
an imaging tool for infections of the bone (Robiller, Stumpe et al. 2000). PET with 
fluorine- 18-fluoro-D-deoxyglucose (FDG) as a biologically active molecule has 
also been shown to be superior to normal bone scans in diagnosing chronic 
osteomyelitis of the central skeleton (Guhlmann, Brecht-Krauss et al. 1998; 
Zhuang, Duarte et al. 2000). Moreover FDG-PET combined with CT scan appears 
particularly promising for delineation of lesions and their concomitant 
inflammatory or infectious activity (Robiller, Stumpe et al. 2000; Schmitz, Kalicke 
et al. 2000).
1.6.6. Treatment of osteomyelitis
Osteomyelitis treatment depends on the stage of the disease when diagnosed. 
Following establishment of the causative microorganism, treatment includes 
antibiotic therapy and in most cases, debridement of the dead bone (Gitelis and 
Brebach 2002). A balance between medical and surgical therapy is needed for
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complete healing and total recovery from the disease state (Dougherty 1988; 
Snyder, Cohen et al. 2001).
Antibiotic therapy
Oral therapy brings obvious economic benefits: decreased hospital stay, reduced 
pharmacy and supply costs, no need for surgical insertion of a catheter, and thus 
decreased catheter-related complications. Nonetheless, intravenous 
antimicrobial therapy targeting the causative organism is also used as standard 
treatment for chronic osteomyelitis (Berendt and Byren 2004). Furthermore, 
antibiotic-impregnated acrylic beads have been used for local treatment of bone 
infections. Although the beads deliver a high concentration of antibiotic to the 
area of infection, bactericidal levels of antibiotic are present locally for only 2 to 
4 weeks. Thus, the beads are to be used in conjunction with systemic antibiotics 
(Gitelis and Brebach 2002). Both biodegradable and non-biodegradable beads 
have been used, and both require surgical placement. Non-biodegradable beads 
must be surgically removed after 2 to 4 weeks while the biodegradable do not 
require surgical removal and provide local bactericidal concentrations for 
extended periods (Calhoun and Mader 1997; Kanellakopoulou and Giamarellos- 
Bourboulis 2000).
Early antibiotic therapy produces the best results, whereby antibiotics must be 
administered for at least 4 to 6 weeks to achieve an acceptable rate of cure 
(Mader, Shirtliff et al. 1999; Lew and Waldvogel 2004). A summary of the 
antibiotic therapy for osteomyelitis patients is detailed below in Table 1-6.
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Table 1-6 -  Antibiotic treatment for osteomyelitis patients according to the respective infecting 
microorganism
S. aureus or coagulase 
negative methicillin sensitive 
staphylococci
S. aureus or coagulase 
negative methicillin resistant 
staphylococci 
Streptococci (groups A and B 
ß-hemolytic organisms or 
penicillin-sensitive 
Streptococcus pneumoniae 
Penicillin resistant S. 
pneumoniae
Enterococcus species
Serratia species or 
Pseudomonas aeroginosa 
Mixed aerobic and anaerobic 
organisms_________
Nafcillin, 
gatifloxacin or 
Clindamycin 
phosphate
(Norden, Bryant et al. 1986; Shirtliff, 
Calhoun et al. 2002; Kaplan 2005)
Vancomycin, (Bailey, Rybak et at. 1991; Eady and Cove 
rifampin 2003; Cohen and Grossman 2004)
Penicillin G (Bradley, Kaplan et al. 1998; Kaplan 2005)
Vancomycin
Ampicllin or 
vancomycin 
oxazolidinone
Ceftazidime
Amoxicillin-
clavulanate
(Friedland, Paris etal. 1993; Naktin and 
DeSimone 1999)
(Dresser and Rybak 1998; Till, Wixson et 
al. 2002)
(Sheftel and Mader 1986)
(Gadepalli, Dhawan etal. 2006; Brook 
2007)
Recently, few studies have Investigated the treatment of osteomyelitis. This is 
most likely due to the heterogeneity of the causing pathogens and clinical 
situations, and also due to the time line needed for disease follow up for results 
confirmation. Therefore, most recommendations for antibiotic treatment of 
osteomyelitis are based on the specific clinical scenario and medical opinion 
(Carek, Dickerson et al. 2001).
Osteomyelitis related to implanted devices
For implant-related staphylococcal osteomyelitis patients who have stable 
implants and symptoms of short duration, long-term treatment with the 
ciprofloxacin and rifampin has been successful (Zimmerli, Widmer et al. 1998). 
Moreover the use of ofloxacin together with rifampin for 6 months has also been 
showed to be efficient in diabetic patients with mild to moderate foot lesions 
associated with osteomyelitic bones (Senneville, Yazdanpanah et al. 2001).
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In acute haematogenous osteomyelitis, when diagnosed early and promptly 
administrated, the appropriate antibiotic therapy usually lasting 4 to 6 weeks, 
will be sufficient to treat infection (Berendt and Byren 2004). Children with acute 
osteomyelitis should receive two weeks of initial intravenous antibiotic therapy 
before the oral agent (Tetzlaff, McCracken et al. 1978; Mader, Mohan et al. 
1997). Cure rates of 95 % have been obtained in children administrated with 
intravenous antibiotic from 4 to 14 days and supplemented with oral therapy for 
14 to 26 days (Unkila-Kallio, Kallio et al. 1994). Surgical debridement is rarely 
recommended in acute haematogenous osteomyelitis in children, however, 
when patients do not respond to antibiotic therapy, surgery must be considered 
together with additional and prolonged antibiotic therapy (Mader, Ortiz et al. 
1996; Mader, Mohan et al. 1997). In adults with haematogenous osteomyelitis, 
abscesses drainage and surgical debridement are often necessary (Gentry 1997).
Chronic osteomyelitis
In chronic osteomyelitis, therapy generally couples antibiotic administration and 
surgical debridement. Depending on the type of chronic osteomyelitis, 
debridement of the necrotic area will be performed followed by the appropriate 
intravenous antibiotic administration during 2 to 6 weeks. Adequate 
debridement of the necrotic area is imperative for better results with the 
antibiotic therapy (Mader, Mohan et al. 1997; Carek, Dickerson et al. 2001).
Surgical therapy
As previously mentioned when antibiotic therapy fails, but also when the extent 
of infection and necrotic area requires, such in cases of chronic osteomyelitis, 
surgical debridement is essential for successful treatment. However, inadequate 
surgical debridement, regardless of antibiotic therapy, is the most common
Acute haematogenous osteomyelitis
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cause of treatment failure as sequestered dead bone might serve as a locus for 
persistent infection (Patzakis, Wilkins eta l. 1994).
During surgical therapy, following removal of the dead area it is necessary to fill 
the dead space created by debridement and re-establish the blood supply. 
Therefore, healthy bone grafts are commonly used to fill the wound and muscle 
used for the revascularization of the affected area. Antibiotic-impregnated beads 
are also used in order to prevent recurrence (Carek, Dickerson eta l. 2001)..
1.6.7. Osteomyelitis causative microorganisms
The pathogenic microorganisms isolated from patients with osteomyelitis are 
associated with the type of infection, age of the patient and with pre-disposing 
clinical condition (see Table 1-7). However, among the several infective 
microorganisms implicated in causing osteomyelitis, S. aureus is by far the most 
common, accounting for approximately 80 % of all cases of osteomyelitis (Cole, 
Dalziel et al. 1982; Ellington, Reilly et al. 1999; Lew and Waldvogel 2004). S. 
epidermidis is also an important cause of chronic osteomyelitis mostly related 
with prosthetic joint devices and intravascular catheters, and is commonly 
isolated from immuno-compromised patients, intravenous drug abusers, 
patients under immunosuppressive therapy, and premature newborns 
(Tacconelli et al., 1997; (Carek, Dickerson eta l. 2001).
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Table 1-7- Common infecting microorganisms recovered from different types of osteomyelitis 
and pre-disposing condition (Adapted from (Carek, Dickerson et al. 2001)
Type of Pre-disposing
Haematogenous
osteomyelitis
(commonly
monomicrobiotic)
Overall
5. aureus 60 % to 90 %
Gram-negative bacteria 25 %
(Lew and Waldvogel 2004; ßrady, Leid et al. 2008)
Newborn none
S. aureus, S. epidermidis, Streptococcus agalactiae, 
Escherichia coli, Group B streptococci and Grom- 
negative bacilli (Song and Sloboda 2001; Lew and 
Waldvogel 2004; Brady, Leid et al. 2008)
Children
none
S. aureus, Streptococcus pyogenes, and 
Haemophilus influenzae (Song and Sloboda 2001; Lew 
and Waldvogel 2004; Brady, Leid et al. 2008)
Sickle cell disease Salmonella (Paget, Gibofsky et al. 2005)
Urinary tract infection 
or instrumentation
S. aureus, Gram negative group B, Streptococci (Shirtliff 
ME 1999; Paget, Gibofsky et al. 2005)
Skin infection 5. aureus, Streptococci
Respiratory infection Streptococci, Mycobacterium tuberculosis
Adult
Intravenous drug 
abusers or vascular 
catheters
Gram negative bacilli, Staphylococci, Pseudomonas 
aeruginosa, Serratia species and Candida species 
(Holzman and Bishko 1971; Sapico 1996; Lew and 
Waldvogel 1997)
Sickle cell anemia 
Patients
Salmonella species (Sadat-Ali 1998) and Streptococcus 
pneumoniae (Brady, Leid et al. 2008)
Immunodeficient
patients
Candida species and Mycobacteria (Miller and Mejicano 
2001; Malani, McNeil etal. 2002)
Overall
5. aureus and coagulase-negative staphylococci 75 % 
(Mader, Ortiz et al. 1996).
Bone fractures
S. aureus, S. epidermidis, Gram negative bacilli (Laughlin, 
Armstrong et al. 1997)
Contiguous focus 
of infection
(poli-microbiotic)
Puncture wounds Pseudomonas aeruginosa, S. aureus, anaerobes
Prosthetic joints S. aureus, S. epidermidis
Skin ulcer
Staphylococci, Streptococci, Gram negative bacilli, 
Anaerobes
Sinusitis, Dental 
abscess
Streptococci, Anaerobes
Overall S. aureus
Vascular
Insufficiency
Diabetic foot
Staphylococci, Streptococci and Enterococcus species. 
Gram-negative bacilli, and anaerobes (Calhoun, Cantrell 
ef al. 1988; Berendt and Byren 2004; Rao and Lipsky 
2007)
Chronic or previously 
treated infections
Aerobic, mixed Gram-positive and Gram-negative bacilli 
(Calhoun, Cantrell etal. 1988)
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1.7. Staphylococci
1.7.1. Staphylococci biology
Staphylococci are round single cells with a 
diameter ranging from 0.5 to 1.5 pirn. 
Structurally they can be found in pairs, 
tetrads, short chains, but characteristically 
dividing In more than one plane forming 
grape-like irregular clusters (Figure 1-16). 
Bacteria from this genus are Grom-positive 
meaning that are protected by a thick cell 
wall, composed of layers of peptidoglycan, 
telcholc acid and lipotelchoic acid (Schlelfer 
and Kandler 1972; Ward 1981). Staphylococci
Figure 1-16 - Coloured transmission 
electron micrograph (TEM) of S. 
aureus bacteria undergoing cell 
division. Magnification: x 5,000 at 35 
mm size.
(http://www.sciencephoto.com/medi 
a/12804/)
are facultative anaerobes that grow most
rapidly under aerobic conditions and in the presence of C02 (Tegmark, Morfeldt 
et al. 1998). These microorganisms are also characterized as non-motlle, non- 
sporulatlng, catalase-posltlve and highly salt and lipid-tolerant. In addition, 
Staphylococci can be distinguished from other organisms by their ability to grow 
on manittol agar.
1.7.2. History and division into S. aureus and 5. epidermidis
Staphylococci were first seen by Koch in 1878 in human pus. Koch recognized 
that the presence of Grom-positive cocci clusters it was correlated with 
abscesses diseases. In 1880, the Scottish surgeon Alexander Ogston also verified 
that a cluster forming coccus was the cause of certain pyogenous abscesses. 
Shortly thereafter, in 1882, Ogston named that microorganism as Staphylococcus 
which became the name of the genus and derives from the Greek words 
staphyle, bunch of grapes and kokkus meaning berry or grain. The name of the 
genus correlates directly to its morphology; therefore, on microscopical 
examination, Staphylococci are presented as spherical grains organized in grape-
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like clusters. Two years later, Rosenbach distinguished two different species 
inside the genus based on the colonies pigmentation and the correspondent 
pathogenicity, whereby the golden colonies were the most pathogenic species 
and the white colonies less pathogenic. These were formally named as S. aureus 
and Staphylococcus albus, respectively, from the Latin "aureus"  meaning golden 
and "albus" meaning white. Since then, S. albus was renamed to 5. epidermidis, 
and today around 36 species of staphylococci are recognised (Gotz 2006). The 
measure of pathogenicity it was based on the bacteria ability to cause blood 
plasma clots via the expression of protein coagulase. Only a few staphylococcal 
species are coagulase-positive and in clinical practice, S. aureus is the only 
coagulase-positive species colonising humans. However, it is now known that 
this division into coagulase-positive and negative can be misleading in some 
cases, as some natural isolates of 5. aureus are defective in coagulase and as 
there is no direct evidence of coagulase as a virulence factor (Foster 1996).
Staphylococci are normally found on skin and mucous membranes of mammals. 
S. epidermidis is found on the skin of all humans and 5. aureus is found in the 
nose of more than 30 % of the healthy human population (van der Mee- 
Marquet, Achard et al. 2003).
1.8. S. aureus
S. aureus it was the first member of the 
Staphylococci genus to be identified, and as 
mentioned previously, is distinguished from the 
other staphylococci species on the basis of their 
golden colonies (Figure 1-17) and positive 
results of coagulase (Crossley and Archer 1997).
S. aureus is persistently carried by 30 % of the 
population and transiently found in 70 % (von 
Eiff, Becker et al. 2001; Kluytmans and
Figure 1-17 -  Coloured scanning 
electron micrograph (SEM) of 5. 
aureus bacteria. Credit: Juergen 
Berger, Science Photo Library.
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Wertheim 2005). S. aureus causes a very broad range of human diseases with 
many clinical manifestations. Infections associated with this microorganism 
include endocarditis, folliculitis, food poisonings, meningitis, osteomyelitis, 
scalded skin syndrome, skin abscesses and suppurative arthritis; and is therefore, 
considered the most virulent of the staphylococci, and consequently the main 
pathogen (Novick 1990; Lowy 1998; Crossley 2009).
1.8.1. 5. aureus virulence factors
The ability of S. aureus to colonise and survive within the host relies on its ability 
to express a large number of extracellular and cell-associated factors which 
contribute to its virulence and success as a pathogen.
1.8.1.1. Surface proteins
S. aureus expresses on its surface a wide range of cell-wall-associated proteins 
that provide attachment to various structures and surfaces. Some of them have 
been showed to play a central role in the colonization of the host and implanted 
biomaterials during invasive disease (Patti, Allen et at. 1994; Waldvogel 2000). 
Also called adhesins, these proteins share some structural characteristics: 
including a ligand-binding domain at the N terminal that is exposed on the 
bacterial surface enabling these proteins to function as adhesins; and at the C- 
terminal end, a hydrophobic region spanning the membrane with an LPXTG motif 
(Leu-Pro-X-Thr-Gly) that extends into the cytoplasm and allow it to be retained in 
the cell wall (Foster and McDevitt 1994). The LPXTG motif is recognized by 
sortase A (SrtA), a membrane-associated enzyme that cleaves the motif between 
the threonine and glycine residues. The liberated carboxyl group of threonine 
then forms an amide bond with the amino group of the peptidoglycan, tethering 
the C-terminus of the protein to the bacterial peptidoglycan (Schneewind, Fowler 
et at. 1995; Mazmanian, Liu et al. 1999; Ton-That and Schneewind 1999). 5. 
aureus mutants defective in expressing sortase A, fail to anchor several of the
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surface proteins on the bacterial cell wall, these strains have been shown to be 
less virulent in animal models of S. aureus infection (Mazmanian, Liu etal. 2000). 
Some of the 5. aureus surface proteins have been designated as microbial- 
surface components recognizing adhesive matrix molecules (MSCRAMM) for 
their ability to recognize and bind to extracellular proteins, such as collagen, 
fibrinogen and fibronectin (Ponnuraj, Bowden et al. 2003). The best 
characterised are protein A (SpA) (Forsgren and Forsum 1970; Uhlen, Guss et al. 
1984; Hartleib, Kohler et al. 2000), two fibronectin-binding proteins (Fnbps), 
fibronectin protein A (FnbpA) and fibronectin protein B (FnbpB) (Signas, Raucci et 
al. 1989; Jonsson, Signas et al. 1991; Greene, McDevitt et al. 1995), the 
fibrinogen binding proteins clumping factors A and B (ClfA and ClfB) (McDevitt, 
Francois et al. 1994; Ni Eidhin, Perkins et al. 1998) and a collagen binding protein 
(Cna) (Patti, Jonsson et al. 1992). Other MSCRAMMs include three members of 
the serine aspartate family (SdrC, SdrD and SdrE) (Josefsson, McCrea et al. 1998) 
and the bone sialoprotein-binding protein (Bbp) (an allelic variant of SdrE) (Tung, 
Guss eta l. 2000).
• Protein A
S. aureus protein A was the first S. aureus surface-associated protein to be 
characterised (Forsgren and Sjoquist 1966). Since its discovery, it has become the 
best studied and most widely used surface protein of Gram-positive bacteria.
SpA is expressed at high levels in 97 % of all S. aureus strains, (Forsgren 
and Forsum 1970; Fomenko 1980; Sanford, Thomas et al. 1986) and has been 
recognized as an important virulence factor of S. aureus (Palmqvist, Foster et al. 
2002; Fournier and Philpott 2005).
SpA is a 42 KDa protein composed of five Immunoglobulin (lg)- G (IgG) 
binding domains (E - C) lying at the N-terminus end followed by regions of the 
wall spanning region (W), membrane spanning region (M) (Figure 1-18) and the 
LPXTG motif at the C-terminus attaches SpA covalently to peptidoglycan layer 
following sortase cleavage (Uhlen, Guss et al. 1984).
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Figure 1-18 - Structural organization of SpA. S, Represents the signal sequence; E, D, A, B, C are 
the five IgG binding domains; Wr and Wc are the wall spanning regions; and M represents the 
membrane spanning region (adapted from (Burman, Leung etal. 2008)).
Structural analysis of a single domain revealed that each one of SpA domains 
comprise a triple helical bundle (Figure 1-19) (Gouda, Torigoe et al. 1992; Zhou 
and Karplus 1999; Zhou and Karplus 1999). SpA has been shown to interact with 
different immunoglobulins, such as IgG 1, 2 and 4, IgA, IgM and IgE (Deisenhofer 
1981; Inganas 1981; Langone 1982; Sasso, Silverman et al. 1991).
Figure 1-19 - Zhou and Karplus simulation of the folding of SpA that forms a triple helix 
bundle structure. (Zhou and Karplus 1999)
In serum, each one of SpA domains has the ability to bind the Fc region of IgG 
(Figure 1-20) (Uhlen, Guss et al. 1984). This SpA- IgG interaction impedes 
neutrophils to recognize IgG- Fc receptor therefore disrupting opsonisation and 
phagocytosis. In vitro experiments with S. aureus mutants lacking SpA have been 
shown to be more efficiently phagocytised by neutrophils than the WT 
(Gemmell, Tree et al. 1991). Moreover in vivo studies with a murine model of 5. 
aureus arthritis infection and experimental infection of mice with S. aureus WT 
and SpA defective mutants suggested that SpA enhances S. aureus virulence
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5. a u r e u s  surface
_  ,gGFc. SpA
IgG
(Patel, Nowlan et al. 1987; Palmqvist,
Foster et al. 2002). Furthermore, each 
individual domain of SpA has also the ability 
to interact with B lymphocytes via the VH3 
subclass of the Fab region of IgM molecules 
(Jansson, Uhlen et al. 1998) exposed on 
their surface and thus inducing B 
lymphocytes to proliferate and undergo 
apoptosis resulting in a significant depletion 
of the antibody secreting B cell repertoire (Figure 1-21) (Goodyear and Silverman 
2004; Viau and Zouali 2005).
Figure 1-20 -  Schematic
representation of the interaction 
between SpA on the bacterial surface 
with the IgG Fc receptor (Foster 2005).
Figure 1-21 -  Schematic representation of the interaction between SpA on the bacterial surface 
and the VH3 region of IgM Fab fragment on the surface of B lymphocytes (adapted from (Foster 
2005)).
In addition, SpA also binds to von Willebrand factor (vWf) which main function is 
to interact with platelets via Gplb-a receptor and immobilize them at the site of 
blood vessel damage stimulating clot formation. Thus when interacting with the 
vWf (A1 domain), SpA mediates the adherence between S. aureus and platelets 
or to damaged blood vessels (O'Seaghdha, van Schooten et al. 2006).
Finally, SpA has been shown bind to Tumor Necrosis Factor Receptor-1 (TNFR-1) 
inducing Tumor Necrosis Factor alpha (TNF-a) responses in epithelial cells and 
thus acting directly as an immune effector in the lungs and respiratory system 
(Gomez, Lee et al. 2004; Gomez, O'Seaghdha et al. 2006). In vivo studies 
demonstrated that TNFR-1 null mice are not susceptible to S. aureus pneumonia
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and S. aureus protein A defective mutants of do not cause infection in wild-type 
animals, emphasizing the role of SpA-TNFR-1 interaction in the pathogenesis of 
pneumonia.
• 5. aureus binder IgG (Sbi)
Sbi is a more recently discovered immunoglobulin binding protein from S. aureus 
and therefore denominated S. aureus binder IgG. Sbi has also been shown to be 
expressed at high levels in S. aureus strains 8325-4 and Newman (Zhang, 
Jacobsson et al. 1998). This protein is 45 KDa long and shares high homology with 
SpA via identical IgG binding properties. However, whereas SpA has the ability to 
interact with both Fc and Fab regions of IgG, on the other hand, Sbi only interacts 
with the IgG Fc region (Atkins, Burman et al. 2008). Moreover, Sbi lacks the 
LPXTG cell wall anchoring sequence, but it does have a predicted proline-rich cell 
wall spanning sequence (Wr) (Figure 1-22) and it has also been suggested to be 
attached to the S. aureus surface through electrostatic interactions (Zhang, 
Jacobsson et al. 1998; Bouma, de Groot et al. 1999).
‘  Y r
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Figure 1-22 -  Structural organization of Sbi. S, represents the signal sequence; I, II, III and IV
are the IgG binding domains; Wr, is the predicted cell wall spanning proline-repeat region; 
and Y, is the C-terminal tyrosine-rich region. Extracellular domains are represented in 
grayscale (adapted from (Burman, Leung et al. 2008)).
Sbi has been shown to interact with the binding protein p2-glycoprotein I (P2-GPI) 
also termed apolipoprotein H. p2-GPI is a plasma protein reported to have varied 
biological functions when bound to negatively charged lipids, such as promoting 
clearance of liposomes and foreign particles from the bloodstream (Chonn, 
Semple et al. 1992), and also in the inhibition of coagulation by affecting the 
activity of pro-thrombinase in platelets (Nimpf, Bevers et al. 1986). It is therefore
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suggested that S. aureus benefits from the Sbi- p2-GPI interaction in the 
attachment to host cells for intracellular growth and by inhibition of clot 
formation.
Recent studies show that Sbi is secreted from the S. aureus cell wall surface and 
binds to the human serum factor H. This interaction is enhanced in the presence 
of complement component C3 forming a tripartite complex. The complement 
component C3 binds to specific molecules of the immune system, being this 
interaction crucial in the induction of immunological memory and optimal 
antibody response (Nielsen and Leslie 2002; Rickert 2005). Therefore, formation 
of the tripartite complex Sbi-factor H-C3 will disrupt the natural complement 
activation of the immune response activated following infection, thus providing 
S. aureus a mechanism for evasion (Burman, Leung et al. 2008; Haupt, Reuter et 
al. 2008).
• Fibronectin binding proteins A and B (FnbpA and FnbpB)
Fibronectin is a high molecular weight glycoprotein (approximately 440 KDa) 
found in the plasma and body fluids such as cerebrospinal fluid and urine and 
also on many cell surfaces and extracellular matrix (Yamada and Olden 1978). 
Fibronectin is involved in several processes via direct interaction with different 
proteins such as collagen, heparin and fibrin. These processes include cell 
binding, spreading and cell alignment (Yamada and Olden 1978); growth, 
differentiation and migration processes (Tamura, Gu et al. 1998), including 
embryogenesis (George, Georges-Labouesse et al. 1993; Francis, Goh et al. 
2002), wound healing (Herard, Pierrot et al. 1996), blood coagulation, host 
defence (Magnusson and Mosher 1998) and metastasis (Akiyama, Olden et al. 
1995).
S. aureus binding to fibronectin is mediated by two related fibronectin-binding 
proteins, the FnbpA and FnbpB, expressed by most strains and encoded by two 
closely related but independently transcribed genes (Jonsson, Signas et al. 1991; 
Greene, McDevitt et al. 1995). The fibronectin proteins, as other MSCRAMMs,
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are anchored to the staphylococcal cell wall at the C- terminal LPXTG motif 
(Figure 1-23) and the ability to interact with fibrinogen, was first attributed to 
FnbpA repeat region D (Wann, Gurusiddappa etal. 2000).
LPXTG
D W M
Figure 1-23 - Structural organization of FnbpA. S, represents the signal sequence; W, 
represents the wall-spanning region; and M represents the membrane-spanning region and 
positively charged residues. LPXTG motif and the A-, B-, C- and D-domains are indicated, 
whereas the D-domains are the ligand-binding domains (Foster and Hook 1998; Fischetti
2000).
The FnbpA and FnbpB proteins have been shown to be crucial factors for the 
initiation of foreign body infection. In vitro studies with S. aureus mutants lacking 
the expression of both FnbpA and FnbpB showed completely defective binding to 
polymethylmethacrylate coverslips that had been coated with fibronectin and to 
coverslips that had been removed from tissue cages implanted subcutaneously in 
guinea-pigs. These results demonstrated that S. aureus Fnbps promote binding 
to fibronectin in both plasma clots and to ex vivo biomaterial that has been in 
long-term contact with the host (Greene, McDevitt et al. 1995; Vaudaux, 
Francois et al. 1995). In addition Fnbps also play a role in the adherence and 
invasion of mammalian cells, including epithelial (Sinha, Francois et al. 1999) and 
endothelial cells (Peacock, Foster et al. 1999). They recruit and bind fibronectin, 
by recognition of the host fibronectin receptor integrin a53i triggering the 
uptake of S. aureus by the host cells and thereby providing an evasion 
mechanism of the host immune system facilitating bacterial persistence 
(Peacock, Foster et al. 1999; Sinha, Francois et al. 1999).
The ability of 5. aureus Fnbps to bind fibronectin is crucial for S. aureus 
pathogenicity. The use of exogenous administration of recombinant fibronectin- 
binding domain has been showed to block this interaction therefore reducing the 
risk of staphylococcal abscess formation, preventing wound infection (Menzies,
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Kourteva et al. 2002). Also, an S. aureus isolate from a murine sepsis model 
whereas the gene encoding for Fnbps was knockdown demonstrated that the 
Fnbps are responsible for mediating systemic inflammation via IL-6 secretion, 
severe weight loss and mortality (Palmqvist, Foster et al. 2005). Moreover, 
studies with S. aureus clinical infective endocarditis isolates showed complete 
inhibition of platelet activation by the use of monoclonal antibodies specific to 
Fnbps. The same study demonstrated the formation of a bridge between 5. 
aureus Fnbps and fibronectin which in turn interacts with the platelet receptor 
Fey Rlla inducing platelet activation (Fitzgerald, Loughman eta l. 2006).
• Collagen binding protein
Collagen is the major insoluble fibrous protein in the extracellular matrix and in 
connective tissue, being the most abundant protein in mammals (Kreis and Vale
1999). There are several types of collagen, however, approximately 80 to 90 % of 
the collagen in the body consists of types I, II, and III (Lodish 1999). The various 
collagens types and structures and the interactions between collagen and non­
collagen molecules regulate the architecture of several tissues helping in 
withstanding and stretching (Heinegard, Hultenby etal. 1989; Lodish 1999).
5. aureus collagen binding protein Cna mediates bacterial binding to collagen 
substrates and collagenous tissues (Switalski, Speziale et al. 1989; Patti, Jonsson 
et al. 1992). The structural organization of Cna is represented in Figure 1-24.
LPXTG
B B B W M
Figure 1-24 - Structural organization of Cna. S, represents the signal sequence; W, represents 
the wall-spanning region; and M represents the membrane-spanning region and positively 
charged residues. The positions of the LPXTG motif and A and B- domains are indicated, 
whereas the A domain is the ligand binding domain (Foster and Hook 1998; Flschetti 2000).
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In vitro experiments have demonstrated that the cna gene is both necessary and 
sufficient for the binding of 5. aureus to cartilage (Switalski, Patti et al. 1993). Cna 
binding was shown to be a virulence factor in a rat experimental model of 
endocarditis and in a mouse septic arthritis model (Patti, Bremell et al. 1994). 
However, there was some contradictory data published from two separate 
studies. In one, nearly all of the strains causing infection were Cna positive 
(Switalski, Patti et al. 1993) while in the other study, the proportion of Cna 
positive was no greater in strains causing infection than in the control sample. 
The last one indicating that collagen binding is probably not a pre-requisite for 
these types of infection and also that the cna gene is only found in approximately 
50 % of the S. aureus strains (Ryding, Flock et al. 1997; Smeltzer, Gillaspy et al.
1997). Nevertheless, one year later, vaccination with Cna recombinant A domain, 
previously identified as Cna ligand-binding domain (Patti, House-Pompeo et al.
1995), was reported to provide protection against 5. oureus-mediated septic 
death (Nilsson, Patti etal. 1998).
•  Fibrinogen binding proteins- clumping factors A and B
Fibrinogen is the main protein of the blood coagulation system. It is 340 KDa 
large, composed of two identical subunits that contain three polypeptide chains: 
a, p and y (Doolittle 1984; Ruggeri 1993). Fibrinogen is the most abundant ligand 
for platelet interaction via the allbP3 integrin triggering platelet aggregation and 
formation of platelet-fibrin thrombi in vivo (Hawiger 1995). Fibrinogen clotting 
underlies the pathogenesis of thrombo-embolism and thromboses of arteries 
and veins.
5. aureus is known to form clumps in the presence of blood plasma, this is due to 
its ability to bind fibrinogen (Hawiger, Timmons et al. 1982). Fibrinogen is 
present in large amounts at wound sites and is quickly deposited on synthetic 
surgical material such as catheters (Foster and McDevitt 1994). Therefore, 
binding to fibrinogen is seen as a major primary virulence factor in S. aureus, 
especially in infections due to the presence of foreign bodies.
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5. aureus ClfA and ClfB have been primarily shown to be responsible for 
promoting cell clumping in the presence of soluble fibrinogen and to mediate 
adherence to immobilized fibrinogen and to ex-vivo biomaterial (McDevitt, 
Francois et al. 1994; Ni Eidhin, Perkins et al. 1998). However, S. aureus Fnbps can 
also promote cell-clumping in a solution of fibrinogen if expressed at sufficiently 
high levels (Wann, Gurusiddappa eta l. 2000).
The ClfA and ClfB are structurally related but they recognise different parts of the 
host ligand and might act synergistically allowing S. aureus to adhere more firmly 
to thrombi under flow conditions in the bloodstream. ClfA defective isogenic 
mutants have been shown to act as a virulence factor in a rat model of 
endocarditis and in a murine model of septic arthritis (Vaudaux, Francois et al. 
1995; Josefsson, Hartford et al. 2001). The clfA gene is present in almost all 5. 
aureus strains (Peacock, Moore et al. 2002), and its virulence has been related to 
its potent anti-phagocytic activity, whereas the A domain of ClfA strongly 
interferes with the binding of leukocytes to fibrinogen (Figure 1-25) (Vernachio, 
Bayer et al. 2003). The ClfB is only expressed during the exponential phase of 
growth under aerobic conditions (Ni Eidhin, Perkins et al. 1998) and despite of its 
fibrinogen binding function it has also been shown to promote in vitro adherence 
to immobilized epidermal cytokeratins and therefore playing a major role in the 
S. aureus nasal colonization (O'Brien, Walsh et al. 2002; Wertheim, Walsh et al.
2008).
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Figure 1-25 - Structural organization of 5. aureus ClfA and ClfB. S, represents the signal 
sequence; W, represents the wall-spanning region; R, represents the Ser-Asp dipeptide 
repeats and M represents the membrane-spanning region and positively charged residues. 
The positions of the LPXTG motif and the A domain are indicated, whereas the A domain is 
the ligand binding domain (Foster and Hook 1998; Fischetti 2000).
• Sdr family of proteins
The ClfA and ClfB are also members of Sdr family of proteins, these are 
structurally related S. aureus proteins characterized by the presence of the R- 
domain containing the tandem repeats of serine (Ser) and aspartic acid (Arp) (SD) 
dipeptides, however the number of SD repeats is variable from protein to protein 
(Josefsson, McCrea etal. 1998). S. aureus SdrC, SdrD and SdrE have a comparable 
structural organization (Figure 1-26), however, they are not closely related, with 
only 20 to 30 % identical amino acid residues suggesting that different Sdr 
proteins might have different roles in S. aureus pathogenicity. Some studies in 
another S. aureus protein from the Sdr family of proteins, the bone sialoprotein- 
binding protein (Tung, Guss et al. 2000), which is an allelic variant of the SdrE 
protein, have demonstrated that despite their similar structure, SdrE is not 
involved in binding to bone sialoprotein (McCrea, Hartford et al. 2000). The Sdr 
proteins have two, three, or five additional motifs that are tandemly repeated in 
SdrC, SdrE, and SdrD, respectively. These motifs bind Ca2+with high affinity and 
their structure unfolds when calcium ions are removed, still their function 
remains unclear. In alls, aureus strains at least two sdr genes are present 
(Josefsson, McCrea et al. 1998) and these always include the sdrC gene (Peacock,
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Moore et al. 2002). Therefore, the lack of sdr genes must be explained by the 
absence of sdrD or sdrE. Moreover, some studies described a strong correlation 
between S. aureus invasiveness and the presence of one of the allelic variants of 
the sdrE gene (Peacock, Moore et al. 2002). In addition, other studies reported a 
significantly higher prevalence of the sdrD gene in 5. aureus strains isolated from 
bone infections (Trad, Allignet et al. 2004).
SdrC
SdrD
SdrE
LPXTG
W M
W M
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Figure 1-26- Structural organization of S. aureus SdrC, SdrD and SdrE. S, represents the signal 
sequence; W, represents the wall-spanning region; R, represents the Ser-Asp dipeptide repeats 
and M represents the membrane-spanning region and positively charged residues. The 
positions of the LPXTG motif and the A and B domains are indicated (Foster and Hook 1998;
1.8.1.2. Capsule
The capsule or capsular polysaccharide is an important component of the S. 
aureus surface. In 1931, Isabelle Gilbert reported that production of capsular 
polysaccharide by S. aureus covered approximately 90 % of the S. aureus isolates 
(Gilbert 1931; Hochkeppel, Braun etal. 1987). S. aureus can produce 11 different 
capsular serotypes (Sompolinsky, Samra et al. 1985). The serotypes 5 and 8 are 
the most common, being found in respectively, 16 to 26 % and 55 to 65 % of all 
S. aureus human isolates (Arbeit, Karakawa etal. 1984; Sompolinsky, Samra etal. 
1985; Hochkeppel, Braun et al. 1987; Boutonnier, Nato et al. 1989), and 
accounting for 75 % of human infections (Lee 1996; Lowy 1998). The capsule 
forms a layer on the outer surface of the peptidoglycan layer in the bacterial cell 
wall. Its function is not clear but according to several reports it is thought to
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enhance staphylococcal virulence by impairing phagocytosis (Peterson, Wilkinson 
et al. 1978; Xu, Arbeit et al. 1992). In an endocarditis model it was suggested that 
the expression of capsular polysaccharide impeded colonization of damaged 
heart valves by S. aureus (Foster 1996). Moreover, in a mouse model of arthritis, 
mice inoculated with positive capsular polysaccharide strains had a higher 
incidence of arthritis and a more severe form of the disease than animals 
inoculated with the non-encapsulated mutant strain (Nilsson, Lee et al. 1997). 
Furthermore, in vitro experiments demonstrated that S. aureus capsule 
modulates adherence to endothelial cells promoting colonisation and 
persistence on mucosal surfaces in vivo (O'Riordan and Lee 2004).
The use of capsular polysaccharide vaccines serotype 5 and 8 in treating 
S. aureus infections has been reported (Fattom, Schneerson et al. 1990; Fattom, 
Sarwar et al. 1996; Tollersrud, Zernichow et al. 2001; Shinefield, Black et al.
2002) although the differential expression on capsular serotypes narrows their 
use and effectiveness and the inclusion of other antigens is essential for the 
development of an effective S. aureus vaccine.
1.8.1.3. Extracellular toxins
S. aureus produces several different types of toxins grouped on the basis of their 
mechanisms of action that are responsible for symptoms during infections.
Cytotoxins cause pore formation and induce pro-inflammatory events 
leading to cellular damage, thereby contributing to manifestations of the sepsis 
syndrome (Bhakdi and Tranum-Jensen 1991; Walev, Reske et al. 1995).
• Alpha-toxin (a-toxin) is a 34 kDa toxin composed of 293 amino acids 
(Bernheimer 1965) and is the best characterized and most potent cytotoxin of 5. 
aureus. It is a cytolytic pore-forming toxin secreted by almost all S. aureus strains 
into the extracellular environment as monomer that binds to the membrane of 
susceptible cells (Bhakdi and Tranum-Jensen 1991). Susceptible cells have a 
specific receptor for a-toxin which allows the monomeric toxin to oligomerise
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forming a ring-shaped heptameric waterfilled transmembrane pore (Valeva, 
Weisser et at. 1996; Fischetti 2000). In humans, platelets and monocytes are 
sensitive to a-toxin (Hildebrand, Pohl et al. 1991). They carry affinity sites which 
allow toxin to bind, following binding, a complex series of reactions triggers 
cytokines release leading to production of inflammatory mediators. These events 
are associated with the symptoms of septic shock that occur during severe 
infections caused by S. aureus (Novick 1990).
• Beta-toxin (P-toxin) is a catalytic enzyme secreted by S. aureus into the 
extracellular environment (Cohen and Van Heyningen 1982). 3-toxin causes 
invaginations of selected regions of the host cell membrane and is also 
leukotoxic. In human monocytes, beta-toxin inhibits migration and stimulates the 
release of Interleukin (IL) ip , IL-6 receptor and soluble CD14 (Walev, Weller et al.
1996). Impaired chemotaxis and Fc binding in neutrophils is also caused by beta- 
toxin. Although beta-toxin has been shown to contribute to S. aureus 
pathogenesis in a murine mastitis model (Foster, O'Reilly et al. 1988; 
O'Callaghan, Callegan et al. 1997) and in an ocular keratitis model (O'Callaghan, 
Callegan et al. 1997), its effects are thought to be less significant than those from 
alpha-toxin.
• Gamma-toxin (y-toxin) and Leukocidin are bicomponent toxins that 
damage membranes of susceptible cells. These toxins are expressed separately 
but act together to damage membranes. The Panton and Valentine (PV) 
leukocidin is released by some S. aureus strains and is strongly associated with 
severe skin infections such as furunculosis and is active against both human and 
rabbit leukocytes (Prevost, Cribier et al. 1995). On the other hand, y -toxin is 
active against erythrocytes, and is thought to attack cells by inducing pore 
formation (Ozawa, Kaneko et al. 1995).
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1.8.1.4. Epidermolytic toxin
S. aureus expresses two distinct forms of the epidermolytic or exfoliative toxin. 
Both have been implicated in Staphylococcal Scalded Skin Syndrome (SSSS) in 
neonates and children with skin erythema and loss of epidermidis. The SSSS is 
characterized by blisters formation and a widespread of epidermal splitting 
(Bailey, Lockhart et al. 1995). It is possible that these toxins target a very specific 
protein which is involved in maintaining the epidermis integrity, however, their 
mechanism of action remains controversial (Cribier, Prevost etal. 1992).
1.8.1.5. Superantigens
S. aureus expresses two different types of superantigen activity toxins: 
enterotoxins, of which there are approximately nine serotypes and the Toxic 
Shock Syndrome Toxin-1 (TSST-1) (Ulrich, Bavari et al. 1995). The enterotoxins 
are responsible for staphylococcal food poisoning causing nausea, diarrhea and 
vomiting (Harris, Grossman et al. 1993). The TSST-1 is responsible for 75 % of 
Toxic Shock Syndrome (TSS), whereas patients present with fever, rash and 
desquamation during convalescence and have involvement of at least three 
additional organs systems. TSS can be caused by S. aureus TSST-1 expressing 
strains colonising the vaginal or cervical mucosa (menstrual form); or mediated 
by either TSST-1 or enteroxins affecting other areas in the body (non-menstrual). 
These superantigens can bind to Major Histocompatibility Complex (MHC) class II 
proteins and stimulate T cells non-specifically, inducing massive cytokines 
release, causing the symptoms of toxic shock syndrome and certain autoimmune 
diseases (Marrack and Kappler 1990; Schlievert 1993). These toxins are known 
for their potency and severely debilitating effects (Ler, Lee et al. 2006) and are 
effective at picogram per litre concentration (Fraser and Proft 2008).
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The staphylococcal cell wall is mainly 
composed of peptidoglycan and 
teichoic acid making up, respectively, 
about 50 to 60 % and 30 to 50 % of 
the dry weight (Figure 1-27) (Schleifer 
and Kandler 1972). Peptidoglycan is 
therefore, the main structural 
polymer in the wall and consists of 
alternating polysaccharide subunits of 
3-1,4 linked N-acetylmuramic acid 
(MurNAc) and N-acetylglucosamine 
(GlcNAc). The peptidoglycan chains 
are crossed- linked by tetrapeptide 
chains bound to N-acetylmuramic acid 
and by a pentaglycine bridge specific for S. aureus (Schleifer 1973). The cell-wall 
teichoic acid of S. aureus is a water-soluble polymer covalently linked to the 
peptidoglycan acid. The peptidoglycan biological activities have been associated 
with inflammatory skin reaction, stimulation of cytokines release by 
macrophages, inhibition of leukocyte migration and adjuvant and complement 
activation (Franken, Seidl et al. 1984). The major cell wall component of S. 
aureus, has also been reported to cause pro-inflammatory responses and 
platelet aggregation in the host, leading to disseminated intravascular 
coagulation in cases of severe septicaemia (Kessler, Nussbaum et al. 1991) and to 
induce tissue factor expression in monocytes activating the coagulation cascade 
(Mattsson, Herwald et al. 2002). S. aureus peptidoglycan is also recognized by 
the toll-like receptor 2 (TLR2) (Yoshimura, Lien et al. 1999; Kyburz, Rethage et al.
2003). In fewer amounts there is also the lipoteichoic acid (LTA) a glycerol 
phosphate polymer linked to a glycolipid terminus anchored in the cytoplasmic 
membrane, that has been reported to activate immune cells via TLR2, 
lipopolysaccharide (LPS)-binding protein (LBP) and CD14 (Morath, Stadelmaier et 
al. 2002; Schroder, Morath et al. 2003).
I.8.I.6. Cell Wall
Cytoplasm
Figure 1-27 -  Schematic drawing of the S. 
aureus cell wall composition (adapted 
from (Swoboda, Campbell et al. 2010)).
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S. epidermidis (Figure 1-28) is the most 
frequently isolated species of coagulase- 
negative staphylococci. It is distinguished 
from 5. aureus for its inability to produce 
coagulase and also by their characteristic grey 
to greyish-white colonies as opposed to the 
yellowish 5. aureus colonies (Balows 1992).
For a long time, S. epidermidis was considered 
as a non-pathogenic organism, but it is now 
recognised as the most widespread and 
persistent microorganism colonizing the skin and mucous membranes of the 
human body, representing a major part of the human micro-flora accounting for 
65 to 90 % of all staphylococci isolated from these environments (O'Gara and 
Humphreys 2001; Vuong and Otto 2002). S. epidermidis has become the most 
important pathogen associated with nosocomial bloodstream infections, 
cardiovascular infections and foreign body device infections (Kloos and 
Bannerman 1994; Vuong and Otto 2002). In contrast to S. aureus, S. 
epidermidis does not usually cause pyogenic infections due to its distinctly 
reduced arsenal of toxins compared to S. aureus. Infections caused by S. 
epidermidis are often persistent and relapsing, however, S. epidermidis requires 
a predisposed host in order to cause infection, and therefore it is described as an 
opportunistic pathogen. Compromised patients, such as drug abusers and 
¡mmuno-compromised patients and also premature newborns are the main risk 
group, whereas the main port of entry for these infecting microorganisms is the 
intravascular devices (Tacconelli, Tumbarello et al. 1997; Domingo and Fontanet 
2001).
1.9. S. e p id e rm id is
Figure 1-28 - Scanning electron 
microscopy of S. epidermidis 
arranged in grape-like clusters. 
Credit: David Scharf, Science 
Photo Library
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The success of S. epidermidis as a pathogen is associated with its ability to 
adhere and accumulate onto surfaces, under the cover of a self-produced 
extracellular substance (Vuong and Otto 2002). This process is refered to as 
biofilm formation and is considered as one of the important pathogenic factors 
of S. epidermidis in indwelling devices infections (Raad, Alrahwan et al. 1998). A 
summary of some of the S. epidermidis virulence factors and respective functions 
is showed below in Table 1-8.
1.9.1. S. epidermidis virulence factors
Table 1-8 -  Virulence factors of S. epidermidis (Adapted from (Otto 2009)).
Virulence factor I Function
Attachment of the bacteria to the foreign material direct and via host matrix proteins
AtlE Abundant autolysin and adhesin that affects surface 
hydrophobicity and binds to fibrinogen, fibronectin and
Aae
vitronectin
Autolysin and adhesin that binds to fibrinogen, fibronectin and 
vitronectin
SSP-1 and SSP-2 Present in fimbria-like appendages (unknown ligand)
Teichoic acids Enhances binding to fibronectin
Attachm ent o f the bacteria to  the foreign m aterial via host matrix proteins
SdrF Binds to collagen
SdrG Binds to fibrinogen
Biofilm formation
PIA Intracellular polysaccharide adhesin
Extracellular proteins
Cysteine protease Degradation of several host matrix proteins and components of 
the immune system
Accumulation-associated Contributes for the accumulative growth on polymer surfaces
protein Aap
Lipases Skin colonization
FAME Detoxification of bactericidal fatty acids, destroys bactericidal 
properties
Toxins
Delta-toxln Lysis of erythrocytes; Pro-inflammatory cytolysin
Lantibiotics
1 Lantibiotics Anti-bactericidal activity
1.9.1.1. Biofilm
S. epidermidis biofilm formation is thought to protect the bacteria from host 
defence mechanisms and antimicrobial agents (Hoyle and Costerton 1991; 
Costerton, Stewart et al. 1999; König, Schwank et al. 2001; Stewart and 
Costerton 2001). Furthermore, 5. epidermidis growth adapts to the biofilm mode,
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with down-regulation of basic cell processes such as nucleic acid, protein and cell 
wall biosyntheses (Yao, Sturdevant et al. 2005). These changes may directly 
affect antibiotic activity in targeting S. epidermidis biofilms (Konig, Schwank et al. 
2001).
In foreign device infections two different steps occur, firstly the 
attachment of the bacteria to the foreign material followed by biofilm formation 
(Mack, Nedelmann etal. 1994).
Bacterial attachment to the foreign material
The first stage of bacterial adherence to the foreign material is mediated by the 
physiochemical properties, hydrophobicity and surface charges of the foreign 
material (Vuong and Otto 2002). Within this first step, S. epidermidis can colonize 
the implanted material either by direct attachment of the bacterial cells to the 
foreign device, or by binding the host matrix proteins, previously coated onto the 
foreign material (Gottenbos et al., 2000).
When bacteria binds directly to the implanted material, a variety of 
factors such as the major autolysin E (AtlE) (Heilmann, Gerke et al. 1996; 
Heilmann, Hussain et al. 1997), the teichoic acids (Gross, Cramton et al. 2001; 
Vuong and Otto 2002) and the S. epidermidis surface proteins (SSP) 1 and 2 
(Veenstra, Cremers etal. 1996; Fischetti 2000) can be involved.
On the other hand, when bacteria attaches to host matrix proteins 
previously coated on the implanted device, binding occurs via MSCRAMMs, 
considered significant virulence factors of S. epidermidis. The most important 
include the covalently anchored fibronectin binding protein (Fbe) also 
denominated serine-aspartate repeat protein G (SdrG) (Davis, Gurusiddappa et 
al. 2001; Hartford, O'Brien et al. 2001) that has been demonstrated to bind 
fibrinogen and the serine-aspartate repeat protein F (SdrF) that has been 
reported to bind collagen (Arrecubieta, Lee et al. 2007). Moreover, the non- 
covalently bound AtlE and autolysin-adhesin E (Aae) even though with a less- 
specific interaction, can also bind to fibrinogen, fibronectin and vitronectin 
(Heilmann, Hussain et al. 1997; Heilmann, Thumm et al. 2003). Finally the
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teichoic acids for their ability to enhance binding to immobilized fibronectln 
(Hussain, Heilmann et al. 2001) have been also reported to play a role in S. 
epidermidis binding to host extracellular matrix proteins.
Biofilm formation
After the initial binding to the foreign material, biofilm formation develops as 
multilayered S. epidermidis cell clusters linked by a slimy extracellular substance 
that supports cell to cell binding (Figure 1-29) (O'Toole, Kaplan et al. 2000). This 
process requires intercellular binding, provided by the Polysaccharide 
Intercellular Adhesin (PIA) which has been suggested to be a crucial for the 
biofilm accumulation process (Mack, Siemssen et al. 1992; Mack, Nedelmann et 
al. 1994). PIA is a homoglycan molecule located on the S. epidermidis surface as 
fibrous strands and is an important component of the extracellular matrix 
connecting the bacterial cells in a biofilm. Several studies emphasized the role of 
PIA as a virulence factor when in animal models a PIA negative mutant revealed 
reduced ability to cause infection when comparing with the wild-type bacteria 
(Rupp, Ulphani et al. 1999; Rupp, Ulphani et al. 1999; Rupp, Fey et al. 2001; 
Francois, Tu Quoc et al. 2003; Fluckiger, Ulrich et al. 2005; Chokr, Leterme et al. 
2007).
Attachment via host 
Direct attachment matrix proteins
Cell to cell „ . Biofilm . . .  . Blofilm maturation adhesion via PIA detachment
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Bacterial attachment to the foreign material Bacterial blofilm formation
Figure 1-29-S . epidermidis biofilm formation (adapted from (Otto 2009)).
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1.9.1.2. Surface proteins 
Fbe/SdrG
The serine-aspartate repeat-containing protein G (SdrG) also known as 
fibrinogen-binding protein (Fbe) is the most intensively studied MSCRAMM and 
the most predominant fibrinogen-binding protein on S. epidermidis (Otto 2009). 
Being present in approximately 67 to 91 % of the clinical strains tested (Arciola, 
Campoccia et al. 2004; Brennan, Loughman et al. 2009) this protein that belongs 
to the sdr family of proteins and has been described as necessary and sufficient 
to promote bacterial attachment to both soluble and immobilized forms of 
fibrinogen in a dose-dependent manner. SdrG binds to the thrombin cleavage 
site in the fibrinogen using a 'dock, lock and latch' mechanism (Ponnuraj, 
Bowden et al. 2003) which is thought to stabilize the SdrG -fibrinogen 
interaction. SdrG antibodies are present in human blood (McCrea, Hartford et al.
2000) and in vivo environment expression of SdrG has been shown to increase 
(Sellman, Timofeyeva et al. 2008). Moreover, SdrG has also been implicated in 
promoting central venous catheter-associated infection in vivo (Guo, Zhao et al.
2007). For these reasons SdrG is considered a major factor for S. epidermidis 
infection.
Several additional S. epidermidis MSCRAMMs have been predicted and 
have undergone preliminary characterization (Bowden, Chen et al. 2005), 
although their role in matrix protein binding and virulence remains to be 
clarified.
1.9.1.3. Extracellular proteins
5. epidermidis has been described to secrete a cysteine protease (Sloot, Thomas 
et al. 1992) implicated in the degradation of several host matrix proteins and 
components of the immune system in vitro. Also the extracellular Accumulation- 
Associated Protein (AAP), has been shown to be contribute for the accumulative 
growth of 5. epidermidis on polymer surfaces (Hussain, Herrmann et al. 1997). 
Other studies also suggested that two very similar lipases found in S. epidermidis
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might be important for skin colonization (Longshaw, Farrell et al. 2000). 
Moreover the Fatty acid modifying enzyme (FAME) secreted by S. epidermidis 
seems to work by esterifying fatty acids to cholesterol and thereby destroying 
their bactericidal properties (Chamberlain and Brueggemann 1997).
Toxins
In contrast to the vast toxin repertoire of S. aureus and many other bacteria, S. 
epidermidis toxin production is limited to the haemolytic peptide delta- 
toxin (McKevitt, Bjornson et al. 1990) implicated in the lysis of erythrocytes by 
forming pores in the cytoplasmic membrane (Gemmell and Thelestam 1981). 
Moreover, S. epidermidis delta-toxin (6-toxin) has been showed to contribute to 
sub-acute and chronic infections by S. epidermidis (Vuong and Otto 2002; Otto, 
O'Mahoney et al. 2004). Although the biological role of this toxin deserves 
specific further investigation, 6-toxin has also been reported to take part on 
inflammatory response modulation for its involvement in cytokine and NFkB 
production in cells of macrophage lineage (Mehlin, Headley et al. 1999).
Lantibiotics
Some S. epidermidis strains produce lantibiotics which are extremely stable 
antibacterial peptides (Fischetti 2000) that seem to play an important role in 
bacterial interference on skin and mucous membranes by the exclusion of 
competing microorganisms sensitive to their bactericidal activities (Bierbaum, 
Gotz et al. 1996).
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1.10. Bone Infection
Osteomyelitis involves bone inflammatory destruction and is mainly caused by S. 
aureus  and S. ep iderm id is . This infectious disease is painful, debilitating and 
associated with serious morbidity and often difficult to diagnose (Berendt and 
Byren 2004). Moreover, due to the rise of antibiotic resistance, treatment is 
increasingly difficult. In addition, the number of prosthetic joint replacement 
procedures is also increasing providing new opportunities for the development 
of new infections (Wright and Nair 2010). Therefore, a lot of studies have been 
undergoing in order to understand the mechanisms by which Staphylococci 
interacts and destroys bone.
Microbiological virulence and osteomyelitis
Several studies investigated the correlation between Staphylococci virulence 
factors and invasive bone disease. A combination of virulence factors such as 
adhesins and toxins or genes involved in biofilm formation were associated with 
invasive bone disease, and increased severity of infection (Peacock, Moore e t al. 
2002). In 2004, a study from a range of orthopaedic infections, identified the 
genes fn b A  and fn b B  encoding for the 5. aureus  fibronectin-binding proteins 
FnbpA and FnbpB in 98 % and 99 %  of the clinical isolates, respectively. On the 
other hand, the cna  gene encoding for the collagen-binding protein was present 
only in 46 % of the isolates (Arciola, Campoccia e t  al. 2004). Another study 
identified the gene encoding for the Panton-Valentine leukocidin in 59 of 89 S. 
aureus  isolates and suggested an association between this virulence factor with 
enhanced inflammatory response in a case of haematogenous osteomyelitis in 
children (Bocchini, Hulten e t a l. 2006). However, a major problem associated 
with these findings is that there was no report of strain typing, so it is unclear 
how representative they are around the world. Therefore, there is a lack of 
knowledge related to the association of specific microbiologic genetic features 
and bone infections.
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Bacterial colonization is not sufficient to cause infection, and many surgical 
wounds become contaminated but not all undergo infection. The wound location 
can be limited to the medullary surface of bone, or exposed in the bone surface 
at the base of the wound, but it can also be localized in a cortical sequestration 
that can be removed without compromising bony stability or it can be diffused 
requiring resection of bone and loss of stability. On the other side, the host 
predisposition is also important in the development of infection, if it is 
systemically compromised such as in cases of malnutrition, renal failure, and 
diabetes, immune disease or even if the treatment is worse than the disease.
Molecular mechanisms underlying bone inflammation and destruction
Osteoblasts are known to modulate osteoclast differentiation and activity 
through the interaction between RANK expressed by osteoclasts and its ligand 
RANKL expressed by osteoblasts (Henderson and Nair 2003; Matsuo and Irie
2008). Following RANK-RANKL interaction a signalling pathway is triggered 
activating a number of transcription factors including the NFkB which ultimately 
will end in osteoclast differentiation (Wada, Nakashima e t  al. 2006; Matsuo and 
Irie 2008). On the other hand if OPG, an endogenous inhibitor of RANKL 
signalling, is present it will function as a decoy receptor for RANKL blocking the 
interaction with RANK and therefore inhibiting osteoclastogenesis (Yasuda, 
Shima e ta l .  1998; Wada, Nakashima e ta l .  2006).
Staphylococci induction of cytokine production after infection has also 
been reported as an evidence of bone inflammation and destruction in 
osteomyelitis disease. The inflammatory cytokines TNF-a and IL-6 seem to be 
greatly involved in bone physiology and pathology (Kwan Tat, Padrines e t  al.
2004) as high levels of these cytokines were identified to be up-regulated locally 
and systemically in cases of acute osteomyelitis (Klosterhalfen, Peters e ta l .  1996; 
Evans, Jellis e t  a l. 1998), in rats experimentally implanted with S. aureus  infected 
needles (Garcia-Alvarez, Navarro-Zorraquino e t al. 2009) and in a murine model 
of osteomyelitis (Yoshii, Magara e t al. 2002). The mechanism by which
Host physiology and predisposition
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Staphylococci induces the release of these cytokines is not clear; however the 
effects of it are highly implicated in osteomyelitis pathology. The release of IL-6 
by osteoblasts in response to S. aureus infection has been reported (Ishimi, 
Miyaura e t al. 1990; Bost, Ramp e t al. 1999), and further associated with the 
increase of bone resorption by direct stimulation of osteoclasts differentiation in 
a mouse model (Ishimi, Miyaura e t al. 1990). In a murine model following LPS 
injection, deletion of TNFR-1 and TNFR-2 receptors has been demonstrated to 
decrease osteoclast number and bone resorption (Chiang, Kyritsis e t al. 1999). 
Several investigations with different cell-types have demonstrated that TNF-a 
inhibits osteogenesis (Lacey, Simmons e t al. 2009) and suppresses the 
production of osteogenic markers such as osteonectin, osteopontin, type I 
collagen, osteocalcin and alkaline phosphatase, consequently reducing bone 
matrix deposition and mineralisation (Canalis 1987; Li and Stashenko 1992; 
Nanes 2003). Moreover, studies with S. aureus and S. epiderm idis  surface 
material revealed that these bacterial components induce bone resorption, and 
that blocking TNF-a totally abolishes this effect (Nair, Song et al. 1995; Meghji, 
Crean e t al. 1997; Meghji, Crean e t al. 1998). Furthermore induction of bone 
resorption with S. aureus surface material did not require co-culture with 
osteoblasts suggesting a total independence on the RANKL signalling (Lau, Wang 
e ta l.  2006).
Staphylococcal invasion of bone cells
Following infection, 5. aureus has been shown to be able to invade osteoblasts, 
therefore leading to bacterial persistence within the host cells. S. aureus in v itro  
uptake has been reported in different cell types such as epithelial and 
endothelial cells, keratinocytes and also in osteoblasts (Hudson, Ramp e t al. 
1995; Ellington, Reilly e t al. 1999; Jevon, Guo e t al. 1999; Reilly, Hudson e t al. 
2000; Kintarak, Whawell e t al. 2004; Khalil, Williams e t al. 2007; Garzoni and 
Kelley 2009). In 2000 Reilly e t al captured in vivo internalisation of S. aureus 
bacteria by embryonic chick osteoblasts by electron microscopy following 
infection (Figure 1-30) (Reilly, Hudson et al. 2000).
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Figure 1-30- Transmission electron microscopy o f human osteoblasts infected w ith S. 
aureus. Scale represented by black bar corresponds to 1 |im. From right to left, arrow points 
to S. aureus Interacting with the osteoblast cell surface, arrow Indicates an Internalized S. 
aureus within the osteoblast membrane (Jevon, Guo et al. 1999).
This bacterial internalization process by the host cells is thought to prolong 
infection by providing an evasion system to the bacteria from the host immune 
system and from the action of antibiotics (Henderson and Nair 2003; Wright and 
Nair 2010). The Fnbps on the S. aureus surface are essential for S. aureus 
internalisation as mutants deficient in Fnbps have been shown to have a 
significant reduction in invasion rates by osteoblasts (Sinha, Francois e t al. 1999; 
Ahmed, Meghji et al. 2001; Garzoni and Kelley 2009). Uptake of 5. aureus by 
osteoblasts occurs therefore, by interaction between the Fnbps on the bacterial 
surface with the integrin a5|3i on the osteoblast surface via fibronectin binding 
(Dziewanowska, Patti e t al. 1999; Sinha, Francois e t al. 1999; Fowler, Wann et al. 
2000). However, S. epiderm idis  internalisation by osteoblasts seems to be 
independent of the fibronectin-integrin mechanism (Khalil, Williams e t al. 2007). 
Furthermore, expression of Tumor necrosis factor Receptor Apoptosis Inducing 
Ligand (TRAIL) has been shown to be up-regulated after S. aureus internalization 
by osteoblasts which may be triggering the activation of a cascade of caspases 
leading to apoptotic events, previously reported in S. aureus infected osteoblasts 
(Alexander, Rivera e t al. 2003; Mahalingam, Szegezdi e t al. 2009). TRAIL has also 
been reported to induce apoptosis in human osteoclasts and to inhibit
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osteoclastogenesis (Zauli, Rimondi e t  a l. 2004; Colucci, Brunetti e t  a l. 2007) 
which might be contributing to bone loss in osteomyelitis patients (Henderson 
and Nair 2003). Therefore, Staphylococcal invasion of osteoblasts may play a role 
in the pathogenesis of bone infections by providing a sheltered environment for 
bacteria, enabling evasion of antimicrobials and host immune mechanisms and 
causing further bone destruction by inducing apoptosis prolonging the 
persistence of infection.
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S t u d y  o f  t h e  m o l e c u l a r  m e c h a n i s m s  i n v o l v e d  i n  
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2.1. Introduction
The integrity of the human skeleton is maintained by the normal growth, 
modeling and remodeling of the bone. Osteoblasts together with osteoclasts, 
osteocytes and bone lining cells, are the basic units sustaining these processes 
(Frost 1986; Bilezikian, Raisz e t  a l. 2008). Also defined as bone forming-cells, 
osteoblasts produce an organic collagen matrix that undergoes mineralization 
and forms new bone (Bilezikian, Raisz e t a l. 2008). An inability to perform their 
function and generate new bone, results in abnormal bone growth.
In bone diseases such as osteomyelitis, the processes that maintain the integrity 
of the skeleton are compromised. Osteomyelitis is a debilitating infectious 
disease mainly characterised by bone destruction and inflammation caused by 
infecting microorganisms (Lew and Waldvogel 1997). Among these pathogenic 
microorganisms, 5. aureus  is by far the most commonly found in any type of 
osteomyelitis, accounting for 80 % of all cases (Lew and Waldvogel 2004).
S. aureus  expresses a range of extracellular and cell-associated factors that 
contribute to its virulence. Bacterial binding to host tissues is the first step in the 
establishment of an infection. S. aureus  expresses on its surface MSCRAMMs 
that promote bacterial attachment to the host (Waldvogel 2000). The 
MSCRAMMs are covalently bound to peptidoglycan by the LPXTG motif (Navarre, 
Ton-That e t al. 1998) and can only be released from the cell by enzymatic 
degradation. This sorting reaction is catalysed by an enzyme called sortase. 
Sortase recognizes the LPXTG sequence and cleaves the LPXTG motif between 
the Thr and Gly residues (Navarre and Schneewind 1994; Ton-That and 
Schneewind 1999).
Some of these S. aureus  MSCRAMMs have been well characterised and play an 
essential role in S. aureus  pathogenicity. For example the Fnbp A and FnbpB 
(Signas, Raucci e t al. 1989; Jonsson, Signas e t al. 1991) have affinity to bind to 
fibronectin, a glycoprotein that occurs in body fluids and in the extracellular 
matrix. S. aureus  can bind to fibronectin on the host via a53! integrin whereas
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fibronectin forms a bridge between the Fnbps on the bacterial surface and the 
mammalian cell integrin stimulating the internalization of the bacteria. This 
process has been shown in 5. aureus  invasion of fibroblasts (Usui, Murai et al. 
1992; Fowler, Wann et al. 2000), endothelial (Ogawa, Yurberg et al. 1985; 
Peacock, Foster et al. 1999) and epithelial cells (Dziewanowska, Patti et al. 1999; 
Lammers, Nuijten et al. 1999; Sinha, Francois et al. 1999). Additionally this 
process is also involved in bacterial escape from the blood stream leading to 
invasion of the internal organs and initiation of invasive diseases. These adhesins 
can have multiple interactions with the host, the Fnbps have also been shown to 
bind fibrinogen, together with the ClfA and ClfB, also members of the 
MSCRAMMs. Fibrinogen is the most abundant ligand for the glycoprotein 
gpllb/llla on the surface of platelets. The interaction between fibrinogen and the 
MSCRAMMs results in platelet aggregation and consequently thrombi formation 
likely to be important in endovascular infections such as endocarditis (McDevitt, 
Francois e t al. 1994; Hawiger 1995; Ni Eidhin, Perkins e t a l. 1998; Wann, 
Gurusiddappa e t al. 2000; Rivera, Vannakambadi e t  al. 2007). Other important 
MSCRAMMs are the Sdr family of proteins. These proteins contain a distinct 
serine-aspartate repeat region and include the SdrC, SdrD, and SdrE. Strains 
lacking the sdrD  and sdrE genes have been demonstrated to have decreased 
potential to infect bones (Foster and Hook 1998; Sabat, Melles e ta l .  2006).
Moreover, Bbp also a member of the Sdr family of proteins has been shown to 
bind the bone sialoprotein and collagen on the host (Ryden, Tung e t  a l. 1997; 
Arrecubieta, Lee e t  a l. 2007). Finally, SpA is one of the best characterised 
MSCRAMMs and is an exceptionally complex virulence factor known to have 
multiple interactions with host molecules, interfering with their functions. SpA is 
known primarily for its ability to bind the Fc region of IgG with anti-phagocytic 
properties (Cedergren, Andersson e t al. 1993). SpA also binds to the vWf a large 
glycoprotein involved in mediating platelet binding at sites of endothelial 
damage promoting blood clot formation (Hartleib, Kohler e t al. 2000; 
O'Seaghdha, van Schooten e t a l. 2006) and to the VH3 receptor of B-cells 
resulting in depletion of a significant part of the B cell repertoire (Sasso,
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Silverman et al. 1989; Hillson, Karr e t al. 1993; Goodyear and Silverman 2004; 
Viau, Longo e t al. 2005). In addition SpA has been shown to mimic TNF-alpha's 
role and directly interact with the TNFR-1 In airway epithelial cells stimulating 
inflammatory processes (Gomez, Lee e t al. 2004; Gomez, O'Seaghdha e ta l.  2006) 
and regulating TNFR-l's availability on mucosal and immune cells by direct 
binding of its IgG binding domain to the epidermal growth factor receptor (EGFR) 
(Gomez, Seaghdha e t al. 2007). Finally recent studies have proposed SpA as a 
vaccine target for Methicillin Resistant S. aureus (MRSA) (Kim, Cheng e t al. 2010).
In order to successfully colonize and infect bone tissue S. aureus must bind to 
osteoblasts. The main aim of this chapter was to investigate the molecular 
interactions between S. aureus and osteoblasts. As such the contribution of 5. 
aureus cell surface molecules, such as the capsule, teichoic acids and surface 
proteins were Investigated. Therefore, isogenic mutants of S. aureus lacking the 
expression of capsule and a wide range of cell surface proteins previously shown 
to be involved in host recognition were tested. Additionally the role of the cell 
wall teichoic acid was investigated in this interaction by the blockage of the 
respective receptor TLR2 on osteoblasts surface. These studies demonstrated 
that only the lack of SpA on the surface of different S. aureus strains significantly 
inhibited the binding to osteoblasts. Moreover, further studies examining 
osteoblasts proliferation after infection with S. aureus revealed that in the 
presence of SpA, osteoblasts growth was inhibited. In summary it can be 
concluded that SpA binds to osteoblasts and plays a crucial role in inducing the 
inhibition of osteoblast proliferation.
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2.1.1. Chapter Aims
• Investigate the ability of a range of different S. aureus  strains to interact 
with osteoblasts.
• Identify the cell wall component that is responsible for binding to 
osteoblasts.
• Identify the effects of the deletion of the identified cell wall component 
on osteoblast function.
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2.2. Chemicals and general conditions
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrlch
(Dublin, Ireland). The other suppliers are listed below in Table 2-1.
All solutions were prepared using pure deionised water. Room
temperature (RT) was 20±5 °C.
Table 2-1- List of chemicals and equipment used in this chapter.
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Product
Alpha Minimal Essential Medium
Blclnchoriinicacld assay
Brain Heart Infusion broth
Developing solution
Fixer solution
rara
Clear flat bottomed high binding 96-well plates
Supplier Address
Biosera Ltd. East Sussex, UK
Merck Chemical
UK
Calbiochem
Oxoid Basingstole, UK
New England Biolabs UK
FUJIFILM Ireland Ltd Ireland
FUJIFILM Ireland Ltd Ireland
MILLIPORE Ireland
MILLIPORE Ireland
ATCC Middlesex, UK
Corning’ Costar’ , VWR Blanchardstown,
International Ireland
Bio-RAD UK
Marvel UK
Bio Sciences
Dun Laoghalre, 
Ireland
BioRAD UK
Pharmacia Biotech UK
Perkin Elmer Cambridge, UK
FUJIFILM Ireland Ltd Ireland
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2.3. Methods
2.3.1. Bacterial culture conditions 
Bacterial strains
All the bacterial strains used In this chapter are listed in Table 2-2.
Table 2-2- List of strains used in this chapter,
Strain name
S. aureus
Nev/man
SH100D
5. aureus mutants
Nowman A cap
Relevant Characteristics
Newman A clfB
Newman A spo
NCTC8178 wild type 
Isolated from a case o f secondarily infected 
tubercular osteomyelitis in man 
NCTC 8325 cured of prophages 
8325-4 with repaired defect in rbsU
(Duthie and Lorenz 
1952)
(Novick 1967) 
(Horsburgh, Aish et 
al. 2002)
capSBl:: Tn917; DU5912 (Wann, Dassy e ta l.
Defective in Capsular polysaccharide 1999)
clfA2:: Tn917; DU5876 (McDevitt, Francois
Defective in Clumping factor A e t  al. 1994)
clfB:: Tcr; DU5943 (Ni Eidhin, Perkins
Defective in Clumping factor B e t  al. 1998)
clfA:: Tn917, clfB:: Tcr; DU5944 (Ni Eidhin, Perkins
Defective in Clumping factor A and B e ta l. 1998)
spa:: Kar ; DU5971 (O'Brien, Kerrigan e t
Defective in Protein A al. 2002)
sdrC:: pG+Host9; DU5988 (O'Brien, Kerrigan e t
Defective in Serine aspartate repeat protein C al. 2002)
sdrD:: pG+Host9; DU5989 (O'Brien, Kerrigan e t
Defective in Serine aspartate repeat protein D al. 2002)
sdrCDE:: Tcr (O'Brien, Kerrigan e t
Defective in Serine aspartate repeat protein C, al. 2002)
D and E
sbi:: Kar (Sibbald, W interet
Defective in Sbi al. 2010)
spa::EtBrr, sbi::Kar (Sibbald, Winter e t
Defective in SpA and Sbi al. 2010)
Cmr Apr spa  gene cloned into pCUl. *
Insertion of pCUlspa capable of replicating in 
E. coli and S. aureus expressing Protein A.
spa:: Tcr (Hartleib, Kohler et
Defective in Protein A al. 2000)
spa:: Tcr transduced from 8325-4 spa *
Defective in Protein A
/nM ::Tetr,/nbß::Ermr (Greene, McDevitt
Defective in Fnbps e ta l. 1995)
spa : : Ka nr, fnbA  : :Tetr, fnbB: : Er nïr (Provenza,
Defective in Fnbps and Protein A Provenzano e t al. 
2010)
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* The S. aureus  strains Newman pCUlspa  and SHlOOOAspo were a kind gift from 
Prof. Timothy Foster in Department of Microbiology in Trinity College Dublin, 
Ireland.
Growth conditions
S. aureus  strains were grown in Brain Heart Infusion (BHI) broth (calf brain 
infusion 12.5 g/l, beef heart infusion 5 g/l, protease peptone 10 g/l, glucose 2 g/l, 
sodium chloride 5 g/l, dlsodium phosphate 2.5 g/l) in sealed tubes overnight at 
37 °C. For some experiments, 1 ml of the S. aureus  SH1000 strains, WT, 
AFnbpA/B and AFnbpA/B/SpA overnight cultures was inoculated in 9 ml of BHI 
and incubated at 37 °C for 4 h of early exponential phase of growth.
Bacterial stocks
Original strains were provided as frozen glycerol stocks. The bacterial stocks 
were grown in 50 ml BHI statically overnight at 37 °C. One ml aliquots were 
stored in cryovials containing 10 %  glycerol and kept at -80 °C for future use. 
Aliquots were thawed only once and each time one volume was used to 
inoculate nine volumes of BHI broth. Sub-culturing was minimized by preparation 
and storage of large numbers of aliquots. Periodically aliquots were tested for 
cross-contamination by streaking samples on agar plates and inspected by eye 
for contaminants.
Bacterial isolation
Overnight bacterial cultures were harvested by centrifugation at 15,000 g for 5 
mln. The supernatants were discarded and the bacterial pellets were washed by 
re-suspending pellets in 5 ml of Phosphate Buffered Saline (PBS) pH 7.5 and 
further centrifuged for 5 min at 15,000 g. The washing step was repeated once 
more and the bacterial supernatants discarded.
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Bacterial cell count
Following bacterial isolation, the bacterial pellets were re-suspended in 1 ml PBS, 
the bacterial suspensions were then adjusted to the relevant optical density (OD) 
measured at 600 nm wavelength using the Ultraspec III spectrophotometer by 
dilution in PBS. By means of colony-forming units (CFUs) it was determined that 
the number of S. aureus  for an OD600 nm of 1 corresponds approximately to lx lO 9 
cells. An OD6oo nm of 1 was used in all binding studies and an OD6oo nm of 2 was 
used for osteoblasts proliferation and infection studies.
Bacterial fixation in 4.8 % formaldehyde
Following bacterial growth overnight and isolation, the bacterial pellets were re- 
suspended In 5 ml of 4.8 % formaldehyde followed by 10 min agitation in a 
shaker platform. The formaldehyde fixed bacterial suspensions were further 
centrifuged for 10 min at 15,000 g and washed by re-suspension in 5 ml PBS. The 
bacterial suspensions were re-centrifuged for 5 min at 15,000 g and the washing 
step repeated once more. Fixed bacterial pellets were then re-suspended in 5 ml 
PBS and the OD adjusted to an OD6oonm of 2 by dilution in PBS. Following re­
centrifugation for 10 min at 15,000 g pellets were re-suspended in the same 
volume of Alpha Minimal Essential Medium (a-MEM) osteoblast media.
2.3.2. Cell culture conditions 
Cell type
The MC3T3-E1 pre-osteoblastic adherent cell line ATCC, Middlesex (UK) was used 
in this study.
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Routine cell culture
The MC3T3-E1 osteoblasts (passage 22-28) were cultured in standard tissue 
culture flasks in a-MEM supplemented with 10 % Foetal Bovine Serum (FBS), 2 % 
Penicillin/Streptomycin and 1 % L-Glutamine in a tissue culture incubator at 37 °C 
in 5 % C02 atmosphere. The media was replaced every three days. When 100 % 
confluent, cells were routinely passaged to maintain optimum cell number per 
flask. In order to do this, media was removed from the flask and cells were gently 
washed by addition of 10 ml PBS. After removing the used PBS, cells were 
harvested by addition of 3 ml of 0.25 % trypsin-EDTA solution for 3 min in tissue 
culture incubator at 37 °C in 5 % C 0 2 atmosphere. The flask was gently tapped in 
order to detach all the cells from the flask surface. Following this cells were re­
suspended in 5 ml of warm medium. Finally the total volume of cells suspension 
was divided into 2 new flasks, 4 ml into each flask with 11 ml of previously added 
warm medium.
Cell counting
Osteoblasts were washed in PBS and harvested using 3 ml of 0.25 %  trypsin-EDTA 
solution. Following this cells were re-suspended in 5 ml of media. The 
osteoblasts suspension was centrifuged at 9,000 g for 5 min. Finally the pellet 
was re-suspended in 1 ml of media. Ten nl of the cell suspension was diluted 
into 10 ¡j.1 of 0.4 % trypan blue solution. Trypan blue solution is a dye that can be 
applied to living cells without harming them, therefore it is used to distinguish 
between live and dead cells. Trypan blue is not absorbed by viable cells, however 
in a dead cell the membrane is damaged, and the dye is able to traverse the 
membrane staining the cytoplasm with a distinctive blue colour that can be seen 
under the microscope. Cell counting was performed using a haemocytometer. A 
haemocytometer is a widely used counting chamber (see Scheme 1) in tissue 
culture. Prior addition of the cell suspension, a coverslip is placed over the 
counting surface. Then the haemocytometer is placed under the microscope. The 
full haemocytometer grid contains nine squares; the counting area is the central 
square that contains 25 large squares and each of these contain 16 smaller
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squares. To calculate the number of cells in the sample, the number of live cells 
In the counting area was multiplied by 104 and by the trypan blue dilution factor 
2 that Is the total number of counted cells per ml.
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Scheme 1 -  Haemocytometer grid where the middle square is the counting area. Source: 
http://www.hDacultures.ore.uk/technical/ccp/cellcountine.isp (2011).
Cell storage in liquid nitrogen
Cells from a 100 %  confluent T175 flask were washed and harvested as 
previously described (see Routine cell culture). Following this cells suspension 
was centrifuged at 9,000 g for 5 min. The pellet was re-suspended in freezing 
media (72 %  alpha-MEM, 20 %  FBS, 2 %  Penicillin/Streptomycin, 1 %  L-Glutamine 
and 8 % Dimethyl Sulfoxide (DMSO)) and transferred to cryovials in 1 ml aliquots. 
Vials were placed Into an isopropanol container and kept at -80 °C overnight to 
ensure cells integrity by dropping temperature gradually. The next day vials were 
transferred to liquid nitrogen cell storage chamber at approximately -196 °C.
Cell recovery from storage in liquid nitrogen
Cryovials from liquid nitrogen storage were defrosted at 37 °C In a waterbath 
ensuring that the vial lid was not in contact with the water thus avoiding 
contamination. Defrosted cells were transferred to a tube with 5 ml of warm 
media and gently re-suspended to dilute the toxic DMSO present in the freezing 
media. The cells suspension was then centrifuged at 9,000 g for 5 min, the 
supernatant was discarded and the pellet re-suspended in 5 ml of new warm
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media. Following this cells were transferred to a new T175 flask containing 11 ml 
of media. Flask was maintained in tissue culture incubator at 37 °C with 5 %  C02 
atmosphere.
2.3.3. Functional assays 
Osteoblasts binding assay
Clear flat bottomed high binding 96-well plates (Corning* Costar*, VWR 
International) were coated with 100 ul of OD600nm = 1 bacteria (lx lO 9 cells/ml) or 
purified protein (SpA or ClfA= 50 [ig/ml). The plate was sealed with a 
hydrophobic porous sealing film to minimize cross-contamination, spillage or 
evaporation and incubated at 37 °C for 2 h. Following this the plate was washed 
with 100 nl of PBS per well to remove any unbound bacteria or protein. The 
plate was then blocked with 100 nl of 1 % bovine serum albumin (BSA) per well 
and incubated for a further lh  at 37 °C. The BSA was then gently removed and 
the plate washed once with PBS. MC3T3-E1 cells (1.5xl06 cells/ml) were added 
into each well and allowed to bind for 45 min at 37 °C. Each well was carefully 
washed with 100 nl of PBS to remove any non-adhered osteoblasts. Adherent 
osteoblasts were then lysed with 100 pil of lysis buffer containing a substrate for 
osteoblast acid phosphatase (0.1 M Na acetate pH 5.5, 0.1 %  Triton X-100, and 
10 mM p-nitrophenol phosphate) and incubated for 20 min at 37 °C. Adherent 
osteoblasts were quantified by measuring the content of acid phosphatase at an 
absorbance of 405 nm wavelength using the Wallac Victor2 micro plate reader 
system.
• Trypsin treatment
In some osteoblasts binding assays S. aureus  was pre-incubated with 1 U/ml 
trypsin-EDTA for 30 min at 37 °C prior to addition to the 96-well plate. Trypsin 
cleaves the peptides on the C-terminal side of lysine and arginine amino-acid 
residues, allowing the detachment of the anchored proteins from the bacterial 
surface.
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• Pre-incubation of osteoblasts with inhibition antibodies
In some binding assays studies, osteoblasts were pre-incubated with 10 ng/ml 
anti-TLR2 and anti-TLR4 antibody for 30 min at RT prior to their addition to the 
96-well plate.
Osteoblasts proliferation assay
One ml of 4.8 % formaldehyde fixed bacteria (see section Bacterial fixation in 4.8 
% formaldehyde) or 50 ng/ml of purified SpA was allowed to adhere onto a 6- 
well plate for 2 h in tissue culture incubator at 37 °C with 5 % C02 atmosphere. 
Unbound bacteria were carefully removed from each well using a transfer 
pipette and 3 ml of MC3T3-E1 osteoblasts (5x10s cells/well) were added. Un­
infected osteoblasts were seeded and cultured in the absence of bacterial 
suspension as control. The 6-well plate was returned to the tissue culture 
incubator at 37 °C with 5 % C02 atmosphere. Twenty-two and 46 h later, old 
media was carefully discarded using a transfer pipette and replaced with new 
warm media. The plate was returned to the incubator and 2 h later, osteoblasts 
were harvested using 1 ml of 0.25 % trypsln-EDTA, and cells counted using a 
haemocytometer in a 1:1 dilution with the dye trypan blue as detailed previously 
(see Cell counting section).
2.3.4. Protein biochemistry 
Bacterial cell wall preparation
Overnight bacterial cultures were harvested by centrifugation at 15,000 g for 10 
min at 4 °C. Supernatants were discarded and pellets washed in 1 ml PBS and 
transferred to 1 ml eppendorf tubes. Samples were micro-centrifuged for 10 min 
at 13,000 rpm at 4 °C to pellet the cells. Bacterial pellets were then re-suspended 
In 250 1^ Trls EDTA Lysozyme (TEL) buffer [1 M Tris pH 8, 10 mM EDTA and 1 % 
Lysozyme] plus 10 nl of 10 x Protease Inhibitor Cocktail (PIC) [23 mM 4-(2-
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aminoethyljbenzenesulfonyl fluoride (AEBSF), 2 mM Aprotlnin, 130 |iM Bestatin, 
100 mM EDTA, 0.3 mM E-64 and 0.3 mM Pepstatin A] followed by 37 °C 
Incubation for 3 h with inversion every 15 mln. Samples were then micro­
centrifuged at 13,000 rpm at 4 °C for 10 min. Supernatants were collected and 
transferred into chilled eppendorf tubes and stored at -20 °C.
Cell lysate preparation
Protein extraction from osteoblasts and 4.8 % formaldehyde fixed bacteria 
lysates were performed by re-suspending each sample pellet in 100 pil of Radio- 
Immunoprecipitation assay (RIPA) buffer, 10 x PIC and 100 mM of 
Phenylmethylsulfonyl Fluoride (PMSF). Samples were left on ice for 10 min and 
subsequently centrifuged at 13,000 rpm and 4 °C for 10 min. The supernatant 
was transferred into chilled eppendorf tubes and stored at -20 °C.
Protein quantification
The protein content of all samples was quantified using a bicinchoninic acid 
(BCA) assay. The principle of the BCA assay is based on a biuret reaction, the 
reduction of Cu2+ to Cu1+ under alkaline conditions. The amount of reduction is 
proportional to the protein present. Bicinchoninic acid is a chromogenic reagent 
that chelates with the reduced copper, producing a purple reaction that can be 
read at 562 nm wavelengths (an interval of 540-590 nm can also be used 
successfully). The absorbance is directly proportional to the protein 
concentration (Smith, Krohn e t al. 1985; Kessler and Fanestil 1986). Standard 
curve samples were prepared by diluting 2 mg/ml of BSA solution in RIPA buffer 
from a 1,000 ng/ml to 0 ng/ml concentration. Twenty-five micro-litres of each 
standard or protein sample were added in replicate into individual wells of a 96- 
well plate. Following this 200 |il of BCA working reagent was added into each 
well. The plate was sealed with hydrophobic porous sealing film and Incubated 
for 30 min at 37 °C. Plate was read at 570 nm wavelength absorbance using the 
Wallac Victor2 micro plate reader system. The standard curve was obtained by
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plotting the absorbencies of the standard samples versus the correspondents 
BSA concentrations. The equation of the line from the standard curve was then 
used to calculate the protein concentration of each sample. Final protein 
concentration was adjusted to 500 [ig/ml per sample by dilution in RIPA buffer 
for Western blot analysis.
Western blot and SDS-PAGE analysis
Western blot analysis is used to detect specific proteins of interest in cell lysates. 
In order to separate the protein mix based on their size a Sodium Dodecyl 
Sulphate- Polyacrylamide Gel Electrophoresis (SDS-PAGE) is used. The separated 
proteins in the gel are then transferred to a membrane using electrical current 
and finally probed with specific antibodies that recognize and bind the target 
proteins.
SDS-PAGE analysis was carried out using a Mini PROTEAN electrophoresis 
apparatus (Laemmll 1970). Separating and stacking gel were prepared at 10 % 
and 5 %, respectively, as described below in Table 2-3. The 10 % separating gel 
was poured into the electrophoresis apparatus and overlaid with ethanol in 
order to maintain a flat surface. The separating gel was allowed to set at RT, the 
stacking gel was then added on top of the first one followed by comb insertion to 
allow the wells formation for sample application.
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Table 2-3- SDS-PAGE composition
Reagent
m a Ê Ê Ê m s m Ê Ê Ê Ê Ê m 5.84 ml 4.5 ml
3.5 ml -------
■ 1 W
— — 1.88 ml
4.66 ml 1.15 ml
m m m m m s m m m . 82 Hi 55 Hi
82 55 Hi
7.8 \i\ 7.5 til
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Samples were prepared by adding 20 pil of each lysate plus 5 |il of 5 X sample 
buffer (250 mM Tris-HCI, pH 6,8, 10 %  SDS, 0.5 % bromophenol blue, 50 % 
glycerol plus 50 ng/ml of DTT that were added to the sample buffer immediately 
prior use) and boiled at 95 °C for 5 min. After being briefly centrifuged at 13,000 
rpm for 2 min, samples were loaded into the gel alongside a pre-stained protein 
ladder (10-230 KDa). The SDS-PAGE running buffer (25 mM Trls-HCL pH 8.3, 250 
mM glycine, 0.1 % SDS) was added to the electrophoresis tank and samples and 
marker were resolved through the gel at constant current of 200 V.
The resolved proteins were transferred to PVDF membrane using a Trans-Blot 
Electrophoretic Cell. The pads and filter paper were soaked in transfer buffer (25 
mM Tris-HCI pH 8.0, 0.2 M glycine, 20 % methanol) and the PVDF membrane 
activated in methanol for 5 sec. The gel was placed onto a layer of filter paper 
and sponge, the PVDF membrane was placed on the top and overlaid with 
another piece of filter paper and sponge. The entire assembly was placed into 
the transfer cassette and inserted in the apparatus chamber filled with transfer 
buffer. A constant current of 200 mA was used for transfer for 1 h at RT.
The PVDF membrane with the transferred proteins was removed from the 
transfer apparatus and incubated for lh  in blocking buffer (5 %  non-fat dried 
milk in Tris Buffered Saline (TBS) -  0.1 % (v/v) Tween (TBST)) in a roller platform. 
The primary antibody was diluted in blocking buffer according to the required 
concentration as documented in Table 4. Membrane was then incubated with 
the primary antibody overnight at 4 °C in a roller platform. After primary 
incubation the membrane was washed three times over 10 min each time in 
TBST. The respective horseradish peroxidase (HRP) conjugated antibody was 
prepared in blocking buffer according to the respective concentration (see Table 
2-4). Membrane incubation on secondary antibody run for 1 h at RT in a roller 
platform followed by three washes in TBST for 10 min each time. Finally equal 
volumes of Luminol Reagent and Peroxide Solution of the Immobilon™ Western 
Chemiluminescent HRP Substrate solution were mixed in a cleaned tube. The 
PVDF membrane was incubated with the HRP substrate for 5 min at RT. After
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draining the exceeding substrate membrane was exposed to X-ray film using a 
dark room, and developed by immersion in developing solution followed by fixer 
solution and water.
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T a b le  2 -4 -  Western blot conditions
Molecular P rim a ry  a n tib o d y S eco n d ary  a n tib o d yT a rg e t
P ro te in weight(K O j) antibody concentration antibody concentration
SpA 50
Monoclonal chicken
IgY anti-SpA 1:1000 
produced in mouse
Goat anti­
mouse IgG 
HRP
1:10000
L _ 50
Monoclonal IgG 
antibody produced in 1:1000 
mouse
Goat anti­
mouse IgG 
HRP
1:10000
2.3.5. Statistical analysis
Statistics were performed using SSC-Stat V2.12. Data shown are the means plus 
or minus standard error of the mean (SEM). Comparisons between mean values 
were performed using a 2-tailed paired Student's t-test.
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2.4. Results
2.4.1. S. aureus binding to osteoblast
Binding of bacteria to osteoblasts is the first stage of infection in bone disease. 
Osteoblast binding to immobilized S. aureus  strains including the Wild-Type (WT) 
Newman, 8325-4 and SH1000 was assessed. 5. aureus  Newman strain is a 
commonly used laboratory strain originally isolated from a case of secondarily 
infected tubercular osteomyelitis patient (Duthie and Lorenz 1952). Previously it 
has been shown that 5. aureus  Newman does not possess cell wall- anchored 
fibronectin binding proteins (Grundmeier, Hussain et al. 2004) so it is unlikely to 
be internalized rapidly by the osteoblasts. The 5. aureus  8325-4 and SH1000 
strains are two modified laboratory strains with a common progenitor and, in 
contrast to S. aureus  Newman they have Fnbps anchored on their surface. In this 
section it is demonstrated that S. aureus  strain Newman bound with slightly 
more intensity to osteoblasts than S. aureus  8325-4 and SH1000 strains (Figure 2- 
!)•
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Figure 2-1- Distinct 5. aureus strains bind to  osteoblasts. Osteoblasts were allowed to bind 
to immobilized S. aureus wild-type strains Newman, 8325-4 and SH1000 (lx lO 9 cells/ml) for 
45 min at 37 °C. Binding was determined by measuring the intracellular enzyme alkaline 
phosphatase content at 405 nm In a micro-plate reader. Bars indicate SEM, n=6.
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2.4.2. Contribution of the cell surface molecules in the S. aureus 
binding to osteoblast
After confirming that distinct S. aureus strains bind to osteoblasts, the 
contribution of bacterial surface molecules in this interaction was investigated. S. 
aureus is surrounded in a polysaccharide capsule. Many of the sugars found in 
the capsule have been previously shown to interact with other cell types 
(Pohlmann-Dietze, Ulrich et al. 2000). For that reason it was explored whether 
the S. aureus capsule could be mediating the interaction with osteoblasts. S. 
aureus Newman expresses capsule whereas S. aureus strain SH1000 is naturally 
defective in capsule. Here it was demonstrated that using a S. aureus Newman 
strain defective in capsule increased the binding to osteoblasts. On the other 
hand, the capacity of S. aureus SH1000 strain to bind to osteoblasts it was 
comparable to that of S. aureus Newman WT. Thus neither disruption of the cap 
gene in the Newman strain nor the use of the strain naturally defective in 
capsule inhibited the binding to osteoblasts (Figure 2-2A). These results suggest 
that S. aureus capsule is not mediating bacterial interaction with osteoblasts.
Teichoic acids are constitutively produced glycopolymers anchored to the 
peptidoglycan layer [Wall teichoic acid (WTA)] or to the cytoplasmic membrane 
[Lipoteichoic acid (LTA)] in Gram-positive bacteria including S. aureus. A variety 
of roles have been assigned to the teichoic acids in bacterial survival under 
disadvantageous conditions and in other basic cellular processes (Weidenmaier 
and Peschel 2008). Some studies demonstrated that the teichoic acids are crucial 
for S. aureus nasal colonization and endovascular infection (Weidenmaier, Kokai- 
Kun et al. 2004; Weidenmaier, Peschel et al. 2005; Weidenmaier, Kokai-Kun et al.
2008). Previously, it has been shown that teichoic acids in Gram-positive bacteria 
are recognized by the TLR2 on the host (Fournier and Philpott 2005; Kaji, 
Kiyoshima-Shibata et al. 2010), while Lipopolysaccharide (LPS) in Grom-negative 
bacteria is recognized by Toll Like receptor 4 (TLR4) (Poltorak, He et al. 1998; 
Akira, Uematsu et al. 2006). The contribution of the teichoic acids in S. aureus 
binding to osteoblast was therefore investigated. Anti-TLR2 antibody was used to 
block the interaction between the teichoic acids on S. aureus and its recognition
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molecule, TLR2, on the osteoblasts surface (Figure 2-2B). Anti-TLR4 antibody was 
also used as negative control. The blockade of this interaction had no effect on 
the binding intensity of S. aureus  to osteoblasts, thus teichoic acids do not seem 
to be involved in S. aureus  binding to osteoblasts.
Surface protein interactions are the most common way of bacteria to interact 
with the host. S. aureus  expresses a wide variety of proteins localized on the 
bacterial surface that recognize and bind ligand(s) found within the host (Patti, 
Allen e t al. 1994). Trypsin is a proteolytic enzyme that cleaves proteins at the C- 
terminal of the amino-acids lysine and arginine (Rawlings and Barrett 1994). In 
order to remove S. aureus  surface proteins and evaluate their contribution in 
binding osteoblast, a trypsin-EDTA treatment was performed. The removal of the 
S. aureus  surface proteins significantly reduced the bacterial binding to 
osteoblasts (Figure 2-2C, P<0.05), suggesting a major role for these proteins in 
mediating S. aureus  binding to osteoblasts.
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Figure 2-2 -  S. aureus surface proteins mediate binding to osteoblasts. Osteoblasts were 
allowed to bind to immobilized (A) S. aureus Newman, Newman A cap (Newman capsule 
defective mutant) and SH1000 (naturally defective in capsule) (lx lO 9 cells/ml) for 45 min at 37
•C (B) Osteoblasts were pre-incubated with 10 |ig/ml anti-TLR2 and anti-TLR4 blocking 
antibodies prior to binding to immobilized S. aureus Newman (C) Un-treated and 30 min 
trypsin-EDTA (1 U/ml) treated S. aureus Newman for 45 min at 37 °C. Binding was determined 
by measuring the intracellular enzyme alkaline phosphatase content at 405 nm in a micro-plate 
reader. *P<0.05, bars indicate SEM, n=3.
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2.4.3. The role of S. aureus Fibronectin protein A and B in the binding 
to osteoblast
The S. aureus fibronectin binding proteins A and B have been previously shown 
to be essential in the process of S. aureus uptake by osteoblasts and other 
mammalian cells through the bridging interaction with the host fibronectin 
receptor integrin a5(3i (Jevon, Guo et al. 1999; Sinha, Francois et al. 1999; 
Ahmed, Meghji et al. 2001). The role of these proteins was investigated in S. 
oi/reus-osteoblasts interaction. However, in S. aureus Newman strains the Fnbps 
are completely secreted and, previous studies demonstrated that S. aureus 
Newman does not support binding functions through these proteins 
(Grundmeier, Hussain et al. 2004). Thus, in order to test the role of the Fnbps A 
and B In osteoblast binding, the S. aureus strain SH1000, which optimally 
expresses these proteins at early exponential phase of growth, was used 
(Saravia-Otten, Muller et al. 1997). S. aureus SH1000 strain isogenic mutants 
defective in FnbpA and FnbpB and in both FnbpA/B and SpA were tested for their 
role in osteoblast binding. Despite a slight reduction in binding intensity when 
compared with the WT strain, both S. aureus SH1000 FnbpA/B and FnbpA/B and 
SpA mutants were still able to highly support binding to osteoblasts (Figure 2-3). 
These results suggest that the FnbpA/B proteins despite being essential for 5. 
aureus invasion of osteoblasts are not crucially required to support osteoblast 
binding in the first contact with the host.
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Figure 2-3 -  S. aureus FnbpA/B are not crucial in mediating 5. aureus -  osteoblasts interaction.
Osteoblasts were allowed to bind to immobilized S. aureus SH1000 WT( ASpA, AFnbpA/B and 
AFnbpA/B/SpA (1 x 109 cells/ml) for 45 min at 37 °C. Binding was determined by measuring the 
intracellular enzyme alkaline phosphatase content at 405 nm in a micro-plate reader. *P<0.05, 
bars indicate SEM, n=3.
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2.4.4. The role of S. aureus surface proteins in the binding to 
osteoblast
Having established that the S. aureus  cell surface proteins are partially involved 
in mediating bacterial binding to osteoblasts, the individual role of specific S. 
aureus surface proteins was investigated. Belonging to the MSCRAMMs family, 
the ClfA and ClfB, the SpA, and the SdrC, D and E (Patti, Allen e t  al. 1994; 
Waldvogel 2000) were previously reported to be involved in host recognition, 
and therefore, these were tested for their ability to mediate binding to 
osteoblasts. Several S. aureus  Newman isogenic mutants were generated by 
genetic manipulation resulting in strains defective in the expression of ClfA 
(McDevitt, Francois e t a l. 1994) and B (Ni Eidhin, Perkins e t a l. 1998), SpA and Sdr 
C, D and E (O'Brien, Kerrigan e t a l. 2002). The results obtained demonstrated 
that SpA defective mutant bound significantly less than the WT strain. In contrast 
the other mutant strains tested had similar levels of osteoblast binding when 
compared to the wild-type strain (Figure 2-4, P<0.05).
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Figure 2-4 - SpA mediates S. aureus binding to osteoblasts. Osteoblasts were allowed to bind 
to immobilized 5. aureus Newman wild type and isogenic mutants (1 x 109 cells/ml) for 45 min 
at 37 °C. Binding was determined by measuring the intracellular enzyme alkaline phosphatase 
content at 405 nm in a mlcro-plate reader. *P<0.05, bars indicate SEM, n=6.
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2.4.5. Confirmation of the role of S. aureus protein A in the binding to 
osteoblast
In order to confirm the involvement of SpA in the binding to osteoblasts, this 
interaction was further investigated using different S. aureus strains. For that 
reason, the strains S. aureus SH1000 and 8325-4 WT along with their SpA 
defective mutants were used and tested for their ability to bind to osteoblasts. 
As result, the 5. aureus SH1000 and 8325-4 strains defective in SpA revealed a 
significant reduction, of approximately 50 %, in the osteoblast binding intensity 
when comparing with the respective WT (Figure 2-5A, P<0.05). These data 
support the previous results where S. aureus Newman strain binding to 
osteoblast was significantly reduced when using the respective SpA defective 
strain (Figure 2-5A, P<0.05). Moreover, complementation of the S. aureus 
protein A mutant with a multicopy plasmid carrying the spa gene (strain 
pCUlspcr), showed a total recovery on the capacity to bind osteoblast, with levels 
similar to those obtained for the S. aureus Newman WT strain (Figure 2-5B). To 
ensure that SpA was being expressed on the surface of the complemented strain 
S. aureus Newman pCUlSpA, Western imunoblotting detection was performed 
using the cell wall preparations of both 5. aureus Newman WT and 
complemented strain pCUlSpA. Immunoblotting analysis revealed a band of 42 
KDa, the correspondent molecular weight of SpA, in both lanes for S. aureus 
Newman WT and S. aureus Newman pCUlSpA (Figure 2-5C). In addition, the 
ability of purified SpA and recombinant ClfA to bind osteoblasts was also tested. 
The purified SpA bound positively to osteoblasts (Figure 2-5D). On the other 
hand, and complementary to the above findings the recombinant ClfA did not 
support binding to osteoblasts (Figure 2-5D, P<0.05 when comparing with 
purified SpA).
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Figure 2-5 -  SpA binding to osteoblasts is not a strain dependent interaction (A) Osteoblasts 
were allowed to bind to immobilized S. aureus Newman, 8325-4 and SH1000 wild type, SpA 
defective mutants and (B) Newman SpA complemented strain (Newman pCulSpA) (1 x 109 
cells/ml) for 45 min at 37 °C. Binding was determined by measuring the intracellular enzyme 
alkaline phosphatase con tent at 405 nm in a micro-plate reader. *P<0.05, bars indicate SEM, 
n=6. (C) S. aureus Newman and pCUlSpA cell wall preparations were separated on a 10 % SDS- 
PAGE gel and electroblotted onto PVDF membrane. Membranes were probed with anti-SpA 
antibody. Protein bands were detected using species specific horseradish peroxidase- 
conjugated secondary antibody and chemiluminescence. (D) Osteoblasts were allowed to bind 
to immobilized purified SpA or recombinant ClfA (50 ng/ml) for 45 min at 37 °C. Binding was 
determined by measuring the intracellular enzyme alkaline phosphatase content at 405 nm in a 
micro-plate reader. *P<0.05, bars indicate SEM, n=6.
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2.4.6. Contribution of the 5. aureus protein A domains in the binding to 
osteoblast
SpA is a major protein from S. aureus  and it is present in over 90 % of S. aureus  
strains (Forsgren 1970; Forsgren and Forsum 1970; Lachica, Genigeorgis et al. 
1979; Fomenko 1980; Easmon and Adlam 1983; Sanford, Thomas et al. 1986). 
This 42 KDa long protein has been shown to comprise 7 % of the cell wall 
(Forsgren 1969). Structurally SpA is composed of five highly homologous 
extracellular IgG-binding domains in tandem E, D, A, B, and C linked to the S. 
aureus  cell wall surface by an LPXTG motif (Figure 2-6A) (Langone 1982; Uhlen, 
Guss e t a l. 1984). To further characterise the interaction of SpA with osteoblasts 
the ability of SpA E-C and D domains to bind osteoblasts along with the full 
length purified SpA was investigated. The osteoblast binding intensity of SpA D 
domain by itself was comparable to the levels obtained for the full length SpA. 
SpA D domain seemed to comprise more than 50 % of the full length SpA binding 
intensity to osteoblasts (Figure 2-6B, P=NS). Alternatively, SpA E-C domains did 
not support as much osteoblast binding as the full length SpA (Figure 2-6B, 
P<0.05). The data obtained suggests that SpA D domain may be a crucial domain 
in SpA contributing to the interaction with osteoblasts.
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Figure 2-6 -SpA D-domain highly contributes to the SpA -  osteoblasts interaction. (A)
Structural organization of SpA; S, Represents the signal sequence; E, D, A, B, C are the five IgG 
binding domains; W is the wall spanning region; and M represents the membrane spanning 
region. (B) Osteoblasts were allowed to adhere to immobilized purified SpA, SpA E-C domains 
and SpA D domain (50 ng/ml) for 45 min at 37 °C. Binding was determined by measuring the 
intracellular enzyme alkaline phosphatase content at 405 nm in a micro-plate reader. 
*P<0.05, bars indicate SEM, n=6.
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2.4.7. The role of Staphylcococcus aureus Sbi in the binding to 
osteoblast
S. aureus  expresses another IgG binding protein that shares high homology with 
SpA, the 5. aureus  binder of IgG (Sbi). Given their sequence similarity it was 
investigated whether Sbi plays a role in binding osteoblasts. Using the ClustalW2, 
a program for alignment of protein sequences, the amino-acid sequences of SpA 
and Sbi were compared. The results revealed approximately 50 % of homology 
between SpA and Sbi (Figure 2-7A). A S. aureus  Newman isogenic mutant 
defective in Sbi expression was used to evaluate the role of Sbi in osteoblast 
binding. This study shows that unlike for SpA mutant strains, there were no 
significant differences in the binding between the 5. aureus  Newman WT and the 
S. aureus  Newman strain defective in Sbi (Figure 2-7B, P=NS). These data suggest 
that despite the high homology between SpA and Sbi, Sbi does not play a role In 
S. aureus  - osteoblasts Interactions.
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Figure 2-7 - 5. aureus Sbi is not involved in S. aureus binding to osteoblasts. (A) Alignment of 
SpA and Sbi from S. aureus with ClustalW2 (web automatic program for alignment of protein 
sequences) (B) Osteoblasts were allowed to bind to immobilized S. aureus Newman , SpA and 
Sbi defective mutants (1 x 109 cells/ml) for 45 min at 37 °C. Binding was determined by 
measuring the intracellular enzyme alkaline phosphatase content at 405 nm in a micro-plate 
reader. *P<0.05, bars indicate SEM, n=3.
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2.4.8. The role of 5. aureus protein A in osteoblast proliferation
After confirming a crucial role for 5. aureus protein A in mediating bacterial 
binding to osteoblasts the outcome of this interaction was further investigated. 
To explore this, the strains S. aureus Newman WT, SpA defective strain, pCulSpA 
complemented strain and the purified SpA were pre-incubated with osteoblasts 
and their effect on growth and proliferation over a 48 h period were determined. 
Addition of live S. aureus to tissue culture media will starve osteoblasts of 
essential nutrients necessary to grow as the bacteria will compete for those 
nutrients for their own growth. To address this problem, S. aureus strains were 
fixed in a mild formaldehyde solution (4.8 %), to maintain bacterial cell integrity 
yet stunt bacterial growth. To ensure that formaldehyde fixation of the bacteria 
had no adverse effect on the expression of SpA by S. aureus, detection of SpA in 
both live and formaldehyde fixed bacterial cell lysates was determined by 
western blot (Figure 2-8A). Western blot analysis demonstrated consistent levels 
of SpA, at the correct molecular size 42 KDa, for both live and formaldehyde fixed 
bacterial cells lysate preparations. Formaldehyde fixed S. aureus Newman was 
added to osteoblasts and proliferation determined after 24 h and 48 h (Figure 2- 
8B). A proliferation control with resting osteoblasts, in the absence of S. aureus, 
demonstrated a regular proliferation profile as expected. However, osteoblast 
proliferation was inhibited by the addition of S. aureus Newman wild-type 
(P<0.01). Interestingly, the presence of S. aureus Newman defective in SpA did 
not prevent osteoblast from proliferating (P=NS to uninfected osteoblasts). 
Complementation of the S. aureus protein A defective mutant with pCUlspo 
restored the inhibitory effect on proliferation to levels comparable for Newman 
WT (PcO.Ol). Consistent with this, addition of purified protein A to osteoblasts 
also prevented proliferation (P<0.01). These results suggest that S. aureus 
protein A binds to osteoblasts triggering a signalling pathway which results in the 
inhibition of osteoblast proliferation.
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Figure 2-8- 5. aureus protein A inhibits proliferation. (A) Live or formaldehyde fixed S. aureus 
Newman were lysed for 10 min on ice in RIPA buffer containing protease inhibitors and probed 
with anti-SpA antibody. Protein bands were detected using species specific horseradish 
peroxidase-conjugated secondary antibody and ehemiluminescence (western blot 
representative of 3 independent experiments). (B) Osteoblasts (5 xlO5 cells/ml) were pre­
incubated with either control buffer or formaldehyde fixed S. aureus Newman wild-type, 
Newman SpA defective mutant or Newman pCUlSpA (1 x 109 cells/ml) or purified protein A (50 
Hg/ml) over 48 h. After 0, 24 h and 48 h osteoblast were removed by trypsinization and 
proliferation was determined by counting cells on a haemocytometer. *P<0,01, error bars 
indicate SEM, n=5.
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2.5. Discussion
To date many attempts have been made to understand bone destruction 
following bacterial infection, most notably on S. aureus Infections. Some studies 
have investigated the effects that S. aureus has on osteoblasts, and have 
demonstrated that the Fnbps on S. aureus surface interact with osteoblasts via 
a53i integrin (Sinha, Francois et al. 1999; Ahmed, Meghji et al. 2001). This 
interaction leads to bacterial invasion of osteoblasts and triggers a series of 
events that ultimately cause bone destruction. This is not a unique concept, S. 
aureus has evolved with many mechanisms to interact with the host cells, indeed 
S. aureus has many proteins that interact with human blood platelets in 
cardiovascular disease (Kerrigan, Clarke etal. 2008).
In this chapter, additional specific interactions between S. aureus and osteoblasts 
were exploited. The S. aureus cell wall components such as the capsule, teichoic 
acids and surface proteins were tested for their involvement in promoting 
bacterial binding to osteoblasts.
The capsular polysaccharides expressed on the S. aureus cell surface are a major 
virulence factor known to promote evasion or interference with the host 
immune system (Nilsson, Lee et al. 1997; Luong and Lee 2002). Furthermore, the 
teichoic acids have been demonstrated to play a crucial role in S. aureus nasal 
colonization and endovascular infection (Weidenmaier, Kokai-Kun et al. 2004; 
Weidenmaier, Peschel et al. 2005; Weidenmaier, Kokai-Kun et al. 2008). In 
addition, S. aureus owes much of its pathogenicity to an array of cell wall- 
anchored surface proteins, the microbial surface components recognizing matrix 
molecules (MSCRAMMs). Many MSCRAMMs expressed on S. aureus have now 
been identified and functional studies have demonstared their ability to bind 
specific components of various host cells either directly (direct binding between 
the MSCRAMM and host cell receptor) or indirectly (MSCRAMM binds a plasma 
protein such as fibrinogen, fibronectin, collagen, bone sialoprotein or von 
Willebrand factor) (Patti, Allen et al. 1994; Waldvogel 2000).
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A series of S. aureus mutants defective in specific components of the cell wall of 
S. aureus were used to investigate their interaction with osteoblasts. Deletion of 
capsule from S. aureus Newman or using the capsule negative strain S. aureus 
SH1000 failed to have any effect on binding, suggesting that the polymeric 
carbohydrates that are found in the capsule do not mediate attachment to 
osteoblasts (Figure 2-2A). Deletion of the teichoic acids on the S. aureus cell wall 
is very difficult and often leads to defective growth of the bacteria. Therefore, in 
order to investigate if this interaction plays a role in the bacterial binding to 
osteoblasts, antibodies (fAb fragments) against osteoblast toll like receptors 
(which recognise teichoic acids) were used. Blocking TLR2 did not interfere with 
the S. aureus binding to osteoblasts (Figure 2-2B), suggesting that the teichoic 
acid is not mediating the interaction between S. aureus and osteoblasts. Finally, 
removal of the surface proteins from S. aureus using a trypsin-EDTA treatment 
before binding to osteoblasts, revealed a significant reduction in the binding 
intensity (Figure 2-2C), and proved the importance of these in 5. aureus 
interaction with osteoblasts.
As already mentioned the S. aureus Fnbps A and B have been previously shown 
to be essential in 5. aureus invasion of osteoblasts (Jevon, Guo et al. 1999; Sinha, 
Francois et al. 1999; Ahmed, Meghji et al. 2001). However, in S. aureus Newman 
strain the Fnbps are not expressed at stationary phase and therefore do not 
account for binding to osteoblasts (Grundmeier, Hussain et al. 2004). Therefore, 
the S. aureus strain SH1000 expressing Fnbps A and B at exponential phase of 
growth was used to evaluate the specific role of Fnbps A and B in osteoblast 
binding (Saravia-Otten, Muller et al. 1997). S. aureus SH1000 isogenic mutants 
defective in FnbpA/B revealed a slight decrease in osteoblast binding ability. This 
is most likely due to the Fnbps capacity to interact with the osteoblasts integrin 
«5pi, yet this decrease was not significant when compared with the WT strain 
(Figure 2-3, P=NS). Despite being essential for the internalization of S. aureus by 
osteoblasts, it seems that the FnbpA/B proteins are not important in the initial 
binding interaction between 5. aureus and osteoblasts.
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S. aureus expresses a number of surface proteins that play a critical role in host 
cell interactions. For example, S. aureus ClfA and ClfB can bind specifically to 
fibrinogen, fibronectin, and IgG which play a critcal role in S. aureus adhesion to 
damaged heart valves in both human and rat model of endorcaditis (McDevitt, 
Francois et al. 1994; Vaudaux, Francois et at. 1995; O'Brien, Kerrigan et al. 2002). 
S. aureus protein A is a major protein expressed on S. aureus and has been 
shown to play an important role in the success of S. aureus as a human pathogen 
in many host cell interactions (O'Seaghdha, van Schooten et al. 2006; Foster
2009). Finally, although a relatively newly identified family of proteins the role of 
the Sdr family of proteins have yet to be fully elucidated. Early studies have 
demonstrated that the SdrC can bind bone sialoprotein and collagen (Ryden, 
Tung et al. 1997; Arrecubieta, Lee et al. 2007). Using a series of S. aureus 
Newman isogenic mutants defective in the expression of several S. aureus 
surface proteins (ClfA, ClfB, SpA and SdrC, D and E) it was demonstrated that only 
the lack of SpA significantly reduced the osteoblast binding intensity (Figure 2-4). 
Furthermore different 5. aureus strains lacking the expression of SpA also 
reduced the binding to osteoblasts (Figure 2-5A). In order to confirm the 
involvement of SpA, a complemented strain S. aureus Newman (pCUlSpA) 
expressing SpA was used, which completely recovered the binding to osteoblasts 
intensity (Figure 2-5B). Finally, it was also conclusively demonstrated that 
immobilized purified SpA from S. aureus supported osteoblast binding while the 
control pruified recombinant ClfA did not, complementing the previous results 
(Figure 2-4). Collectively these results suggest that S. aureus protein A is critical 
in mediating and interaction with osteoblasts.
Since its discovery in 1961 the structural make-up of SpA has been the focus of a 
lot of attention. It comprises five IgG binding domains, and is anchored to the cell 
wall by a hydrophobic C-terminal region (Figure 2-6) (Patel, Kornblum et al. 
1992). To further try and identify a particular domain or region on Spa that binds 
to osteoblasts purified fragmants of SpA encoding the EDABC domains were 
used. Immobilized SpA D domain supported around 70 % of the full length SpA
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binding intensity to osteoblasts (Figure 2-6B, P=NS), while the SpA E-C domains 
only sustained approximately 20 %  (Figure 2-6B, P<0.05). These data suggests 
that the D domain of SpA may be the specific binding site for binding osteoblast 
however, further studies are required to support this and identify a more specific 
amino acid location.
Recent studies have identified another immunoglobulin binding protein from S. 
aureus  called Sbi (Zhang, Jacobsson e t  a l. 1998). This surface protein similar to 
SpA interacts with the Fc part of IgG, however unlike SpA, which requires the 
presence of both Fc and (VH3) Fab for precipitating human IgG, Sbi only requires 
the Fc portion (Atkins, Burman e t a l. 2008). Furthermore, Sbi binds the serum 
glycoprotein (32-GPI implicated in blood coagulation by affecting the activity of 
pro-thrombinase (Zhang, Jacobsson e t a l. 1999). Sequence homology of SpA and 
Sbi identified their similarities (Figure 2-7A). However, despite the high 
homology, a Sbi defective strain maintained the capacity to bind osteoblasts, as 
seen for the WT strain. These results suggest that Sbi is not important for the 
establishment of the interaction between S. aureus  and osteoblasts (Figure 2- 
7B).
After establishing the importance of SpA in binding osteoblasts, its role in 
developing infection was further investigated. A common feature of infected 
bone samples from patients is the widespread loss of cells. Therefore studies 
were carried out to investigate if SpA binding to osteoblasts had downstream 
effects that resulted in inhibition of proliferation. To do this, osteoblasts were 
pre-incubated in the presence and absence of S. aureus  strains and proliferation 
was assed over a 48hr period. Osteoblasts failed to proliferate in the presence of 
S. aureus  expressing SpA over a 48 h time course (Figure 2-8). Infection of 
osteoblasts with a an isogenic mutant of S. aureus  lacking expression of SpA 
failed to have any effect on proliferation, suggesting that when S. aureus  protein 
A binds to osteoblasts it triggers a signal that results in inhibition of proliferation.
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To date the mechanism by which S. aureus  causes weakening of the bones in 
osteomyelitis is not fully understood. Previous results demonstrate that 
osteoblasts internalise the S. aureus  via an indirect interaction between the 
fibronectin binding proteins that bind fibronectin and form a bridge to osteoblast 
as a result S. aureus  can evade Immune responses and antibiotics. Here it is 
described for the first time that S. aureus  also binds to osteoblasts through a 
mechanism that involves protein A. This interaction results in the generation of a 
critical signal that leads to inhibition of osteoblast proliferation. This finding 
provides new information on the underlying mechanisms likely to be involved in 
the significant bone loss seen in osteomyelitis patients. Results presented in this 
study provides evidence for the first time that protein A is likely to play a critical 
role in the success of S. aureus  as a human pathogen in osteomyelitis and is a 
potential novel drug target for the treatment of this debilitating disease.
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3.1. Introduction
The previous chapter demonstrated the importance of S. aureus  protein A in 
binding to osteoblasts and inhibiting their proliferation over time. This is a major 
step into the first stage of infection however more experiments are needed to 
fully understand the mechanisms underlying the virulence of SpA in osteoblast 
infection and consequent pathway towards disease.
In this chapter it is hypothesised that SpA from S. aureus  may play a role in bone 
destruction and inflammation following infection.
Osteomyelitis is mainly characterized by progressive inflammation and bone 
destruction. Although there are few studies investigating immune responses in 
osteomyelitis, production of pro-inflammatory mediators such as cytokines in 
response to S. aureus  infection have been previously reported (Lowy 1998; 
Bannerman, Paape e t a l. 2004; Fournier and Philpott 2005). Interleukin-6 (IL-6) is 
a member of a family of pro-inflammatory cytokines that play a crucial role in the 
immune response (Wong and Clark 1988; Heymann and Rousselle 2000). IL-6 can 
be released by several cell types such as endothelial cells (Jirik, Podor e t a l. 1989; 
Sironi, Breviario e t al. 1989), fibroblasts (Helfgott, May e t a l. 1987) and 
osteoblasts (Ishimi, Miyaura e t al. 1990) in response to bacterial infection 
inducing leukocytes recruitment and fever (Gabay 2006; Lipsky 2006). In bone, 
IL-6 expression has been shown to be regulated by the transcriptional factor 
NFkB (Libermann and Baltimore 1990; Tak and Firestein 2001). NFkB represents a 
group of transcriptional factors controlling different biological processes such as 
immune and inflammatory responses (Ghosh and Karin 2002; Kalthoff 2009). In 
turn, Ikp belongs to a family of cytoplasmic inhibitory proteins that regulate the 
translocation of NFkB from the cytoplasm to the nucleus. In resting cells, lk(3 
binds to NFkB and sequesters it in the cytosol while in stimulated cells Ikp is 
degraded allowing NFkB translocation to the nucleus where it will affect the 
expression of genes, such as IL-6 that mediates inflammatory responses (May 
and Ghosh 1997; Kalthoff 2009; Panzer, Steinmetz e t al. 2009). Previous studies
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using a murine model of staphylococcal osteomyelitis demonstrated the 
expression of IL-6 by osteoblasts (Marriott, Gray e t al. 2004). Moreover, other 
studies demonstrated that IL-6 is involved in mediating osteoclastogenesis and 
bone resorption (Kotake, Sato e t al. 1996) in human marrow cultures (Kurihara, 
Bertolini e ta l.  1990) and in the increase of the interactions between osteoblasts 
and osteoclasts (Kwan Tat, Padrines e t al. 2004).
It is important to note that SpA is present on the surface of over 90 %  of S. 
aureus  strains (Forsgren 1970; Forsgren and Forsum 1970; Lachica, Genigeorgis 
et al. 1979; Fomenko 1980; Easmon and Adlam 1983; Sanford, Thomas et al. 
1986). SpA is a well-established and exceptionally complex virulence factor 
known to have multiple interactions with host molecules, interfering with their 
functions. Particularly, SpA is best known to bind the Fc region of IgG with anti­
phagocytic properties (Cedergren, Andersson e t al. 1993), the vWf, a large 
glycoprotein involved in mediating platelet binding at sites of endothelial 
damage promoting blood clot formation (Hartleib, Kohler et al. 2000; 
O'Seaghdha, van Schooten e t al. 2006) and the VH3 receptor of B-cells (Sasso, 
Silverman e t al. 1989; Hillson, Karr e t al. 1993). However, SpA has also been 
shown to mimic the role of TNF-a via direct interaction with the TNFR-1 in airway 
epithelial cells stimulating inflammation processes (Gomez, Lee et al. 2004; 
Gomez, O'Seaghdha e t al. 2006). SpA can also regulate the availability of TNFR-1 
on mucosal and immune cells by direct binding of its IgG binding domain to the 
epidermal growth factor receptor (EGFR) (Gomez, Seaghdha e t al. 2007). On the 
other hand, among the known SpA ligands, both TNFR-1 and EGFR have been 
implicated in the bone metabolism regulation. The TNFR-1 has been shown to be 
involved in bone destruction by regulation of osteoclast formation following 
microbial stimulation (Hussain Mian, Saito e t al. 2008; Ochi, Hara e t al. 2010). In 
addition the EGFR has been demonstrated to regulate bone homeostasis by 
suppressing osteoblast differentiation and mineralization (Zhu, Shimizu e t al. 
2011)
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3.1.1. Chapter Aims
• Identify the ligand for S. aureus  protein A that is responsible for 
mediatingthe interaction with osteoblasts
• Investigate the downstream signalling events that occur as a result of 5. 
aureus  binding to osteoblasts that may play a role in bone destruction
• Investigate the downstream signalling events that occur as a result of S. 
aureus  binding to osteoblasts that may play a role in inflammation
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3.2. Chemicals and general conditions
The chemicals and conditions used in this study are described in detail in section
2.2, additional chemicals and equipment for this specific chapter are stated 
below in Table 3-1.
Table 3-1- List of chemicals and equipment used in this chapter.
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a-actlnin mouse IgG
ApoAlert Ospase Colorimetric Assay Kits
r-ACSCalibur flow cytometer
Goat anti-mouse IgG HRP
Goat anti-mouse IgG Alexa Fluor 488
Goat anti-rabbit IgG R-PE
lood of a healthy
donor)
■
Supplier
Santa Cruz Biotechnology
Merck 
Clontech Laboratories 
Becton Dickison 
PIERCE, Fisher Scientific
Invitrogen
Invitrogen
GE Healthcare 
eBIOSCIENCE LTD 
BDH laboratory supplies
RCSI
Santa Cruz Biotechnology
Santa Cruz Biotechnology
Applied Biosystems 
Europe
R&D Systems Ltd
Lonza Cologne AG
Heidelberg, 
Germany 
UK 
CA, US 
UK 
Ireland 
Carlsbad, CA, 
USA 
Carlsbad, CA, 
USA 
UK 
UK 
UK
Dublin, Ireland
Heidelberg,
Germany
Heidelberg,
Germany
Dublin, Ireland
UK
Germany
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3.3. Methods
3.3.1. Bacterial culture conditions
The bacterial culture conditions used in this chapter are described in detail in 
section 2.3.1,
Bacterial strains
The bacterial strains used in this chapter are listed below Table 3-2.
Table 3-2 - Bacterial strains used in this chapter
Relevant Characteristics Reference
S. aureus 
mutants
NCTC 8178 wild-type 
Isolated from a case of secondarily infected 
tubercular osteomyelitis in man
(Duthie and Lorenz 
1952)
spa:: Kar; DU5971 
Defective in Protein A 
Cmr Apr spa gene cloned into pCUl. 
Insertion of pCUlspa capable of replicating in E.
coli and S. aureus expressing Protein A. 
Expresses spa with an L17A substitution in each 
IgG binding domain.___________
(O'Brien, Kerrigan et al. 
2002)
* The S. aureus  strain Newman pCUlspoL17A was a kind gift from Prof. Timothy 
Foster in Department of Microbiology in Trinity College Dublin, Ireland.
3.3.2. Osteoblast culture conditions
The osteoblasts culture conditions of the MC3T3-E1 cell line used in this chapter 
are described in detail in section 2.3.2..
3.3.3. Functional assays 
Osteoblast binding assay
The osteoblast binding protocol is described in detail in section 2.3.3. In some 
experiments 100 \i\ of Platelet Poor Plasma (PPP) was added to the immobilised
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bacteria for 30 rrrin at 37 °C, prior to adding the osteoblasts. In other 
experiments osteoblasts were pre-incubated with 50 ng/ml of a-TNFR-1 antibody 
for 30 min at RT prior to their addition to the immobilised bacteria.
Osteoblasts infection assay
MC3T3-E1 osteoblasts (5x10s cells/ml) were added into a 6-well plate. The plate 
was incubated for 1 h at 37 °C with 5 % C02 atmosphere in tissue culture 
incubator. Following this one ml of formaldehyde fixed bacterial suspension 
(section 2.3.1.) was added to each well of the previously incubated 6-well plate. 
The plate was returned to the tissue culture incubator for different time-points 
depending on the experiment (0, 15, 30, 45, 60 and 90 min or 24 h and 48 h). 
Osteoblasts in the absence of bacteria were used as a control. The 6-well plate 
was then centrifuged for 10 min at 5,000 g at RT. The supernatant of each well 
was transferred to a new plate and stored at -20 °C for further analysis.
3.3.4. Protein biochemistry
The cell lysate preparation, the protein quantification and Western blot analysis 
were carried out as detailed in section 2.3.4.
The specific Western blot conditions used in this chapter are listed below 
in Table 3-3.
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Table 3-3- Western blot conditions
42
55
35
105
47
Monoclonal chicken 
IgY anti-SpA 
produced in mouse 
Monoclonal IgG 
antibody produced in 
mouse
Polyclonal anti-TNFR- 
1 produced in rabbit
Anti-Ik^ produced in 
mouse
Polyclonal a- actinin 
produced in rabbit
Polyclonal 0-actin 
produced in rabbit
concentration
1:1000
1:1000
1:1000
1:1000
1:5000
1:1000
antibody concentration
Goat anti­
mouse IgG 
HRP 
Goat anti­
mouse IgG 
HRP 
Goat anti- 
rabbit IgG 
HRP 
Goat anti­
mouse IgG 
HRP 
Goat anti­
rabbit IgG 
HRP 
Goat anti­
rabbit IgG 
HRP
1:10000
1:10000
1:10000
1:10000
1:20000
1:10000
3.3.5. Flow cytometry
Flow cytometry is used to measure physical and chemical properties of single 
cells or particles as they pass in a fluid stream by a beam of laser light. As cells 
capture the light source they scatter light and the fluorochromes are excited to a 
higher level of energy. This energy is released as a photon of light with specific 
spectral properties unique and characteristic to different fluorochromes. 
Scattered and emitted light from cells is then converted to electrical pulses by 
optical detectors. To measure cells fluorescence a logarithmic amplification is 
used, spreading out the scale for weak signals and compressing the scale for 
strong or specific fluorescence signals. After amplification the different signals or 
pulses are processed by an analog to digital converter (ADC) which plots the 
events on a graphical scale, histogram (Melamed, Lindmo e t al. 1990; Givan 
1992; Shapiro 1995).
Seventy five jil of osteoblasts (lx lO 6 cells/ml) were incubated with 25 nl of 
primary a- TNFR-1 rabbit polyclonal antibody or 25 nl of a-actinin rabbit IgG 
(Isotype control) for 1 h at RT followed by 30 min incubation with 2 nl of
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secondary Goat anti-rabbit IgG R-PE at 4 °C in the dark. Four hundred \x\ of PBS 
were then added to both cells suspension to stop antibody binding. A cell 
suspension with 100 nl of osteoblasts and 400 nl of PBS was used as buffer 
control. Five thousands viable cells from each sample were counted without gate 
using a fluorescent-activated cell sorter FACSCallbur™ and analysed using the 
Cell Quest software Becton Dickinson.
3.3.6. Confocal microscopy
Confocal microscopy is an optical imaging technique that enables deep 
visualization within living and fixed cells and tissues. It is advantageous over the 
conventional microscopes for its ability to use spatial filtering that eliminates the 
out-of-focus light in specimens that are thicker than the focal plane. Moreover, it 
enables the collection of sharply defined optical sections from which three- 
dimensional structures can be obtained (Masters 2006; Pawley 2006).
Slide preparation
For confocal microscopy imaging pre-treated poly-L-lysine slides (poly-prep 
slides) were used. Slides were rinsed with ethanol, dried for 2 min and washed 
with dH20 and allowed to dry. Following this, slides were blocked for 2 h at 37 °C 
with 1 % BSA prepared in TBS. All TBS was sterile filtered using 0.22 |im filters.
Osteoblast binding on slides
Slides were washed with TBS and subsequently coated with MC3T3-E1 
osteoblasts (5x10s cells/ml) in TBS and incubated in a humidity chamber for 1 h 
at 37 °C, a control without osteoblasts was also incubated with TBS only. Slides 
were then fixed using 3.8 % formaldehyde for 10 min at RT. After a new wash 
with TBS, slides were permeabilized for 5 min with acetone at 4 °C and 
subsequently stained using a-actin mouse IgG and a-TNFR-1 rabbit antibody for 
1 h at 37 °C. Slides were washed twice with TBS. Secondary staining followed
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using a Goat anti-mouse IgG Alexa Fluor 488 and a Goat anti-rabbit IgG R PE 
antibodies for 45 min at 37 °C. Slides were washed with TBS to remove excess 
stain and covered with a glass cover slip and mounting media. Slides were kept at 
4 °C until visualization using an oil-immersion 63 X objective lens and a Zeiss LSM 
510 confocal microscope.
3.3.7. Apoptosis 
Caspase 3
Caspase 3 is a downstream effector caspase important in death receptor 
apoptotic mechanisms. Caspase 3 activity was detected using the ApoAlert 
Caspase Colorimetric Assay Kit. The colorimetric assay uses the 
spectrophotometric detection of the chromophore p-nitroaniline (pNA) after its 
cleavage by caspases from the labelled caspase-specific substrates (Scheme 3-1). 
Comparing the reading of an apoptotic sample with an un-induced control allows 
determination of the protease activity. Units of protease activity are quantified 
accurately and reproducibly using a standard curve established with free pNA.
Induction of apoptosis in cells 
1
Protease activation 
1
Caspase-3
DEVD-pNA
DEVD
pNA
colorimetric
detection
Scheme 3-1- The colorimetric assay uses spectrophotometric detection of the chromophore 
p-nitroanilide (pNA) after cleavage from the labeled substrate DEVD-pNA (ApoAlert Caspase 
Colorimetric Assay Kits brochure, Clontech Laboratories)
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Twenty-four hour S. aureus  infected and un-infected osteoblasts were adjusted 
to 2xl06 cells/ml and cell suspension was centrifuged at 9,000 g for 5 min. Pellets 
were re-suspended in 50 .^1 of chilled cell lysis buffer transferred to eppendorf 
tubes and incubated on ice for 10 min. Cell suspensions were then centrifuged at 
15 000 g in a micro-centrifuge for 10 min at 4 °C and supernatants transferred to 
new eppendorf tubes. Cell lysates were incubated with 50 1^ of 2X reaction 
buffer, lOOmM of DTT and 5 |il of 1 mM caspase 3 substrate DEVD-pNA in a 37 °C 
waterbath for 1 h. Two parallel control reactions were set up with Caspase 3 
inhibitor and without conjugated substrate. The pNA calibration curve was 
generated by diluting 100 mM of pNA solution in cell lysis buffer making 0, 0.5,1, 
2, and 4 mM stock solutions, and further diluted to obtain the final pNA 
concentrations of 0, 2.5, 5, 10 and 20 nmol. The absorbance of standard and 
samples was read at 405 nm wavelength using the Wallac Victor2 micro plate 
reader system. The caspase 3 activity of each sample was then extrapolated from 
the equation of the line recovered from the standard curve (Scheme 3-2).
pNA Calibration curve
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Scheme 3-2- Example of a pNA standard curve. The equation of the line it is used to calculate the 
units of caspase 3 activity.
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Annexin V detection by Flow Cytometry
One of the applications of flow cytometry is the analysis of cell apoptosis. 
Apoptosis is characterized by a number of intracellular phenomena such as 
membrane blebbing, chromatin condensation and nuclear DNA fragmentation. 
Annexin V allows identification of cell surface changes that occur early during the 
apoptotic process. The AnnexinV-FITC conjugate facilitates rapid fluorometric 
quantification of apoptotic cells. Early in the apoptosis process, 
phosphatidylserine (PS) becomes exposed on the cell surface by flipping from the 
inner to outer leaflet of the cytoplasmic membrane (Scheme 3-3). PS is therefore 
detected and bound by the Annexin-FITC conjugate. Propidium iodide (PI) is also 
used to identify cells that have lost membrane integrity. As cells disintegrate, 
greater access to the inner cell membrane allows for additional Annexin V 
binding. Thus, double labelling is used to help differentiate between early and 
late apoptotic/necrotic events (Scheme 3-4).
Annexin V —
Ca=I
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Nucleus
Mild convolution, chromatin 
compaction and segregation, 
and condensation ol cytoplasm
During apoptosis phosphatidyl serine 
flips to the outer leaflet of the mem­brane and is subsequently detected by FITC or Biotin labeled Annexin
Scheme 3-3- The flipping of PS from the inner leaflet to the outer leaflet of the cell membrane 
represents a hallmark (early and widespread) in detecting dying cells (Annexin V brochure, 
Trevigen®).
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Early
Apoololic
D e x a m e th a s o n e  tre a te d  T h y m o c y te s  
A n n e x in  V FITC + P ro p id iu m  Io d id e
102 103Annexin V FITC
Scheme 3-4 - (A) Example of a dot plot of untreated and (B) Dexamethasone treated thymocytes 
showing viable, early apoptotic (Annexin V FITC positive) and late apoptotic or necrotic cells, 
respectively (Annexin V brochure, Trevigen®).
Apoptosis detection was carried out using the TACS* Annexin V kit- Apoptosis 
detection by flow cytometry. Un-infected and S. aureus  infected osteoblasts over 
24 h were collected by centrifugation at 9,000 g for 5 min at RT. Cells were 
washed once in 500 (il of PBS at 4 °C followed by centrifugation at 9,000 g for 5 
min. Cells were then re-suspended in 100 nl of Annexin V Incubation Reagent 
and left in the dark at RT for 15 min. Finally 400 pil of IX  Binding buffer was 
added to the cell suspension, and each sample was processed within 1 h by 
FACSCalibur™ instrument with the Cell Quest software (Becton Dickinson).
3.3.8. ELISA
Enzyme-linked immunosorbent assay (ELISA) is a biochemical technique widely 
used to determine the presence and the amount of a particular protein in a 
sample.
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Antibody Labeling Reagents
Enzyme
Binding
Sie Target Analy 
I Antigen}
Second Antibody
>  *
Substrate
Ssnip e
l te or Product
Target Analyte
V .  y '  V
Solid Phase
Bind Wash Label Read
Scheme 3-5- ELISA assay illustration. A capture antibody is immobilised to a surface. The specific 
protein present in the sample is applied over the same surface allowing their interaction. After 
washing, the protein of interest will be recognized by the detection antibody which in turn will be 
linked to an HRP linked antibody that will be detectable by the addition of a chemical substrate 
that causes a colorimetric change (Illustration adapted from biosystemdevelopment.com).
The amount of IL-6 released from non-infected and S. aureus  infected 
osteoblasts over 24 h and 48 h was quantified using the Mouse IL-6 ELISA Ready- 
SET-Go (eBIOSCIENCE LTD, UK). A 96-well micro plate was coated with 100 |al per 
well of IL-6 capture antibody and sealed with hydrophobic porous sealing film. 
The plate was then incubated overnight at 4 °C. Following this, wells were 
washed by addition of 250 |il of Wash Buffer. The plate was inverted and blotted 
on absorbent paper to remove any residual buffer. Each well was blocked with 
200 |il of 1 X assay diluent and the plate was incubated at RT for 1 h. Standard 
curve samples were prepared by diluting mouse recombinant IL-6 in 1 X assay 
diluent from a 5,000 pg/ml to 0 pg/ml concentrations. The plate was washed 
again by adding 250 nl of Wash Buffer per well. Finally, 100 |il of standard or 
sample was added to the 96-well plate. The plate was sealed using hydroporous 
sealing film and incubated at RT for 2 h. Following washing the plate, 100 pil of 
detection antibody was added to each well. The plate was incubated for 30 min 
at RT. After three washes with 250 nl of Wash Buffer per well, 100 nl of Substrate 
solution was added to each well, the plate was incubated for 15 min at RT. Finally
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50 |jl of stop solution was added to each well. Absorbance was read at 450 nm 
wavelength using the Wallac Victor2 micro plate reader system (Perkin Elmer, 
Cambridge, UK).
3.3.9. siRNA mediated silencing of the TNFR-1 gene
Small interfering RNA (siRNA) or silencing RNA is a short (21-23bp) double 
stranded RNA with several functions in cells. siRNA transfection involves silencing 
genes in order to suppress the expression of a particular gene. The success of 
these experiments depends on the method of delivery of siRNA (transfection or 
electroporation) and on the transfection agents used, also on the cell type that 
might be hard to transfect.
The silencer siRNA for TNFR-1 from Applied Biosystems was used to knockdown 
the expression of the TNFR-1 gene on MC3T3-E1 osteoblasts (Scheme 3-6). To do 
so the VCA 1001 Cell line nucleofector kit R protocol (Lonza Cologne AG, 
Germany) was used.
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Scheme 3 -6 -Alignment Map with a graphical representation of TNFR-1 Silencer siRNA.
Osteoblasts were harvested by trypsinization and the cell number adjusted to 
1x10s cells per reaction. After centrifugation at 9,000 g for 5 min, supernatant 
was removed and each pellet was re-suspended in 100 ja,l of RT Nucleofector® 
solution R and 150 nM of silencer siRNA for TNFR-1. The cell- siRNA suspension
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was then transferred into the certified cuvette. After selecting the 
Nucleofector® Program A-024 on the Nucleofector system apparatus the 
cuvette was inserted and the program runs for 5 s. Immediately after the 
program finished, 500 |xl of 37 °C pre-equilibrated osteoblast media was added 
to the cuvette and gently transferred into a 6-well plate (final volume of 1.5 ml 
per well). Plate was incubated at 37 °C with 5 % C02 atmosphere until analysis 
(after 24 h and 48 h).
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Efficiency test
The efficiency of gene knockdown was tested by Western blot, as detailed in 
section 2.3.4. using the antibody dilutions described below, in Table 3-4.
Table 3-4- Western blot conditions
Primary antlbod
antibody
Polyclonal anti- 
TNFR-1 produced in 
rabbit 
Polyclonal a- 
actinin produced in 
rabbit
1:1000
1:5000
Secondary antibod
concentration antibody concentration
Goat anti­
rabbit IgG 
HRP 
Goat anti­
rabbit IgG 
HRP
1:10000
1:20000
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3 .4 . R e s u lt s
3.4.1. Identification of the S. aureus protein A ligands that are involved 
in binding osteoblast
S. aureus protein A is well known for its multiple interactions with host ligands. 
Some studies have already demonstrated that SpA residues exposed on the 
helices I and II bind to the Fc region of IgG and that the binding site for the vWF 
regions also recognizes a region on helices I and II of SpA, overlapping the IgG Fc 
binding site (O'Seaghdha, van Schooten et al. 2006). Other studies demonstrated 
that the TNFR-1 also binds to this face but there are some differences in the 
residues of SpA that are involved. In particular, leucine 17 is crucial for binding to 
IgG but not for TNFR-1 binding (Gomez, O'Seaghdha etal. 2006).
Human plasma is rich in several proteins such as albumin, fibrinogen, 
immunoglobulins and von Willebrand factor (vWf). Platelet poor plasma (PPP), 
which is rich in plasma proteins, was pre-incubated with S. aureus Newman prior 
to binding to osteoblasts. There was no significant difference between S. aureus 
Newman binding to osteoblast in the absence of PPP compared to PPP pre­
incubation (Figure 3-1A, P=NS). These results show that even after bacterial 
binding to plasma proteins, S. aureus Newman strain binding to osteoblasts was 
not affected.
Previously, it was demonstrated that deletion of a single amino-acid at the 
Leucine 17 of each IgG binding domain of SpA in S. aureus Newman pCulSpA 
L17A resulted in the loss of the ability of SpA to bind IgG (unpublished Magnhus 
O'Seaghdha 2008, Trinity College Dublin). The S. aureus Newman pCulSpA L17A 
strain was used to investigate whether the IgG binding site was important for 
binding to osteoblasts. S. aureus NewmanpCulSpA L17A binding to osteoblasts 
was similar to the binding observed for S. aureus Newman WT strain (Figure 3- 
1B, P=NS). Consistent with the previous results it was demonstrated that the IgG 
binding site of SpA is not the binding site that mediates S. aureus -  osteoblast
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interaction. More specifically, when SpA binds IgG or vWf it does not affect its 
interaction with osteoblasts, suggesting a distinct binding site.
In order to confirm loss of IgG antibody binding in S. aureus  pCulSpAL17A strain 
two different antibodies were used, an IgG binding antibody and the anti-SpA IgY 
antibody. Western blot analysis confirmed the expression of SpA represented by 
a band at the expected size of 42 KDa for all S. aureus  Newman strains WT, 
pCulSpA and pCulSpAL17A cell wall preparations when using the IgY binding 
antibody (Figure 3-1C). However, as expected, the S. aureus  Newman 
pCulSpaL17A strain did not bind the IgG antibody as the SpA binding site was 
mutated.
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Figure 3-1 (A) -  SpA ligands vW f and IgG do not mediate the binding to osteoblasts. Osteoblasts 
were allowed to adhere to immobilised S. aureus Newman WT control and pre-incubated with 
PPP for 45 min at 37 °C. Binding was determined by measuring the intracellular enzyme alkaline 
phosphatase content at 405 nm in a micro plate reader. Error bars indicate SEM, n=4.
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Figure 3-1 (B + C )- SpA ligands vWf and IgG do not mediate the binding to osteoblasts. (B)
Osteoblasts were allowed to adhere to immobilised 5. aureus Newman WT, pCUlSpA and 
pCUlSpA L17A for 45 min at 37 °C. Binding was determined by measuring the intracellular 
enzyme alkaline phosphatase content at 405 nm in a micro plate reader. Error bars indicate SEM, 
n=4 (C) S. aureus Newman WT, pCUlSpA and pCUlSpAL17A were lysed, separated on a 10 % 
SDS-PAGE gel and electroblotted onto PVDF membranes. Membranes were probed with either a 
non-specific IgG or anti-SpA IgY antibody. Protein bands were detected using species specific 
horseradish peroxidise-conjugated secondary antibody and chemiluminescence.
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3 .4 .2 . In v e s tig a tin g  th e  e xp re ss io n  o f  th e  T u m o r N ecrosis F actor 
R e ce p to r 1 on  o s te o b la s t su rface
C onsistent w ith  th e  lite ra tu re , a 55  KDa band correspond ing  to  th e  TNFR-1  
m o lecu lar size w as observed  in a W e s te rn  b lot o f o s teo b last lysates (Figure 3-2A ) 
(Bu, Borysenko et al. 2 0 0 3 ). The expression o f TNFR -1 on osteoblasts w as also 
eva lu a ted  using FACs analysis. P re-labelling  osteoblasts w ith  an isotype contro l 
or an ti -TN FR -1- FITC an tib o d y  revea led  a positive sh ift o f th e  curve representing  
th e  TNFR -1 positive osteoblasts  w h en  com pared  w ith  th e  isotype contro l curve  
(F igure 3-2B ). In ad d itio n  confocal analysis was used to  visualize th e  expression  
o f TNFR -1 on th e  osteob last surface using a -TN FR -1  -P E  staining. Actin is 
ab un d an tly  fo u nd  in m ost cell types including osteoblasts; th e re fo re  labelling  
osteoblasts w ith  an a -actin -F ITC  was used as co ntro l fo r  th is  exp erim ent. 
O steob last a -TN FR -1  -P E  and a -actin -F ITC  staining are  rep resen ted  respectively  
in green  and red in Figure 3-2C . The results o b ta in ed  co n firm ed  consistent TNFR- 
1 expression on th e  o s teo b last surface.
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Figure 3-2 -  TNFR-l is expressed on osteoblasts surface. (A) Osteoblasts lysates were 
separated on a 10 % SDS-PAGE gel and electroblotted onto PVDF membranes. Membranes 
were probed with rabbit polyclonal anti-TNFR-1. Protein bands were detected using rabbit 
horseradish peroxidase-conjugated secondary antibody and chemiluminescence. (B) 
Osteoblasts were pre-incubated with primary rabbit polyclonal anti-TNFR-1 antibody for 1 h 
at RT followed by 15 min pre-incubation with secondary FITC. Samples were analysed on a 
flow cytometer. (C) Osteoblasts were added to poly-L-lysine slides previously coated with BSA 
for 1 h at 37 °C. Slides were fixed using 3.8 % formaldehyde for 10 min at RT and 
permeabilized with 4 °C acetone for 5 min. Osteoblasts were then stained using a-actin-FITC 
and a-TNFR-l-PE. Visualization was done using an oil-immersion 63 X objective lens in a Zeiss 
LSM 510 confocal microscope.
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3.4 .3 . In v e s tig a tin g  th e  o s te o b la s t re c e p to r  th a t  b in d s  to  5. aureus  
p ro te in  A
In th e  previous section it has been d e m o n s tra te d  th a t S. aureus does not use a 
plasm a p ro te in  (IgG o r V w F) in o rd e r to  bridge th e  b acteria  to  osteoblast and  
m e d ia te  a tta c h m e n t. T h e re fo re  b inding o f S. aureus p ro te in  A to  th e  TNFR1 was 
investigated . To do so, osteoblasts w e re  p re -incu b ated  w ith  an anti-TN FR -1  
polyclonal an tibody. H ow ever, th is  an tib o d y  is o f IgG origin and n o t suitable to  
use w ith  th e  S. aureus N e w m a n  W T  stra in  because it binds to  SpA. T h e re fo re , a 5. 
aureus N ew m an  p C u lL 1 7 A  strain w ith  a ffin ity  to  bind osteoblast w h ile  lacking  
th e  ab ility  to  bind IgG, was used. In th e  presence o f th e  an ti-TN FR -1 an tib o d y  5. 
aureus b inding to  osteoblasts was significantly  reduced (F igure3-3A , PcO.OOl). 
M o re o v e r osteoblasts b inding to  purified  SpA was also significantly reduced  
(P < 0 .0 0 1 ).
In o rd e r to  investigate th a t TN FR -1 on osteoblasts surface is essential fo r  binding  
to  SpA on S. aureus, siRNA was carried  o u t to  knock d ow n  th e  expression o f this  
re c e p to r on osteoblasts surface. Follow ing this, W e s te rn  b lo t analysis confirm ed  
successful silencing o f  th e  expression o f TNFR-1 on osteoblasts (Figure 3-3B ). The  
b lo t shows a 55 KDa band (TN FR -1 m o lecu lar size) fo r  th e  siRNA negative  
osteoblasts and no band fo r  th e  siRNA positive osteoblasts. A lpha-actin in  was  
used as pro te in  loading co ntro l. C onsistent w ith  th e  an tib o d y  inhib ition  results  
above, it was d e m o n s tra te d  th a t silencing o f TNFR -1 expression on th e  
o steo b last surface sign ificantly  reduced  binding to  S. aureus (Figure 3-3C, 
P <0 .05 ). In teresting ly  b ind ing to  purified  SpA was also significantly reduced fo r  
th e  TNFR -1 silenced osteoblasts (P <0 .05 ).
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Figure 3-3 (A)- TNFR-1 is the receptor for SpA on osteoblasts surface. Isotype control and anti- 
TNFR-1 pre- incubated osteoblasts were allowed to adhere to immobilised S. aureus Newman, 
ASpA and pCUlSpAL17A and purified SpA for 45 min at 37 °C. Binding was determined by 
measuring the intracellular enzyme alkaline phosphatase content at 405 nm in a microplate 
reader. *P<0.05, **<0.001 error bars indicate SEM, n=3.
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Figure 3-3 (B + C)- TNFR-1 is the receptor for SpA on osteoblasts surface. (B) siRNA negative and 
siRNA positive osteoblasts lysates were separated on a 10 % SDS-PAGE gel and electroblotted 
onto PVDF membranes. Membranes were probed with rabbit polyclonal anti-TNFR-1 and a- 
actinin as equal loading control. Protein bands were detected using rabbit horseradish 
peroxidise-conjugated secondary antibody and chemiluminescence. (C) siRNA negative 
osteoblasts and siRNA positive osteoblasts were allowed to adhere to S. aureus Newman wild- 
type and ASpA for 45 min at 37 °C. Binding was determined by measuring the intracellular 
enzyme alkaline phosphatase content at 405 nm in a microplate reader. *P<0.05, **<0.001 error 
bars indicate SEM, n=3.
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3.4 .4 . In v e s tig a tin g  d o w n s tre a m  e ve n ts  as a re s u lt o f  5. aureus  p ro te in  
A  b in d in g  to  o s te o b la s t T N F R -1 : A p o p to s is
Given th e  observation  th a t th e  ligand fo r SpA on osteoblast surface is th e  death  
re c e p to r TN FR -1, th e  signalling p a th w ay  fo llow ing  in fection  w ith  S. aureus strains 
w as th e n  investigated . S. aureus has previously  been show n to  induce apoptosis  
in osteoblasts (Tucker, Reilly et al. 20 0 0 ; A lexander, R ivera et al. 2 0 03 ). 
Previously it was d em o n stra ted  th a t SpA is involved in m ed ia tin g  inh ib ition  o f 
osteob last p ro life ra tio n . T h e re fo re , th e  role o f SpA binding to  osteoblasts in 
inducing apoptosis and consequent inh ib ition  o f osteoblast p ro life ra tio n  was 
investigated . O steob last apoptosis w as firs t d e te rm in e d  by m easuring  th e  
a m o u n t o f caspase 3 ac tiv ity  fo llo w in g  incubation  o f cu ltu red  osteoblasts w ith  
and w ith o u t fo rm a ld e h y d e  tre a te d  5. aureus a fte r  a 2 4  h period . Caspase 3 is a 
d o w n s tre a m  e ffe c to r caspase im p o rta n t in th e  a p o p to tic  p a th w ay . In th e  
absence o f S. aureus, caspase 3 activ ity  was m in im al. H ow ever, a fte r  incubation  
w ith  S. aureus N e w m a n  w ild -ty p e , caspase 3 activ ity  was sign ificantly  increased, 
ind icating  th a t th e  osteoblasts w e re  undergo ing  apoptosis (Figure 3 -4A , P <0.05). 
In teresting ly , no increase in caspase 3 ac tiv ity  was seen fo llo w ing  ad d ition  o f th e  
S. aureus p ro te in  A d e fec tive  m u ta n t (P=NS com pared  to  th e  resting osteoblasts). 
The S. aureus N ew m an  p C U lS p A  co m p le m e n te d  strain s ignificantly induced  
caspase 3 activ ity  as was S. aureus N e w m a n  W T  (P <0.01). M o re o v e r, add ition  o f 
p urified  SpA to  osteoblasts also considerab ly increased caspase 3 activ ity  
(P <0 .05 ).
D e tec tio n  o f osteoblast a p o p to tic  events  was also m easured  by quan tify ing  the  
a m o u n t o f A nnexin  V - FITC b inding fo llo w in g  incubation  o f cu ltu red  osteoblasts  
w ith  and w ith o u t fo rm a ld e h y d e  tre a te d  S. aureus over a 2 4  h period . A nnexin  V 
binds to  th e  phosphatidylserine (PS) th a t becom es exposed on th e  cell surface  
w h e n  it flips fro m  th e  in n er to  th e  o u te r  lea fle t o f th e  cytoplasm ic m e m b ran e  o f  
th e  cell, a m ain  characteris tic  o f early  apoptosis. In th e  absence o f S. aureus 
a p p ro x im ate ly  40%  o f th e  resting osteoblasts appeared  to  bind Annexin V 
an tib o d y  (Figure 3-4B ). H ow ever, th e  addition  o f 5. aureus N ew m an  to  th e  
osteoblasts  led to  a sign ificant increase in Annexin V  b ind ing (Figure 3-4B+C,
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P <0.01). In contrast, addition  o f S. aureus N e w m a n  SpA defective  m u ta n t failed  
to  induce apoptosis above th e  levels o b ta in ed  fo r  th e  resting osteoblasts (P=NS). 
M o re o v e r, add ition  o f S. aureus N e w m a n  pC U lS p A  to  osteoblasts significantly  
increased th e  levels o f Annexin-F ITC  b ind ing im plicating  a significant increase on  
th e  levels o f ap op to tic  osteoblasts w h e n  com pared  w ith  th e  resting osteoblasts  
levels (P <0 .05 ). The a m o u n t o f dead  osteoblasts b e fo re  and a fte r  add ition  o f 
fo rm a ld e h y d e  fixed S. aureus w as also q u an tified  by m easuring  th e  Propid ium  
Iod ide  (PI) binding in tens ity  o ver 2 4  h (Figure 3 -4 D ). PI is used to  id en tify  cells 
th a t have lost m e m b ran e  in teg rity  by b inding d e frag m en ted  DNA. The levels o f 
dead osteoblasts fo r  th e  resting co ntro l rem ain ed  lo w er than  20  %, w h ile  a fte r  
incubating  osteoblasts in th e  presence o f S. aureus N ew m an  w ild -ty p e  increased  
to  m o re  th an  4 0  % (Figure 3 -4 D , P <0 .01 ). A dd ition  o f 5. aureus N e w m a n  SpA 
d efec tive  m u ta n t did not change th e  levels o f dead osteoblasts w h e n  com pared  
to  u n -in fec ted  osteoblasts (P=NS). H o w ever, th e  ad d ition  o f S. aureus N ew m an  
w ild -ty p e  and co m p le m e n te d  strain  N e w m a n  pC U lS p A  show ed a significant 
increase in th e  num bers o f PI positive osteoblasts (Figure 3 -4 D , P <0 .01  and  
P <0 .05 , respective ly).
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Figures 3-4 (A) - SpA expressing strains induce osteoblast apoptosis. Osteoblasts (5 x 10 
cells/ml) were pre-incubated with either control buffer or formaldehyde fixed S. aureus Newman 
(1 x 109 cells/ml) for 24 h. Osteoblasts were lysed and incubated with caspase 3 substrate (DEVD- 
pNA) for 1 h at 37 °C. Caspase 3 cleavage was measured at 405 nm in a microplate reader.
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Figures 3-4 (B+C) - SpA expressing strains induce osteoblast apoptosis. Annexin V-FITC binding 
by FACs analysis: pellets from un-infected or S. aureus Newman infected osteoblasts were re­
suspended in 100 nl of Annexin V-FITC labelled antibody. Suspensions were incubated in the dark 
for 15 min at RT and analysed by flow cytometry and plotted (B) in a graphic bar; and (C) in a 
histogram. *P<0.01, **P<0.05, error bars indicate SEM, n=3.
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Figures 3-4 (D)- SpA expressing strains induce osteoblast apoptosis. PI staining by FACs analysis: 
pellets from un-infected or S. aureus Newman infected osteoblasts were re- suspended in 100 
of PI staining. Suspensions were incubated in the dark fo r 15 min at RT and analysed by flow 
cytometry and plotted in a graphic bar. *P<0.01, **P<0.05, error bars indicate SEM, n=3.
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3.4 .5 . In v e s tig a tin g  d o w n s tre a m  e v e n ts  as a re s u lt o f  S. aureus  p ro te in  
A  b in d in g  to  o s te o b la s t T N F R 1 : NFkB a c tiv a tio n
As w e ll as th e  TN FR -1 being recognised as a d ea th  rec e p to r it also plays an 
im p o rta n t role in th e  contro l o f gene transcrip tio n  th ro u gh  NFkB. NFkB is a 
d im eric  p ro te in  w h ich  translocates fro m  th e  cytoplasm  to  th e  nucleus and is 
co ntro lled  by th e  in h ib ito ry  pro te in  Ikp (C arm ody and Chen 2007 ; K a lthoff 2 0 0 9 ). 
W h e n  th e  TNFR -1 p a th w a y  is s tim u la ted  Ikp is d egraded  and NFkB is re leased to  
th e  nucleus w h e re  it activates transcrip tio n a l factors  th a t m ed ia te  th e  expression  
o f in fla m m a to ry  cytokines and chem okines (Panzer, S te in m etz  et al. 2 0 09 ).
As a m easure o f NFkB activa tion , d egradatio n  o f Ikp was investigated  by 
im un o b lo ttin g . N orm al osteoblasts w e re  in fected  o ver a 9 0  m in period w ith  5. 
aureus N e w m a n  W T , ASpA and p C u lS p A  strains. A nti-TN FR -1 p re-incu b ated  
osteoblasts and TN FR -1 silenced osteoblasts w e re  in fected  w ith  S. aureus 
N e w m a n  W T  o ver th e  sam e period . H EK 293t cells w e re  used as a positive  
co ntro l. Ikp degradatio n  was observed  o ver a 90  m in p eriod  fo llo w in g  in fection  
o f osteoblasts w ith  S. aureus N ew m an  W T  (Figure 3 -5A ) and p C u lS pA  (Figure 3- 
5C). H ow ever, fo llo w in g  in fection  w ith  S. aureus N e w m a n  SpA defec tive  strain , 
Ikp was n o t d egraded  o ver th e  90  m in period  (Figure 3-5B ). C onsistent w ith  this  
p re -incu b ating  osteoblasts w ith  an an ti-TN FR -1  an tib o d y  (Figure 3 -5 D ), in o rd er  
to  p re v e n t th e  in te rac tio n  w ith  S. aureus p ro te in  A, p reven ted  th e  d egradatio n  o f 
Ikp. F u rth e rm o re  using osteoblasts lacking th e  expression o f TNFR-1 also fa iled  to  
induce Ikp degradatio n  in th e  presence o f S. aureus N e w m a n  (Figure 3 -5E ). These  
results d em o n s tra te  th a t in th e  absence o f SpA on th e  S. aureus surface o r in 
TN FR -1 blocked o r d e fec tive  osteoblasts, th e  TNFR -1 p a th w ay  is n o t s tim u la ted . 
C onsequently  Ikp retains NFkB in th e  cytosol com prom ising  th e  transcrip tion  o f 
genes involved in in fla m m a to ry  response.
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Figure 3-5 -  SpA binding to TNFR-1 induces NFkB activation. Ik|3 expression over 90 min period in 
normal osteoblasts following infection with S. aureus Newman WT, ASpA and pCulSpA and in a- 
TNFR-1 blocked or defective osteoblasts, following infection with S. aureus Newman WT. Un­
infected and infected osteoblasts lysates were separated on a 10 % SDS-PAGE gel and 
electroblotted onto PVDF membranes. Membranes were probed with monoclonal Ikp antibody. 
Protein bands were detected using mouse horseradish peroxidise-conjugated secondary antibody 
and chemiluminescence. Immunoblots are representative of three independent experiments.
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3.4 .6 . In v e s tig a tin g  d o w n s tre a m  e v e n ts  as a re s u lt o f  S. aureus  p ro te in  
A  b in d in g  to  o s te o b la s t T N F R -1 : C y to k in e  re lease
IL-6 is a m a jo r in fla m m a to ry  cytokine re leased  at th e  site o f in fection  in several 
host cells including osteoblasts. Its expression is co ntro lled  by NFkB. IL-6 release  
in norm al and TN FR -1 silenced osteoblast supernatan ts  b efo re  and a fte r  
in fec tio n  w ith  S. aureus N e w m a n  o ver 2 4  h and 4 8  h was investigated . The levels 
o f IL-6 release 24 h a fte r  in fection  w ith  S. aureus N e w m a n  W T  and pC u lS pA  w ere  
sign ificantly  h igher, th an  th e  levels o f IL-6 released in un -in fected  osteoblast 
contro ls  (Figure 3 -6 , P <0 .05). IL-6 release was fu r th e r  increased 48  h a fte r  
in fection  w h en  osteoblasts w e re  in fected  w ith  both  S. aureus N ew m an  W T  and  
p C u lS p A  (PcO.OOl). In fecting  osteoblasts w ith  S. aureus N e w m a n  strain defective  
in SpA expression did n o t induce release o f th is cytokine o ver 2 4  h o r 4 8  h (P=NS, 
w h e n  com paring  w ith  th e  u n -in fec ted  osteoblasts co n tro l). IL-6 secretion  by 
TN FR -1 silenced osteoblasts rem ain ed  low  b e fo re  and a fte r  in fection  w ith  S. 
aureus N ew m an  W T, o ver 24  h and 4 8  h (P=NS, w h e n  co m p ared  w ith  th e  un­
in fec ted  osteoblasts co ntro l). These results suggest th a t S. aureus p ro te in  A can 
induce NFkB ac tiva tio n  and regu la te  th e  release o f IL-6 fro m  S. aureus in fected  
osteoblasts by d irec t in te rac tio n  w ith  th e  TNFR-1.
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Figure 3-6 - SpA binding to TNFR-1 induces IL-6 release on osteoblasts. The levels of IL-6 
released were quantified in supernatants of un-infected and S. aureus  infected normal and TNFR-
1 defective osteoblasts, over 24 h and 48h infection times. *P<0.05, **P<0.001, error bars 
indicate SEM, n=3.
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3 . 5 .  D i s c u s s i o n
In th e  previous c h a p te r It was d e m o n s tra te d  th a t S. aureus p ro te in  A m ed iates  
bacteria l b inding to  osteoblasts inducing inh ib ition  o f osteoblast p ro life ra tio n  
a fte r  in fec tio n . SpA is one o f th e  m ost p re v a le n t cell w all surface p ro te ins on S. 
aureus and it has been show n to  p lay an im p o rta n t role in th e  success o f 5. 
aureus as a hum an pathogen  (O 'S eaghdha, van Schooten et al. 2 0 0 6 ; Foster 
2 0 0 9 ). By b inding th e  Fc p ortion  o f im m u no g lo b u lin , SpA assists S. aureus in 
evasion o f phagocytosis by neutroph ils  (Foster 2 0 0 5 ). SpA also binds to  von  
W ille b ra n d  fa c to r w h ich  m ay play a ro le  in supporting  p la te le t b inding in th e  
early  stages o f th rom bosis  (O 'Seaghdha, van Schooten et al. 2 0 0 6 ). M o re  
recen tly , G om ez and colleagues d e m o n s tra te d  th a t SpA binds to  TNFR -1 resulting  
in p ro -in fla m m a to ry  signaling (G om ez, O 'Seaghdha et al. 2 0 0 6 ) in lung ep ithe lia l 
cells in staphylococcal pneu m o n ia . In th is chapter, it was investigated  w h e th e r  
any o f th ese  sites w e re  im p o rta n t fo r S. aureus p ro te in  A b inding to  osteoblasts.
In this study, consistent w ith  previous reports , expression o f TNFR-1 on 
osteoblasts surface was co n firm ed , m aking  th is  a possible cand idate  fo r binding  
to  5. aureus p ro te in  A. The  TN FR -1 on osteoblasts plays a p articu larly  im p o rta n t  
ro le  in bone disease as e n g ag em en t o f T N F a  w ith  its re c e p to r has been  
im p lica ted  in a w id e  spectrum  o f bone diseases including osteoporosis and  
rh e u m a to id  a rthritis  (Chen and G oeddel 20 0 2 ; Ochi, Hara et al. 2 0 1 0 ). To 
investigate  th e  ro le o f TN FR -1 in b inding SpA osteoblasts w ere  p re -incubated  
w ith  a blocking polyclonal an tib o d y  against TNFR-1. B lockade o f th e  recep to r  
resu lted  in significantly  reducing S. aureus binding to  osteoblasts and to ta lly  
abolished th e  b inding o f purified  SpA and SpA D -dom ain  to  osteoblast. These  
results suggest th a t  S. aureus pro te in  A binds to  th e  TNFR-1 on osteoblast m ost 
likely th ro u gh  its D d om ain . In su pp o rt o f th is, siRNA was also used, to  knock 
d ow n  th e  TNFR-1 on osteoblasts and investigate  th e  in teraction  w ith  5. aureus. 
C onsistent w ith  above osteoblasts lacking expression o f TNFR1 significantly  
reduced  th e  b inding to  S. aureus. In te res tin g ly  S. aureus lacking expression o f
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SpA d em o n stra ted  reduced b ind ing  to  th e  TN FR -1 silenced osteoblasts  
suggesting o th e r in teractions  exist
The d o w n stream  signalling functions o f TNFR 1 on various cell types is th e  focus 
o f m any research groups th ro u g h o u t th e  w orld . P robably th e  best characterised  
fu n ctio n  o f TNFR1 is its ab ility  to  contro l apoptosis and in fla m m a to ry  processes 
(Locksley, Killeen et al. 2001 ; Chen and G oeddel 2 0 0 2 ). Follow ing en g ag em en t o f 
TNFR -1 by its ligand tw o  in d ep en d en t d o w n s tre a m  pathw ays can be activated : 
th e  activation  o f th e  ap op to tic  cascade th a t w ill end  in cell d ea th , and th e  
activation  o f th e  N FkB signaling w hich m ed ia tes  th e  expression and secretion  
in fla m m a to ry  cytokines (Ghosh and Karin 20 0 2 ; K a ltho ff 2 009 ).
Several reports  have d e m o n stra ted  th a t  S. aureus can induce apoptosis in 
osteoblasts (Tucker, Reilly et al. 2 0 0 0 ; A lexander, R ivera et al. 2 0 0 3 ); how ever  
th e  m echanism  by w h ich  th is  occurs has n o t ye t been e luc idated . Caspase 3 
activ ity  and m e m b ra n e  b lebb lng  are  key m echanism s th a t lead to  cell apoptosis. 
A ctive caspase 3 and annexin  V b inding (as a m easure o f m em b ran e  b lebbing) 
w e re  d e te c te d  in u n -in fec ted  osteoblasts, m ost likely due to  norm al apoptosis  
and cell tu rn o v e r in th e  in vitro osteo b las t tissue cu ltu re  system . C onsistent w ith  
previous observations (A lexander, R ivera et al. 2 0 0 3 ) w h en  osteoblasts w ere  
exposed to  S. aureus, caspase 3 ac tiv ity  and annexin  V  b inding w e re  significantly  
increased. H ow ever, th e  SpA m u ta n t y ie lded  sim ilar results to  th e  un-in fec ted  
osteoblasts w h ereas  th e  S. aureus N e w m a n  p C u lS pA  c o m p lem en ted  strain or 
ad d ition  o f purified  p ro te in  A, increased caspase 3 and annexin  V  in osteoblasts  
to  levels s im ilar to  S. aureus N e w m a n  w ild -ty p e . It is re levan t to  note  th a t even  
though previous results d e m o n s tra te d  th a t S. aureus a -to x in  induced apoptosis  
in Jurkat cells via th e  B cl-2-contro lled  m ito cho n d ria l death  p a th w ay  which  
involves caspase 3 (M en z ies  and K ourteva 2 0 0 0 ) h o w e v e r this m echanism  is not 
playing a ro le in th ese  exp erim ents  as all th e  S. aureus cells w e re  previously  
fo rm a ld eh yd e -fixed  and cannot p roduce a -to x in . T h e re fo re  these findings  
suggest th a t S. aureus pro te in  A binds to  osteoblasts, th ro u gh  an in te rac tio n  w ith
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th e  d ea th  rec e p to r TNFR-1, inducing caspase 3 activation  and m em b ran e  
b lebb ing  w ith  an end p o in t o f apoptosis.
A n o th e r path  d ow n stream  o f TNFR -1 results in th e  degradatio n  o f NF-kB, w hich  
in tu rn  m ed iates gene transcrip tio n . The  nuclear trans location  o f NF-kB is 
reg u la ted  by cytoplasm ic in h ib ito ry  p ro te in  IkB. Follow ing degradatio n  o f IkB, NF- 
kB is re leased and activa ted  (C arm ody and Chen 2007 ; K riete and M ayo  2 009 ). 
Follow ing 5. aureus p ro te in  A b ind ing  to  osteoblast TNFR -1, IkB is degraded  
causing activation  o f NF-kB. D e le tion  o f e ith e r  SpA fro m  S. aureus o r using siRNA  
silenced TNFR-1 on osteoblasts, th e  d egradatio n  o f IkB is in h ib ited . These results  
w e re  consistent w ith  previous findings d em o n stra tin g  th a t S. aureus b inding to  
osteoblasts results in activation  o f NF-kB (N ing, Zhang e t  al. 2 0 1 0 ), h o w e v e r th e  
p resen t study identifies  th e  m echanism  th ro u gh  w hich NF-kB activa tion  occurs.
G iven th e  observation  th a t SpA in te rac tio n  w ith  TNFR -1 m ed ia tes  th e  signalling  
lead ing  to  N FkB ac tiva tio n , and re ly ing  on th e  fac t th a t activation  o f th e  N F-kB 
transcrip tio n  fac to r regulates a n u m b e r o f genes involved in a w id e  va rie ty  o f 
biological processes such as cytokines m ed ia tin g  in fla m m a to ry  processes (Liou
2 0 0 2 ) th e  next step it was to  fu r th e r  investigate  w h e th e r  this activation  could be 
regu la ting  th e  release o f cytokines by osteoblasts in this system . Cytokines are  
signalling pro te ins involved in cell—to -ce ll co m m u n ica tio n , in disease, these  
n etw o rks  can becom e unbalanced. M easu ring  am plifica tion  or d ow n -reg u la tio n  
o f cytokine signaling cascades in response to  pathological insults m igh t be 
benefic ia l to  eva lu a te  disease progression (H ouse and Descotes 2 0 0 7 ). Several 
studies have a lready published th a t fo llo w in g  S. aureus in fection , osteoblasts  
re lease cytokines and chem okines involved in th e  activa tion  o f in flam m ato ry  
responses in osteom yelitis  disease (Bost, Ramp et al. 1999 ; Bost, B ento e t  al. 
2 0 0 1 ; M a rr io tt , G ray et al. 2004 ; W rig h t and Friedland 2 0 0 4 ). IL-6 is a p le io trop ic  
cytok ine  th a t acts as a reg u la to r o f im m u n e  response and in flam m atio n  during  
in fection  o r tra u m a  (N ish im oto  and Kishim oto 2 0 0 4 ). It can be secreted  by 
m acrophages, m onocytes and T-cells m ed ia tin g  fe v e r and sickness behaviour in 
response to  specific pathogen ic  m olecules (Banks, Kastin et al. 1994 ; C artm ell,
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Poole et al. 2 0 0 0 ; H arden, du Plessis et al. 2 0 0 6 ). In bone associated diseases, IL- 
6 inh ib ito rs  have been used to  tr e a t  postm enopausal osteoporosis and  
rh eu m ato id  a rth ritis  (Edw ards and W illiam s  20 1 0 ; Jazayeri, Carroll et al. 2 010 ). 
M o re o v e r studies in osteom yelitis  ind icate  th a t osteoblasts s ignificantly au gm ent 
IL-6 secretion  fo llo w ing  S. aureus in fec tio n  inducing bone resorp tion  (M a rr io tt ,  
G ray et al. 20 0 4 ; M a rr io tt , G ray et al. 2 0 0 5 ; N ing, Zhang et al. 2 0 1 1 ). These  
results confirm  th a t fo llo w ing  S. aureus in fec tio n  IL-6 release is u p -regu la ted . 
H ow ever, also in th e  absence o f SpA o r using siRNA silenced TNFR-1 on 
osteoblasts th is u p -reg u la tion  is in h ib ited . These results suggest th a t th is  specific 
in te rac tio n  b e tw e e n  SpA and TN FR -1 is regu lating  IL-6 secretion  and  
co nsequently  m ed ia tin g  th e  activation  o f an a n ti- in fla m m a to ry  response a fte r  
osteob last in fection  w ith  S. aureus. U p -reg u la tio n  o f IL-6 release by osteoblasts  
has been a lread y  re p o rted  to  induce bone resorp tion  via osteoclast activation  
(Kwan T at, Padrines et al. 2 0 0 4 ). O th e r w o rk  in o u r lab o ra to ry  has d em o n stra ted  
th a t upon cytokine release fro m  osteoblasts it leads to  th e  m igration  and  
subsequent activation  o f th e  bone resorb ing  cells th e  osteoclasts. C ollectively  
th ese  results m ay help explain th e  sign ificant bone destruction  and in flam m atio n  
fo u n d  a t th e  site o f in fection  in o s teom yelitis  patien ts .
In conclusion, th is study describes a novel m echanism  fo r 5. aureus binding to  
osteoblasts, d em o nstra ting  th a t 5. aureus viru lence fa c to r SpA binds d irectly  to  
osteoblasts th ro u gh  TNFR -1. This in te rac tio n  results in th e  genera tio n  o f m u ltip le  
signals lead ing to  inh ib ition  o f osteoblast p ro life ra tio n , osteoblast apoptosis, and  
activation  o f th e  NF-kB p a th w a y  in osteoblasts a fte r  S. aureus in fection . 
F u rth e rm o re  activation  o f NF-kB by SpA -T N F R -1  in teraction  also m ed ia tes  the  
activa tio n  o f in flam m atio n  via secretion  o f IL-6.
Chapter 3- Investigation the osteoblast receptor involved in binding S. aureus protein A and the downstream
signalling events tha t occur as result o f this interaction
157
Chapter 4- Study o f the  molecular mechanisms involved in 5. epidermidis binding to  osteoblasts: early steps
in im plant infection
Chapter 4
Study of the molecular mechanisms involved in 
5. e p i d e r m id i s  binding to osteoblasts: early 
steps in implant infection
158
4 . 1 .  I n t r o d u c t i o n
The previous chapters  focused on th e  m o lecu la r in teractions  underly ing  S. 
aureus a tta c h m e n t to  osteoblasts and induced bone d estru ction  and  
in fla m m a tio n . M a jo r  findings w e re  ach ieved  unravelling  p a rt o f th e  m echanism  
by w h ich  S. aureus in fections cause in fla m m a tio n  and bone fractures in 
osteom yelitis . The second m a jo r cause o f osteom yelitis  and firs t cause o f im p lan t 
re la te d - in fection , S. epidermidis is an im p e ra tiv e  m icroorganism  to  investigate. 
In o rd e r to  fu r th e r  study th e  m echanism s underly ing  osteom yelitis  and bone  
in fections, th e  next step was to  investigate  Staphylococcus epidermis in teraction  
w ith  osteoblasts.
S. epidermidis is recognized as th e  m ost w idespread  and persistent 
m icroorgan ism  colonizing th e  skin and m ucous m em branes  o f all hum ans  
(O 'G ara and H um phreys 20 0 1 ; V uong  and O tto  20 0 2 ; van d e r M e e -M a rq u e t,  
A chard et al. 2 0 0 3 ). It rare ly  causes in fec tio n  in h ea lth y  p eop le , h ow ever, over 
th e  past tw o  decades it has em erg ed  as an im p o rta n t o pp o rtu n is tic  pathogen  
associated w ith  in travascular ca th e ters  and p rosthetic  im p lan ta tio n  (Kristinsson  
19 8 9 ; Bailey, Constance et al. 1990 ; K archm er 1991; M enzies , M acC ulloch et al. 
1991 ; G o ldm ann  and Pier 1993 ; V uong  and O tto  2 0 0 2 ) m ostly  in im m u n o ­
co m p ro m ised , im m uno-suppressed , lo n g -te rm  hospitalised and critically ill 
p atien ts  (D om ingo and F o n tan e t 2001 ; Z iebuhr 2 0 0 1 ). S. epidermidis  has been  
re p o rte d  to  account fo r  5 0  to  8 0  % o f th e  recovered  isolates fro m  im plan ted  
re la ted  infections (A rcher 1 9 9 0 ) being th e re fo re  considered a lead ing  cause o f 
th ese  in fections (Rupp and A rcher 1 994 ). A lthough m any o f th ese  infections are  
m inor, co lonisation and fu r th e r  b io film  fo rm a tio n  o f S. epidermidis in to  foreign  
m edical devices can deve lop  into  m a jo r cases o f bone infections such as 
o steo m yelitis  (Seibold and Betz 1991 ; Barasch, M o s ie r et al. 1993; De W it , M u lla  
et al. 1 9 9 3 ).
The m echan ism  by w hich  S. epidermidis contribu tes  to  th e  co lon ization  o f 
m edical devices p ro m o tin g  bone d estru ction  it is n o t fu lly  understood . Som e  
studies suggest th a t co lon ization  o f fo re ign  m ateria l by S. epidermidis relies on
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th e ir  ab ility  to  fo rm  biofilm s (M ack  19 9 9 ; M ack, Bartscht et al. 2 0 0 0 ). B iofilm  
fo rm a tio n  starts fo llow ing  secretion  o f an ex trace llu la r substance com posed o f 
d iffe re n t polysaccharides im p o rta n t in p ro m o tin g  bacteria l a tta c h m e n t to  foreign  
devices. This step is crucial to  in itia te  in fection  and also serves to  p ro te c t th e  
colonizing m icroorganism  fro m  host d e fe n c e  m echanism s and th e  action  o f 
an tim icro b ia l agents (H oyle and C osterton  1991 ; C osterton , S te w a rt et al. 1999; 
S te w a rt and C osterton  2 0 0 1 ). O th e r studies suggest th a t S. epidermidis surface  
associated m ate ria l is an im p o rta n t v iru lence  fa c to r conferring  this pathogen  
o steo ly tic  activ ity  th a t plays a m a jo r ro le in bone destruction  during  disease 
(M e g h ji, Crean et al. 1 9 97 ).
S. epidermidis ab ility  to  bind to  fib rin o gen  in im p lan t devices has been rep o rted  
and a ttr ib u te d  to  th e  expression o f th e  surface adhesin SdrG (Nilsson, Frykberg  
et al. 1998 ; H artfo rd , O 'Brien et al. 2 0 0 1 ). SdrG is a w e ll know n 5. epidermidis 
M S C R A M M  highly hom ologous to  th e  c lum ping  fa c to r A and B fro m  S. aureus 
w hich have also been  show n to  bind fib rin o gen  in fo re ign  body infections caused 
by S. aureus (M c D e v itt, Francois et al. 1994 ; Ni Eidhin, Perkins et al. 1998). 
M o re o v e r during  S. aureus- o steo b last in te rac tio n , th e  fib ron ec tin  binding  
prote ins also bind to  fib rinogen  w h ich  in tu rn  in teracts  w ith  th e  a 5P! in tegrin  
triggering  bacteria l in te rna liza tio n  by th e  bone cells (H udson, Ram p et al. 1995; 
Ellington, Reilly et al. 1999; Jevon, G uo et al. 1 999 ). F u rth e rm o re , osteoblast 
in tegrin  a 2Pi in te rac tio n  w ith  typ e  I collagen is involved in th e  regu lation  o f m any  
cellu lar activ ities including th e  ac tivation  o f collagenase in bone destruction  
(R iikonen, W e s te rm a rc k  et al. 1 9 9 5 ). These findings support th e  fac t th a t  
bacteria l in te rac tio n  w ith  in tegrin  recep to rs  on osteoblasts m ed ia tes  signaling 
pathw ays on staphylococcal bone infections. N onetheless, desp ite  all th e  studies  
in th e  past, S. epidermidis in fections associated w ith  m ed ical devices continues  
to  p resen t a t an a larm ing  high ra te  (D aro u ich e , M ansouri et al. 2 0 0 7 ). T h ere fo re , 
ad d ition a l investigations are  needed  in o rd er to  deve lop  novel th erap ies  
p reven tin g  S. epidermidis ad heren ce  and consequent b io film  fo rm a tio n , 
th e re fo re  avoid ing  in fection  and fu r th e r  bone destruction , th e  ha llm ark  in 
o steo m yelitis  bone disease.
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4 .1 .1 . C h a p te r A im s
•  Investigate  th e  ab ility  o f S. epidermidis to  in te ra c t w ith  osteoblasts
•  Id en tify  th e  S. epidermidis cell w a ll surface p ro te in  th a t is Invo lved in
b ind ing  to  osteoblasts : P ro teom ic  approach
•  Investigate  th e  ro le  o f  th e  id e n tifie d  p ro te in  fro m  th e  p ro teo m ic  analysis
in m ed ia tin g  o s teo b last a tta c h m e n t
•  In vestigate  th e  d o w n stream  even ts  in osteoblasts as a resu lt o f S. 
epidermidis a tta c h m e n t
Chapter 4- Study o f th e  m olecular mechanisms involved in S. epidermidis binding to  osteoblasts: early steps
In im plant infection
161
4 . 2 .  C h e m i c a l s  a n d  g e n e r a l  c o n d i t i o n s
The chem icals and conditions used in th is  study are  described in d e ta il in C hap ter  
2, section  2.2, ad d ition a l chem icals and e q u ip m e n t fo r  th is  specific ch a p te r are  
sta ted  b e lo w  in ta b le  4 -1 .
Table 4-1- List of chemicals and equipment used in this chapter.
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4 . 3 .  M e t h o d s
4 .3 .1 . B a c te ria l c u ltu re  c o n d it io n s
T he  b acteria l cu ltu re  conditions used in th is  ch a p te r are described in d eta il in 
section 2 .3 .1 .
B a cte ria l s tra in s
The b acteria l strains used In this ch a p te r a re  listed b e lo w  Table  4 -2 .
Table 4-2 - Bacterial strains and isolates used in this chapter
Relevant Characteristics n B B
R f l H
NCTC8178 wild-type 
Isoiated from a case of secondarily infected 
tubercular osteomyelitis in man
(Duthie and Loren* 
1952)
Wild type 
Isolated from a human patient with 
osteomyelitis 
/£e::ermr 
Defective in SdrG (fbe)
Wild type 
Isolated from blood samples 
Defective in SdrG
Biofilm positive, cerebrospinal fluid isolate
Wild type
Insertion of pkS80 (sdrG+) vector 
Highly expresses sdrG protein from S.
____________epidermidis____________
(Nilsson, Frykberg et 
al. 1998)
(Hartford, O'Brien et 
al. 2001)
* (Mack, Siemssen 
et al. 1992)
*
* *  (Conlon, 
Humphreys et al.
2002)
(Wells, Wilson et al. 
1993)
(Hartford, O'Brien ef 
al. 2001)
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*  The S. epidermidis 9 1 4 2 , 9 1 4 2 A sdrG w e re  a kind g ift fro m  Prof. T im o th y  Foster 
in D e p a rtm e n t o f M icro b io lo g y  in T rin ity  College D ublin , Ire land.
* *  The 5. epidermidis C SF41498 was a kind g ift fro m  Dr. James O 'G ara , C onw ay  
In s titu te  o f B iom olecu lar and B iom edical Research, UCD Ire land.
G ro w th  c o n d it io n s
S. epidermidis strains w e re  grow n in Brain H eart Infusion (BHI) b ro th  in sealed  
tubes o vern ig h t a t 3 7  °C. The Lactococcus lactis strains w e re  grow n in M 1 7  broth  
(try p to n e  5 g /l, soya p e p to n e  5 g /l, Lab-Lem co p o w d e r 5 g /l, Yeast ex trac t 2 .5  g /l, 
ascorbic acid 0 .5  g /l, m agnesium  su lphate  0 .2 5  g /l, d i-sod ium -g lycerophosphate  
19 g /l)  su pp lem en ted  w ith  0 .5  % glucose in sealed tubes  overn ig h t a t 3 0  °C. 
E rythrom ycin  (5 pig/m l) w as added  to  m ed ia  w h en  grow ing  L. lactis SdrG+ strain .
4 .3 .2 . Cell c u ltu re  c o n d it io n s
The osteoblasts cu ltu re  conditions o f th e  M C 3T3-E 1  cell line used in this ch ap ter  
are  described in d e ta il in section 2 .3 ,2 ..
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4 .3 .3 . F u n c tio n a l assays 
O s te o b las ts  b in d in g  assay
The osteoblasts b ind ing  p ro tocol is described in d e ta il in section 2 .3 .3 . In this  
ch ap ter, fo r  som e studies, osteoblasts w e re  p re -incu b ated  w ith  1 m M  of 
A rg in in e - G lycine- A spartic  acid- Serine (RGDS) fo r  30  m in a t 37 °C p rio r addition  
to  th e  9 6 -w e ll p la te . RGDS is a p ep tid e  m im etic  o f th e  in tegrin  recognition  site 
A rg in ine- G lycine- A spartic  acid (RGD).
O ste o b la s ts  p ro life ra t io n  assay
T he osteoblasts b inding pro tocol is described in d eta il in section 2 .3 .3 .
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O s te o b la s t liv e  - dea d  assay
O steoblasts w e re  harvested  as described  in section 2 .3 .2 . and cell co un t ad justed  
to  1 .5  x lO 5 cells p er 3 0 0  pi p er w e ll, w ith  subsequent addition  o n to  a 9 6 -w e ll 
tissue cu ltu re  p la te . P late was tra n s fe rre d  to  th e  tissue cu ltu re  in cu b ato r at 37  
°C, 5 % C 0 2 fo r 24  h. S. epidermidis cu ltures w e re  harvested , PBS w ashed  and  
fixed  in 4 .8  % fo rm a ld e h y d e  as described in section 2 .3 .1 .. Bacterial 
co ncen tra tio n  w as th e n  ad justed  to  an O D 60[)nm o f 1 in osteoblast su pp lem en ted  
m edia . A fte r 24  h, osteoblasts w e re  w ashed  in w arm  PBS and b acteria  w e re  
added  in th e  sam e vo lu m e to  w ells w ith  th e  previously incubated  osteoblasts. 
Bacteria and osteoblasts w e re  co -cu ltu red  fo r fu r th e r  24  h. The live assessm ent 
o f osteoblast fo llo w in g  in fection  w ith  S. epidermidis was p e rfo rm e d  using th e  
Live S tain ing Kit fro m  Sigm a-A ldrich, w h ereas  ca lce in -A M  (green -  live) was used 
a t a 1:1 ratio  in a fluo rescence so lu tion . Each w e ll o f th e  9 6 -w e ll p la te  was  
w ashed by ad d itio n  o f 3 0 0  pi o f PBS p er w e ll. Follow ing this th e  fluorescence  
solution w as ad ded  fo r  4 0  m in, and absorbencies read  a t 4 9 0  nm  fo r  C alcein -A M  
using a m ic ro -p la te  read er.
4 .3 .4 . P ro te in  b io c h e m is try  
B a c te ria l ce ll d ig e s tio n  - M u ta n o ly s in
S. epidermidis strains w e re  g row n and harvested  as described in section 4 .3 .1 . S. 
epidermidis pe lle ts  w e re  re-suspended in 1 ml spheroblasting  b u ffe r (26  % (w /v )  
raffinose , 20  m M  Tris pH 8 .0  conta in ing  10 m M  M gC I2) plus 5 0 0  U o f 
m utano lysin  and 75 pi o f PIC. The suspensions w e re  th e n  incubated  fo r 30  m in at 
37  °C w ith  occasional shaking. Sam ples w e re  th en  cen trifuged  a t 3 0 0 0  x g fo r  10  
min a t 4 °C to  p e lle t cells. The su pernatants  conta in ing  th e  solubilised cell w all 
associated p ro te ins  w e re  tra n s fe rred  to  n ew  e p p e n d o rf tu b es . Finally th e  
a p p ro p ria te  vo lu m e o f su p e rn a ta n t plus 5 X SDS sam ple  b u ffe r (2 5 0  m M  Tris-HCI, 
pH 6 .8 , 10 % SDS, 0 .5  % b ro m o p h en o l blue, 50  % glycerol) w e re  boiled a t 95  °C 
fo r  5 m in. The cell w all p ro te ins  presen t in th e  sam ples w e re  separated  in a SDS- 
PAGE, as previously described in section 2 .3 .4 .
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P ro te in  q u a n tif ic a t io n
The  p ro te in  c o n te n t q uan tifica tio n  o f each S. epidermidis stra in  cell w all 
p re p ara tio n  was q u an tified  according to  th e  p ro toco l described in section 2 .3 .4 .
M ass s p e c tro m e try  ana lys is
Mass s p e c tro m etry  can be de fin ed  as an analytical lab o ra to ry  tech n iq u e  used to  
sep ara te  th e  com ponents  o f a sam ple  by th e ir  mass and th e re fo re  id en tify  th e  
m o lecu lar and s tructura l com position  o f th a t sam ple .
In this study, n ano -e lec tro sp ray  liquid ch ro m ato g rap h y  mass sp ec tro m etry  
(N a n o -L C -M S /M S ) analysis was kindly carried  o u t by K ieran W yn n e  in th e  
C onw ay In s titu te  in UCD. Peptides id en tified  w e re  searched using th e  XTandem  
a lg o rith m  against all databases. The p ro bab ility -based  eva lu atio n  program , 
Pro te in  P ro ph et w as used to  f i lte r  identifications.
4 .3 .5 . S ta tis tic a l ana lys is
Statistics w e re  p e rfo rm e d  using SSC-Stat V 2 .1 2 . D ata  show n are  th e  m eans plus 
o r m inus standard  e rro r  o f th e  m ean  (SEM ). C om parisons b e tw e e n  m ean values  
w e re  p e rfo rm e d  using a 2 -ta ile d  paired  S tudent's  t-te s t.
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4 . 4 .  R e s u l t s
4 .4 .1 . In v e s tig a tin g  th e  a b il ity  o f  S. ep ide rm id is  to  in te ra c t w ith  
o s te o b la s t
S. epidermidis b io film  fo rm in g  strains HB, 9 1 4 2  and C SF41498 w e re  orig inally  
recovered  fro m  a hum an  p a tie n t w ith  osteom yelitis , b lood cu ltures and  
cerebrosp inal flu id , respectively . The  level o f staphylococci b inding to  osteoblasts  
was assessed fo r  th e  S. aureus strain  N e w m a n  W T  used as contro l and also fo r  S. 
epidermidis strains HB, 9 1 4 2  and C SF41498. As resu lt all S. epidermidis strains  
bound to  osteoblasts w ith  slightly less in tens ity  w h e n  com pared  to  th e  S. aureus 
N e w m a n  strain  b ind ing  to  osteoblasts. M o re o v e r am o n g  th e  S. epidermidis 
strains used, th e  C SF41498 strain bound significantly  less to  osteoblasts w hen  
co m p ared  w ith  th e  o thers  S. epidermidis strains HB and 9 1 4 2  (Figure 4 -1 , 
P <0.05).
Chapter 4- Study o f the  m olecular mechanisms involved in S. epidermidis binding to  osteoblasts: early steps
in im plant infection
166
Chapter 4- Study o f the  m olecular mechanisms Involved In S. epidermidis binding to  osteoblasts: early steps
in im plant Infection
0.350
■o  J£}
.E §  0.250 .a
Newman
S t a p h y lo c o c c u s
a u r e u s
HB 9142 CF541498
S t a p h yl o c o c c us
epidermidis
Figure 4-1 -  S. epidermidis  strains bind to osteoblasts. Osteoblasts were allowed to bind to 
immobilized 5. aureus Newman and S. epidermidis HB, 9142 and CSF41498 for 45 min at 37 °C. 
Binding was determined by measuring the intracellular enzyme alkaline phosphatase content at 
405 nm in a micro plate reader. *P<0.05, bars indicate SEM, n=4.
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4.4 .2 . A  p ro te o m ic  a p p ro a c h  to  id e n t ify  th e  d if fe re n t ia l p ro te in  
e xp ress io n  b e tw e e n  S. ep iderm id is
Given th e  significant d iffe ren ce  in th e  b inding in tensities to  osteoblasts b e tw een  
th e  S. epidermidis HB and 9 1 4 2  and C SF41498, th e  p ro te in  expression o f these  
strains was stud ied . To  address this, cell wall p reparations  o f S. epidermidis 91 4 2  
and C SF41498 w e re  run in a SDS-PAGE fo r  p ro te in  sep ara tion . Each sam ple was 
th e n  analysed by mass sp e c tro m e try  using N ano- LC -M S /M S  carried  o u t by 
Kieran W yn n e  in th e  C onw ay In s titu te  in UCD. Proteins id en tified  to  be presen t in 
S. epidermidis 9 1 4 2  b u t ab sent in C SF41498 are  p resen ted  b e lo w  in Table 4 -3 . 
The S erin e -asp arta te  rep ea t-co n ta in in g  p ro te in  G was chosen fo r fu r th e r  studies 
as it is one o f th e  best s tud ied  S. epidermidis surface p ro te ins  also because it has 
been  previously show n to  be involved in S. epidermidis m edical devices 
in fections (Foster and M c D e v itt 1994 ; Davis, G urusiddappa e ta i  2 0 0 1 ; H artfo rd , 
O 'B rien  et al. 2001; Sellm an, T im o feyeva  et ai. 2008).
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Table 4-3- Relevant selection of S. epidermidis 9142 surface proteins absent in CSF41498.
CTPAL_STAEQ Q5HPB7 Probable CtpA-like serine protease
Y1947_STAES Q8CN89 Uncharacterized lipoprotein
SDRG_STAEP Q9KL13 Serine-aspartate repeat-containing protein G
GCSH_STAEQ Q5HQR3 Glycine cleavage system H protein
TRXB_STAEQ Q5HQW4 Thioredoxin reductase
ALF1_STAES Q8CMY5 Fructose-bisphosphate aldolase class 1 
ATP-dependent Clp protease ATP-binding subunit
CLPX_STAEQ Q5HNM9 CIpX
GDPA_STAEQ Q5HP71 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
HEMH_STAEQ Q5HNA5 Ferrochelatase
Y1140_STAEQ Q5HNX4 UPF0365 protein SERP1140
Y1381_STAEQ Q5HN91 UPF0342 protein SERP1381
EBPS_STAEQ Q5HP65 Probable elastin-binding protein ebpS
SSAA_STAEP Q9KJT6 Staphylococcal secretory antigen ssaA
HTRAL_STAEQ Q5HQE2 Serine protease htrA-like
ENO_STAEQ Q5HQV0 Enolase
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4 .4 .3 . In v e s tig a tin g  th e  ro le  o f  S. ep ide rm id is  SdrG in  b in d in g  
o s te o b la s t
O ne o f th e  m a jo r d ifferences  in p ro te in  expression am ong  th e  S. epidermidis 
strains in this study w as th e  presence o f  th e  SdrG surface p ro te in  in strains HB 
and 9 1 4 2  cell w all p reparations , b u t n o t in CFS41498 strain . T h e re fo re , taking  
in to  account th a t th e  C FS41498 S. epidermidis strain show ed significant less 
bind ing  to  osteoblasts, th e  ro le  o f th is  specific p ro te in  in S. epidermidis 
in te rac tio n  w ith  osteoblasts was e xp lo ited . To do so, S. epidermidis strains HB 
and 9 1 4 2 , and respective SdrG d e fec tive  m utan ts  b inding to  osteoblast was  
m easu red . In th e  absence o f SdrG on th e  bacteria l surface th e  ab ility  o f both  HB 
and 9 1 4 2  S. epidermidis strains to  bind osteoblasts was significantly reduced  
(F igure 4 -2A , P <0 .05). To fu r th e r  co nfirm  th e  in vo lvem en t o f SdrG in osteoblast- 
5. epidermidis in te rac tio n , a Lactococcus lactis strain expressing SdrG was used to  
te s t its ab ility  to  bind osteoblasts. L  lactis does n o t express SdrG natura lly , fo r  
th a t reason and also because L. lactis is a non pathogen ic  m icroorganism  it is an 
ideal surrogate  to  use. As expected  L  lactis  W T  strain show ed  reduced b inding to  
osteoblasts , w h ile  L. lactis expressing SdrG revealed  a sign ificant increase in 
o steo b last binding w h en  co m p ared  w ith  th e  W T  strain (Figure 4-2B , P <0.05). 
These results suggest th a t S. epidermidis binding to  osteoblasts is m ed ia ted  by 
th e  surface p ro te in  SdrG.
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Figure 4-2 -  SdrG from S. epidermidis  mediates binding to osteoblasts. Osteoblasts were 
allowed to bind to immobilized (A) S. epidermidis HB and A9142, WT and SdrG defective strains 
(B) Lactococcus lactis WT and SdrG expressing strains for 45 min at 37 CC. Binding was 
determined by measuring the intracellular enzyme alkaline phosphatase content at 405 nm in a 
micro plate reader. *P<0.05, bars indicate SEM, n=4.
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4 .4 .4 . In v e s tig a tin g  th e  m e ch a n ism  th ro u g h  w h ic h  S. ep iderm id is  SdrG 
in te ra c ts  w ith  o s te o b la s t
SdrG is a 1 1 9  kDa p ro te in  from  S. epidermidis surface structura lly  re la ted  to  th e  
staphylococcal surface prote ins, ClfA and ClfB o f S. aureus. These p ro te ins share  
th e  ab ility  to  bind to  fib rinogen  (M c D e v itt, Francois et al. 1994; Pei, Palm a et at. 
1 9 9 9 ). F ibrinogen is a soluble p lasm a p ro te in  also p resen t in m ost o f the  
s u p p lem en ted  m edia fo r cell cu ltu re  use. SdrG expression has been  show n to  be 
u p -reg u la ted  in sera fro m  p atien ts  w ith  S. epidermidis in fections (G allian i, V io t et 
al. 1 9 9 4 ). M o re o v e r, S. epidermidis in te rac tio n  w ith  catheters  spontaneously  
co ated  w ith  fib rinogen  has been re p o rte d  in patien ts  (Desai, Hossainy et al. 
1 9 9 2 ). A fte r  show ing th a t SdrG is also involved in S. epidermidis  binding to  
osteoblasts, th e  next step investigated  w h e th e r  SdrG was b inding to  fibrinogen  
o r if  SdrG was d irectly  in te rac tin g  w ith  any receptor(s) on th e  osteob last surface. 
T h e re fo re  S. epidermidis binding to  osteoblasts in th e  absence and presence of 
FBS in th e  osteoblast cu ltu re  m ed ia  was stud ied . The sign ificant decrease  
previously  o b ta in ed  fo r  th e  osteoblasts b inding to  S. epidermidis SdrG defective  
m u ta n t w as co m parab le  to  th a t o b ta in ed  fo r th e  osteob last binding to  5. 
epidermidis W T  strain  in th e  absence o f FBS (fib rinogen) in th e  osteob last cu lture  
m ed ia  (Figure 4 -3 , P= NS). These results suggest th a t S. epidermidis SdrG is 
binding  to  th e  fib rinogen  p resen t in th e  osteoblast cu ltu re  m ed ia  and not d irectly  
in te rac tin g  w ith  th e  osteoblast surface.
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Figure 4-3 -  5. epidermidis  SdrG is binding to the fibrinogen present in the osteoblasts 
nutrient media. Osteoblasts cultured in normal and media without FBS were allowed to bind 
to immobilized S. epidermidis WT; and osteoblasts cultured in normal media were allowed to 
bind SdrG defective mutant, for 45 min at 37 "C. Binding was determined by measuring the 
intracellular enzyme alkaline phosphatase content at 405 nm in a micro plate reader.
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4 .4 .5 . In v e s tig a tin g  th e  o s te o b la s t re c e p to r  th a t  recogn ises 5. 
ep iderm id is  SdrG
Given th e  find ing  th a t SdrG binds to  fib rin o gen  w hich bridges S. epidermidis to  
osteoblasts, th e  origin o f th e  rec e p to r fo r  th is  in te rac tio n  on th e  osteoblast 
surface was investigated .
Integrins a re  a large fam ily  o f pro te ins th a t serve as m ajo r cell surface receptors  
in cell b inding events  (Hynes 1 992 ). M o s t in tegrins express a th re e  am ino  acids 
sequence, described as arg in ine- g lycine- aspartic  acid (RGD) w hich is recognized  
as an essentia l binding site th a t is p resen t in a v a rie ty  o f  adhesive proteins  
including fib rin o gen  (Shankar, Davison et oi. 1993; Ruoslahti 1 996 ). In o rd e r to  
id e n tify  if th e  rec e p to r on th e  osteob last surface is an in tegrin , osteoblasts w ere  
pre -in cu b a ted  w ith  an RGD pep tid e  p rio r to  ad d ition  to  th e  previously  
im m o b ilized  S. epidermidis strains o n to  a 9 6 -w e ll p la te . S. epidermidis SdrG 
expressing and d e fec tive  strains b inding to  osteoblast, w ith  and w ith o u t RGD 
p re -incu b ation , show ed a s ignificant reduction  in th e  osteoblast binding in tensity  
fo r  th e  S. epidermidis W T  strains HB and 9 1 7 2  (Figure 4 -4 ). H ow ever, w h en  using 
th e  S. epidermidis SdrG defec tive  strains th e  osteob last b inding in tensity  
rem ain ed  th e  sam e, suggesting th a t p re -incu b ating  osteoblast w ith  RGD p eptid e  
p revents  th e  in te rac tio n  b e tw e e n  osteoblasts and SdrG, and th a t in th e  absence  
o f SdrG, th e  osteoblast b inding to  5. epidermidis is n o t a ffec ted . T h ere fo re , these  
results im plica te  th a t th e  re c e p to r on osteob last surface th a t m ed ia tes  the  
in te rac tio n  b e tw e e n  fib rin o gen  w hich in tu rn  is b inding to  SdrG on th e  S. 
epidermidis surface, is an RGD recognized p ro te in  and m ost likely an in tegrin .
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Figure 4-4 -  Osteoblasts integrins mediate binding to S. epidermidis. Control osteoblasts and 
osteoblasts pre-incubated with 1 mM RGD were allowed to bind to immobilized S. epidermidis HB 
and A9142, WT and SdrG defective strains in the for 45 min at 37 °C. Binding was determined by 
measuring the intracellular enzyme alkaline phosphatase content at 405 nm in a micro plate 
reader. *P<0.05, bars indicate SEM, n=3.
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4.4 .6 . In v e s tig a tin g  th e  e ffe c t o f  S. ep ide rm id is  b in d in g  on  o s te o b la s t 
p ro life ra t io n
Having established th e  im po rtance  o f th e  S. epidermidis SdrG in b inding  
osteoblasts, th e  effects  o f th is specific p ro te in  on osteoblast p ro life ra tio n  was  
investigated . O steoblasts w e re  in fected  w ith  SdrG expressing and SdrG d e fec tive  
strains o ver 48  h. Form aldehyde fixed  S. epidermidis 9 1 4 2  W T  strain  and 
respective SdrG d efec tive  m u ta n t and L  lactis W T  strain  and respective SdrG  
expressing stra in , w e re  added to  cu ltu red  osteoblasts and p ro life ra tio n  
d e te rm in e d  by cells co un t using a h a e m o c y to m e te r a fte r  2 4  h and 4 8  h (Figure 4 - 
5). U n -in fec ted  osteoblasts w e re  used as contro l and as expected  a regular 
p ro life ra tio n  p ro file  w as observed. In contrast, ad d ition  o f SdrG expressing  
strains S. epidermidis 9 1 4 2  W T  and L. lactis SdrG+ ap peared  to  lim it osteoblast 
g ro w th  over tim e  (F igure 4 -5 , PcO .O l). In teresting ly , osteoblast g ro w th  was 
recovered  in th e  presence o f e ith e r 5. epidermidis 9 1 4 2  SdrG d e fec tive  m u ta n t or 
L. lactis n atu ra lly  d e fec tive  in SdrG (P=NS, w h en  co m p ared  w ith  th e  un-in fected  
osteoblasts). These results highly suggest th a t SdrG is m ost likely playing a ro le in 
th e  inh ib ition  o f o s teo b last p ro life ra tio n  a fte r  S. epidermidis in fection .
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Figure 4-5 - S. epidermidis  SdrG Inhibits proliferation. Osteoblasts (5 xlO cells/ml) were pre- 
Incubated with either control buffer or formaldehyde fixed S. epldermidis wild-type and SdrG 
defective mutant or Lactococcus lactis wild-type and SdrG expressing mutant (1 x 10® cells/ml) 
over 48 h. After 0, 24 h and 48 h osteoblasts were removed by trypslnizatlon and proliferation 
was determined by counting cells on a haemocytometer. *P<0.01, bars indicate 5EM, n=5.
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4 .4 .7 . In v e s tig a tin g  th e  d o w n s tre a m  e v e n ts  as a re s u lt o f  S. ep iderm id is  
SdrG b in d in g  to  o s te o b la s t : Cell D ea th
In o rd er, to  fu rth e r  investigate  th e  v iru lence  o f SdrG, th e  v iab ility  o f osteoblast 
fo llo w in g  in fection  w ith  several S. epidermidis W T  strains and respective SdrG  
d efec tive  m u tan ts  it was eva lu a ted . The  n u m b e r o f live osteoblasts w as counted  
a fte r  in fection  using u n -in fec ted  osteoblasts as positive contro l fo r  live cells. As 
result, w h en  co m p ared  w ith  an u n -in fec ted  osteob last contro l, th e  n u m b e r o f 
live osteoblasts fo llo w in g  in fection  w ith  all S. epidermidis strains was slightly  
reduced (Figure 4 -6 , PcO.OOl). H ow ever, surprisingly no d iffe ren ce  was observed  
am ong th e  S. epidermidis SdrG d efec tive  o r SdrG expressing strains (P=NS), 
suggesting th a t despite  its im po rtance  in m ed ia tin g  b inding to  osteoblasts and  
inh ib iting  osteoblast p ro life ra tio n  SdrG is n o t involved in osteoblast death  a fte r  
in fection .
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Figure 4-6 - SdrG is not involved in osteoblast death after infection. Osteoblasts (1.5 xlO5 
cells/ml) were co-cultured with either control buffer or formaldehyde fixed S. epidermidis wild- 
type and SdrG defective mutant for 24 h. Un-infected osteoblasts were used as positive control 
for live osteoblasts. After 24 h infection the number of live cells was determined by detection of 
Calceln-AM positive cells at an absorbance of 490 nm read in a microplate reader. *P<0.001, bars 
indicate SEM, n=3.
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4 . 5 .  D i s c u s s i o n
S. epidermidis induced bone in fections are m ostly  associated w ith  th e  m edical 
device im plants  during  surgery w hich accounts fo r a lm ost 50  % o f th e  in fections  
associated w ith  ca th e ters , artific ia l jo in ts  and h e a rt valves (Khalil, W illiam s et al. 
2 0 0 7 ). D uring  surgery insertion  o f a m ed ical device such as an o rth o p aed ic  
im p lan t, th e  w o u n d  site is exposed to  th e  externa l en v iro n m e n t, w h e re  bacteria  
fro m  th e  skin o f th e  p a tie n t, m edical personnel, o r sim ply a irb o rn e  b acteria  can 
reach th e  open site (D onlan  and C osterton  2 0 0 2 ). Once in contact w ith  th e  
in te rna l e n v iro n m e n t o f th e  p a tie n t, bac teria  colon ize th e  cells o r th e  im plan ted  
device serving as a septic focus lead ing  to  m a jo r diseases such as osteom yelitis  
(C ram ton , G erke et al. 2 0 0 1 ).
In th is  ch a p te r th e  in teractions  b e tw e e n  S. epidermidis strains and osteoblasts  
w e re  investigated , in o rd e r to  id e n tify  specific in teractions  critical fo r  th e  
d e v e lo p m e n t o f in fection .
In o rd e r to  address th is , th e  ab ility  o f several strains o f S. epidermidis to  bind to  
osteoblasts was firs tly  investigated . All o f th e  S. epidermidis used in this study  
bound to  osteoblasts w ith  less in tens ity  th an  S. aureus N e w m a n , used as positive  
contro l fo r  b ind ing osteoblasts. This resu lt is not surprising, as d iffe re n t bacteria l 
strains have a d iffe re n tia l p ro te in  expression pro file  w hich m aybe re la ted  to  th e ir  
ab ility  to  bind host cells. C haracteris tic  o f th is, S. epidermidis C SF41498 bound  
sign ificantly  less th an  S. epidermidis HB and 9 1 4 2  suggesting d ifferences in 
p ro te in  expression. T h e re fo re  th e  d iffe re n tia l p ro te in  expression am o n g  th e  5. 
epidermidis strains u n d e r study was investigated , w ith  p articu la r in te res t in 
id en tify ing  th e  d iffe ren ce  b e tw e e n  S. epidermidis 91 4 2  and CSF41498. The  
d iffe ren ce  in p ro te in  expression m ay  account fo r th e  ab ility  to  bind osteoblasts. 
For th a t reason, th e  cell w all p ro te ins fro m  S. epidermidis 9 1 4 2  and CSF41498  
w e re  rem oved  using m utano lysin  and th e  sam ples w ere  run th ro u gh  a mass 
s p e c tro m e te r fo r  p e p tid e  id en tifica tio n . A lthough  several p ro te ins w e re  
id en tified  as being p resen t in S. epidermidis 9 1 4 2  and absent in C FS41498, SdrG
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was o f p a rticu la r in terest. The S. epidermidis SdrG was selected  as a good  
c an d id a te  fo r  fu r th e r  studies, as it is one o f th e  m ost characterised  and w ell 
studied  p ro te ins o f S. epidermidis. The ro le  o f SdrG in S. epidermidis binding to  
osteoblasts w as th e re fo re  assessed using strains HB and 9 1 4 2  W T  and respective  
SdrG d e fec tive  m u tan ts  (Figure 4 -2 ). T h e  presence o f SdrG revea led  to  be crucial 
in su pporting  osteob last binding in tens ity  to  S. epidermidis w h ereas  in th e  
absence o f th is  p ro te in  on th e  bacteria l surface th e  levels o f osteoblast binding  
in tens ity  w e re  significantly  low er. In o rd e r to  confirm  th e  role o f S. epidermidis 
SdrG, a su rrogate  host, Lactococcus lactis, w as used to  express th e  p ro te in . It is 
w o rth  noting  th a t L. lactis does n o t express SdrG, th e re fo re  serves as a good  
surro g ate  host. This m odel has been previously successfully used to  express a 
n u m b e r o f o th e r  p ro te ins fro m  various bacteria  (O 'B rien , 2 0 0 2 , Kerrigan 2 0 0 7 ). 
C onsistent w ith  th e  previous observation , o ver expression o f SdrG on th e  surface  
o f L. lactis was fo u n d  to  fa c ilita te  th e  b ind ing  to  osteoblasts.
As previously m en tio n ed  SdrG is o ne  o f th e  best s tud ied  adhesins o f S. 
epidermidis, and various reports  d e m o n s tra te d  SdrG to  be essential fo r  S. 
epidermidis bind ing  to  fib rinogen , p ro m o tin g  centra l in travenous ca th e ters  
associated in fections (N ilsson, Frykberg et al. 1998; H artfo rd , O 'B rien  et al. 2001; 
G uo, Zhao et al. 2007). Fibrinogen is a d o m in a n t g lycoprote in  fo u n d  in plasm a, 
ex trace llu la r m atrix  and is o ften  fo u n d  a t sites o f in fection . T h e re fo re  
exp erim en ts  w e re  carried  o u t to  investigate  if fib rinogen  is im p o rta n t in b inding  
to  S. epidermidis SdrG w hich in tu rn  binds to  an osteoblast recep to r. A dd ition  o f 
fib rinogen  to  m ed ia  o r m ed ia  rich in fib rin o gen  (FBS su p p lem en ted ) resu lted  in 
strong b inding b e tw e e n  S. epidermidis and osteoblasts. Rem oval o f fibrinogen  
fro m  th e  m edia  sign ificantly  reduced  th e  b inding o f S. epidermidis to  th e  
osteoblast.
Thus, it seem s th a t  SdrG on S. epidermidis surface is b inding to  osteoblasts  
th ro u gh  a fib rin o gen  bridging in te rac tio n .
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In tegrins are m ain receptors  involved in cell b inding on osteoblasts and are  
recognized by th e  presence o f an RGD sequence in th e ir  ligands (Ruoslahti 1 9 9 6 ). 
The p resen t study show ed th a t p re -incu b ating  osteoblasts w ith  an RGD p ep tid e  
significantly  reduced  S. epidermidis b ind ing  to  osteoblasts (Figure 4 -4 ). These  
results suggest th a t th e  recep to r on osteob last surface is an in tegrin  w hich binds 
fib rin o gen  and uses th is  in te rac tio n  to  bridge w ith  SdrG on S. epidermidis. This is 
n ot a un ique in te rac tio n  as previous reports  d em o n stra ted  th a t S. aureus binds 
to  fib ro n ec tin  via Fnbps bridging to  th e  in tegrin  a s3 i  w hich triggers the  
in te rn a liza tio n  o f th e  bacteria  in to  osteoblasts (Reilly, Hudson et al. 2000; 
A h m ed , M eg h ji et al. 2 0 0 1 ). In th ese  studies, m u tan ts  lacking th e  tw o  Fnbps on 
th e  S. aureus surface show ed a significant reduction  in th e  invasion o f host cells. 
H o w e v e r o th e r  study d em o n stra ted  th a t th e  m echanism  o f in te rna liza tio n  differs  
b e tw e e n  S. aureus and S. epidermidis w h ereas  S. epidermidis is suggested to  bind 
to  a d iffe re n t region o f fib ron ec tin  fro m  th a t bound by S. aureus (Khalil, W illiam s  
et al. 2 0 0 7 ). The sam e study also reports  th a t unlike S. aureus, S. epidermidis 
invasion m echanism  is in d e p e n d e n t o f th e  in tegrin  a 53 i, th e re fo re  th e  
in te rac tio n  behind  S. epidermidis in te rn a liza tio n  by osteoblasts rem ains to  
id en tify .
As previously d e m o n s tra te d  in C hap ter 2, S. aureus binds to  osteoblasts  
inh ib iting  p ro life ra tio n . Hence, S. epidermidis binding to  osteoblast w as also 
investigated  fo r  its ro le in osteoblast p ro life ra tio n . O steoblast p ro life ra tio n  was 
significantly  inh ib ited  o ver 4 8  h w h e n  using S. epidermidis expressing SdrG. In 
contrast to  this S. epidermidis lacking th e  expression o f SdrG fa iled  to  have an 
e ffe c t on p ro life ra tio n  over a 4 8 h r period  (Figure 4 -5 ). The data  obta in ed  
suggests th a t w h en  SdrG binds to  th e  osteob last in tegrin  it to o  genera tes  a signal 
th a t prevents  p ro life ra tio n . The idea th a t in tegrins play a ro le in regu lating  
p ro life ra tio n  is n o t n ew  (C ru e t-H e n n e q u a rt, M a u b a n t et al. 2 0 0 3 ). A lpha 5 (a 5) 
in tegrins w e re  previously show n to  reg u la te  cell p ro life ra tio n  in ovarian  cancer 
cells. Follow ing a 5 in tegrin -b lockade w ith  a specific an tibody, th e  ovarian  cancer 
cells g ro w th  was in h ib ited  suggesting a connection  b e tw e e n  th e  m o d u la tion  o f
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g ro w th  fa c to r signalling and th e  a 5 integrins. in teg rin -lin ked  kinase (ILK) was also 
show n to  be an im p o rta n t reg u la to r o f cell survival and p ro life ra tio n , as in th e  
sam e study th e  au thors  show ed th a t fo llo w in g  b lockade o f th e  a 5 integrins th e re  
w as a decrease in ILK activ ity  w hich co nsequently  regulates positively th e  cell 
cycle in h ib ito r exp lain ing  th e  inh ib ition  o f cell p ro life ra tio n . O u r results suggest a 
sim ilar m echanism  to  regu lation , as SdrG fro m  S. epidermidis seem s to  be 
in te rac tin g  w ith  an osteob last in tegrin  w hich  m ight be m o d u la ting  th e  cell cycle 
thus inducing th e  inh ib ition  o f osteoblast p ro life ra tio n .
In teresting ly , w h en  eva luating  osteoblast v iab ility  fo llo w ing  S. epidermidis 
in fection , no significant d iffe ren ce  in th e  n u m b e r o f live cells recovered  w ith  th e  
W T  strain  and SdrG defec tive  strain was seen (Figure 4 -6 ). T h e re fo re  it seem s  
th a t th e  signal fro m  th e  in teraction  b e tw e e n  SdrG and osteoblast in tegrin  
triggering  inh ib ition  o f p ro life ra tio n  it is n o t associated w ith  cell d ea th . This 
find ing  is in d irec t contrast to  w h a t was fo u nd  w ith  S. aureus, in th a t binding led 
to  inh ib ition  o f both  p ro life ra tio n  and induction  o f apoptosis. C onsistent w ith  our 
findings S. epidermidis induced cell d ea th  has not been rep o rted  previously  
(H uang , Liao et al. 2000 ; N ilsdotter-A ugustinsson, W ilsson et at. 2004; 
Pharm akakis, P etropou los et al. 2 0 0 9 ).
In su m m ary, in this ch ap ter, S. epidermidis SdrG was id en tified  as an im p o rta n t  
fa c to r  in m ed ia tin g  a tta c h m e n t to  osteoblasts. H ow ever, this is not a d irect 
in te rac tio n  as it appears th a t SdrG requ ires fib rinogen  to  bridge th e  bacteria  to  
an as y e t u n id en tified  in tegrin  expressed on th e  osteoblast. F u rth erm o re , it was 
also d e m o n s tra te d  th a t upon b inding to  th e  osteoblast a signal is g enera ted  th a t  
results in th e  inh ib ition  o f osteoblast p ro life ra tio n . In teresting ly  osteoblast death  
fo llo w in g  S. epidermidis in fection  tu rn e d  o u t to  be strain specific; being verified  
only a fte r in fec tio n  w ith  th e  S. epidermidis 9 1 4 2  stra in , and also in d ep en d en t o f  
SdrG expression. Thus it is suggested th a t SdrG fro m  S. epidermidis plays a ro le  in 
supporting  bacteria l a tta c h m e n t to  osteoblasts and m ay co n trib u te  to  bone loss 
observed in im p lan t in fection  patients.
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O ver th e  last fe w  decades, m an y investigations have been m ade to  try  and  
understand  th e  d e v e lo p m e n t and progression o f o s teom yelitis . Bacteria o f th e  
genus Staphylococcus have been id en tified  as m a jo r causative agents and  
n um erous antib io tics  and surgical th erap ies  are  used in its tre a tm e n t. H ow ever, 
o steom yelitis  cases a re  still increasing, m ostly  due  to  th e  d e v e lo p m e n t o f 
a n tib io tic  resistance o r in fection  relapse fo llo w ing  surgical th e ra p y . T h ere fo re , 
understand ing  th e  m o lecu lar m echanism s underly ing  staphylococcal induced  
o steo m yelitis  rem ains a challenge. In o rd e r to  address th is , th e  in teractions o f S. 
aureus and S. epidermidis w ith  osteoblasts w e re  investigated  in th e  hope o f  
id en tify in g  n ew  in fo rm a tio n  th a t m ay lead to  th e  g e n era tio n  o f n ew  th erap ies  to  
t re a t this disease.
O steom yelitis  is an in fection  o f th e  bone cells and tissue associated w ith  
ab no rm al bone rem od e lin g  and consequent bone d estruction  and in flam m atio n  
(Lew  and W aldvogel 2 0 0 4 ). Lew and W aldvogel categorized  osteom yelitis  relying  
on th e  d iffe re n t w ays by w hich  th e  in fecting  m icroorganism s access th e  bone. 
T h e re fo re  osteom yelitis  can o rig ina te  secondary to  a contiguous-focus o f 
in fection  (fo llow ing  tra u m a  o r surgery), via vascular insufficiency (in im m u n o ­
com prom ised  patien ts  such as d iab etic  patien ts) o r by h aem atogenous source  
(a f te r  a case o f b a c te ra e m ia ) (Lew  and W aldvogel 19 9 7 ; Lew  and W aldvogel 
2 0 0 4 ). Progression o f th e  disease m ay be acute o r d eve lo p  into a chronic, long 
lasting in fection  and m ay involve d iffe re n t bone structures such as th e  bone  
m a rro w , cortex o r su rround ing  tissue. D iffe re n t approaches and th erap ies  are  
ad m in is te red  according to  th e  stage o f in fection  and to  th e  d iffe re n t types o f 
osteom yelitis . The age o f th e  p a tie n t is also im p o rta n t as ch ildren  are m ore  likely  
to  get acute  h aem ato g eno u s  osteom yelitis  in th e  long bones, w h ile  adults are  
m o re  likely to  get in fections  fo llo w ing  tra u m a  o r surgery. In add ition , th e  
id en tifica tio n  o f th e  in fecting  m icroorganism s is crucial fo r  th e  ad m in is tra tio n  o f 
th e  correct tre a tm e n t and m ay also d iffe r  according to  th e  age o f th e  p a tien t, or 
risk g roup  (e.g.: skin in fections, im m unodefic iency , bone fractu res , d iabetes).
5. G e n e ra l D is c u s s io n
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A lthough  m any m icroorganism s are  capable o f causing osteom yelitis , S. aureus is 
by fa r  th e  m ost p ro m in e n t p athogen  accounting  fo r  up to  80  % o f all 
osteom yelitis  cases (E llington, Reilly e t al. 1 9 99 ). S. epidermidis fo llow s 5. aureus, 
being  th e  second m a jo r cause o f osteom yelitis  and lead ing  cause o f im p lan t- 
re la te d  osteom yelitis  (Kloos and B annerm an 1994 ; C adorna and  
W a ta n a k u n a k o rn  1995 ; Lew and W ald vo g e l 2 0 04 ).
S tap hy lo cocc i and  b o n e  - th e  f ir s t  s te p  in to  in fe c tio n
As m e n tio n e d  in th e  In trod u ction  ch ap te r, a lthough  belonging to  th e  sam e  
genus, S. aureus and S. epidermidis are  considerab ly d iffe re n t in th e ir  ab ility  to  
cause in fection . S. aureus is considered  th e  m ost v iru le n t and th e re fo re  th e  
m a jo r pathogen o f th e  genus staphylococci causing a very  broad range o f hum an  
diseases (N ovick 1990; Lowy 1998 ; Crossley 20 0 9 ) w h ile  S. epidermidis requ ires a 
predisposed host in o rd e r to  cause in fection , and is th e re fo re  defined  as an 
o pp o rtu n is tic  pathogen  (V u o n g a n d  O tto  2 0 02 ). C om parison o f th e  genom es o f 5. 
aureus and S. epidermidis d e m o n s tra te d  th a t d esp ite  sharing a core g enom e, S. 
aureus has s tra in -d e p e n d e n t co m binations  encod ing  several v iru lence factors  
m o st o f w hich are  ab sen t in S. epidermidis (G ill, Fouts et al. 2 0 0 5 ). This m ay  
p artia lly  explain th e  d iffe re n c e  in th e ir  pathogen ic ity . In o rd e r to  iden tify  key 
m echanism s involved in th e  in itia l steps to  in fection , th e  d iffe re n t viru lence  
fac tors  o f S. aureus and  S. epidermidis and th e ir  ro le  in in teracting  w ith  
osteoblasts was investigated .
B acterial b inding to  th e  osteoblast surface is th e  firs t stage o f in fection  in 
o steom yelitis  disease. A range o f d iffe re n t 5. aureus strains w e re  studied w h e re  
th e  Staphylococcal p ro te in  A (SpA) w as id en tified  as having a role in b inding to  
osteoblasts, and distinguish it fro m  o th e r im p o rta n t S. aureus viru lence factors  
such as th e  capsule, te icho ic  acid and o th e r surface p ro te ins (e.g. C lfA /B  and th e  
Sdr fa m ily  o f p ro te ins). By using a genetica lly  m o d ified  strain  o f 5. aureus lacking  
th e  expression o f SpA, a crucial ro le fo r  SpA in th e  firs t step o f in fection  was  
d e m o n s tra te d , as th e  absence o f this p ro te in  on th e  bacterial surface
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significantly  reduced (by a p p ro x im ate ly  50  %) th e  b ind ing to  osteoblasts. SpA is a 
w ell know n v iru lence fa c to r  w id e ly  expressed on th e  surface o f th e  m a jo rity  o f 
th e  S. aureus strains. SpA has high a ffin ity  to  bind im p o rta n t pro te ins o f th e  
im m u n e  system  such as im m unog lobu lins . In ad d ition  to  its ab ility  to  m ed ia te  5. 
aureus - osteob last in te rac tio n , th e  im po rtan ce  o f SpA in osteob last inh ib ition  o f  
p ro life ra tio n  was also co n firm ed . F u rth e rm o re  SpA seem s to  be not only  
im p o rta n t fo r  th e  firs t step  o f in fection , but also a m e d ia to r o f th e  p a th w ay  
fo llo w in g  in fection  triggering  osteoblast d ea th .
T he sam e line o f reasoning as p er S. aureus -  o s teo b last in te rac tio n , S. 
epidermidis species express SdrG, a w ell know n M S C R A M M  highly hom ologous  
to  c lum ping fa c to r A and B fro m  S. aureus w hich  have been show n to  bind  
fib rinogen  in fo re ign  body infections caused by S. aureus (M c D e v itt, Francois et 
al. 1994 ; Ni Eidhin, Perkins et al. 1 9 9 8 ). In th is study a S. epidermidis SdrG 
d e fec tive  strain and a non -p ath o g en ic  L. iactis strain  expressing SdrG w e re  used 
to  d e m o n s tra te  th a t SdrG is im p o rta n t in m ed ia tin g  S. epidermidis -  osteoblast 
in te rac tio n . H ow ever, unlike th e  5. aureus pro te in  A -  osteoblast in te rac tio n , 5. 
epidermidis SdrG- o s teo b last b inding is n o t a d ire c t in te rac tio n . It was  
d em o n stra ted  th a t S. epidermidis SdrG binds to  fib rin o gen  th a t is p resent in th e  
osteob last ex te rna l en v iro n m e n t, w hich in tu rn  binds d irec tly  to  th e  osteoblast 
surface via an in tegrin  in te rac tio n . This is not a unique in te rac tio n  since th e  sam e  
m echan ism  had a lready  been show n in p la te le ts  w h e re  it s tim ulates p la te le t  
activation  and supports p la te le t b inding (B rennan, Loughm an et al. 2 009 ). 
M o re o v e r it was also show n th a t unlike SpA, SdrG is n o t requ ired  fo r  osteoblast 
inh ib ition  o f p ro life ra tio n  and th e re fo re  is n o t a co n trib u tin g  fa c to r in th e  death  
o f osteob last fo llo w ing  in fection .
These findings clearly  d e m o n s tra te  th a t S. aureus and S. epidermidis in teract 
d iffe re n tly  w ith  bone. This fac t highlights th e  im p o rtan ce  o f identify ing  th e  
in fecting  m icroorganism  a t th e  tim e  o f th e  diagnosis, so th a t a d iffe re n t  
tre a tm e n t can be ad m in is te red  according to  th e  resu lt o b ta in ed . A t th is po in t, 
based in th e  previous results it w o u ld  m ake sense th e  d e v e lo p m e n t o f a new
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th e ra p y , specifically against SpA w h en  tre a tin g  infections caused by S. aureus and  
against SdrG in o rd e r to  block S. epidermidis binding to  bone. H ow ever, as 
a lread y  m e n tio n ed , th e  em ergen ce  o f an tib iotics resistance m an ifested  in th e  
past revokes this h ypo thetica l so lu tion . In addition  a surgical p rocedure  in o rd er  
to  rem ove  th e  a ffec ted  area m ight n o t be th e  successful so lution  as it encloses a 
high risk o f relapse.
A dvances in  5. aureus  p ro te in  A  in te ra c t io n  w ith  b on e
Even though  SpA b ind ing is n o t a unique in te rac tio n  b e tw e e n  S. aureus and  
osteob last, it seem s to  account rem arkab ly  n o t only fo r in itia tio n  o f in fection  but 
also to  co n trib u te  to  th e  progression o f disease. T h e re fo re , id en tifica tio n  o f th e  
o steo b last rec e p to r fo r  SpA becam e im p o rta n t in o rd e r to  understand  th e  ro le o f 
th is  in te rac tio n  in th e  disease. As previously show n by G om ez e t al on ep ithe lia l 
cells, SpA binding to  TN FR -1 plays an im p o rta n t ro le  in 5. aureus induced  
p n eu m o n ia  (G om ez, Lee et al. 2 0 0 4 ). In th e  course o f o ur investigations, 
fo llo w in g  co n firm atio n  th e  expression o f TNFR-1 on osteob last surface, it was  
d e m o n s tra te d  th a t using 5. aureus p ro te in  A d e fec tive  m u tan ts  and TNFR-1  
blocked a n d /o r  silenced o s teo b last s ignificantly decreased  th e  b inding in tensity  
b e tw e e n  bacteria  and osteoblast. M o re o v e r, in th e  absence o f both  SpA and  
TN FR -1, bacteria l b inding to  osteoblast was considerab ly reduced. These results  
revea led  th a t TNFR -1 is th e  ligand fo r  SpA in S. aureus -  osteoblast in teraction . 
T h e re fo re  investigating  th e  p a th w a y  fo llow ing  bacteria l a tta c h m e n t to  osteoblast 
th ro u g h  SpA -TN FR -1 in te ra c tio n  becam e necessary.
SpA and TNFR-1 in te ra c t io n : P a th w a y  in to  bon e  in f la m m a tio n  and  d e a th
As m en tio n ed  b e fo re , th e  m ain  characteristics o f o s teo m yelitis  disease are bone  
in fla m m a tio n  and bone d estru c tion . During this research it was found  th a t  
in h ib itio n  o f  osteob last p ro life ra tio n  was m e d ia te d  by S. aureus p ro te in  A 
in te rac tio n  w ith  osteob last. O steob last g ro w th  was d isrup ted  a fte r  in fection w ith  
5. aureus W T  w h ile  reco vered  fo llo w in g  in fection  w ith  a SpA knock o u t S. aureus
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stra in . M o re o v e r th e  previously m en tio n ed  w o rk  by G om ez et al in 2 0 0 4  
recognized th e  ab ility  o f SpA to  induce TN F-a lpha like responses th rough  its 
binding to  TNFR-1 on ep ith e lia l cells (G om ez, Lee et al. 2 0 0 4 ). H ere  it is proposed  
th a t th e  sam e m echan ism , SpA b ind ing  to  TNFR-1, activates TN FR -1 d ow n stream  
signals such as apoptosis and in fla m m a tio n . S. aureus m e d ia te d  apoptosis has 
already  been rep o rted  in osteoblasts (Tucker, Reilly et al. 2 0 0 0 ). A n o th e r study  
involving S. aureus induced apoptosis on ep ith e lia l cells d e m o n stra ted  th e  
im po rtance  o f caspase 8 and 3 in th e  p ro gram m ed  cell d ea th  m echanism  
(W esson, D eringer et al. 2 0 0 0 ). In th is study it was d e m o n s tra te d  th e  activation  
o f caspase 3 fo llo w ing  S. aureus in fection  and its inh ib ition  w h en  using a S. 
aureus strain  defec tive  in SpA. It seem s th e re fo re  th a t th e  TN FR -1 d ow n stream  
p a th w ay  leads to  o s teo b last d e a th  and consequent restric tion  o f p ro life ra tio n  
fo llo w in g  SpA binding (Figure 5 -1 ). In flam m atio n  processes in response to  
b acteria  can be m e d ia te d  by th e  activation  o f NFkB w hich  regulates th e  
expression o f cytokines and chem okynes w hich in tu rn  recru it im m u n e  cells such 
as leukocytes and n eu troph ils  responsib le fo r  c learing  in fec tio n . G om ez et al 
have also show n th a t SpA-TNFR-1 p a th w ay  triggers in fla m m a tio n  on ep ithe lia l 
cells w h ereas  SpA induced NFkB activ ity  th ro u gh  its b inding to  TNFR-1 (G om ez, 
Lee et al. 2 0 0 4 ). M o re  recen tly  a n o th e r study confirm ed  th a t  S. aureus binding  
was req u ired  fo r NFkB ac tiva tio n  but also fo r IL-6 release in hum an osteoblasts  
(N ing, Zhang et al. 2 0 1 0 ). A dd itio n a lly  th is  w o rk  d em o nstra tes  th a t fo llo w ing  SpA 
binding to  TNFR -1, IkB d egradatio n  is induced w hich is associated w ith  NFkB 
activation  and consequent s tim u la tio n  o f IL-6 release (Figure 5 -1 ). In add ition , 
th e  release o f this cytokine fro m  osteoblasts has been show n to  fu r th e r  increase  
bone resorp tion  fo llo w in g  S. aureus in fection  (Bost, Ram p et al. 1 999 ). Recent 
w o rk  in o u r lab o ra to ry  d e m o n s tra te d  th a t th e  u p -reg u la tion  o f IL-6 expression  
fo llo w in g  SpA binding to  TNFR -1 on osteoblasts induces osteoclast d iffe re n tia tio n  
and consequently  bone d estruction . F u rth e rm o re , s tim u la tion  o f  
osteoclastogenesis m igh t be re la ted  to  an increase in th e  expression o f RANK-L 
fo llo w in g  SpA-TNFR-1 in te rac tio n  w h ile  SpA d e le tion  p revents  RANK-L expression  
(C laro, W id aa  et al. 2 0 1 1 ).
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Taken  all to g e th e r S. aureus p ro te in  A b inding to  th e  osteob last TNFR -1 induces 
re c e p to r activation  triggering  o s teo b last inh ib ition  o f p ro life ra tio n , osteoblast 
d ea th  via apoptosis and osteoblast in fla m m a tio n  th ro u gh  th e  ac tivation  o f NFkB 
and IL-6 release (Figure 5 -1 ).
5. aureus
Osteoblast
IL6,11-12, CSF 
expression Octeocltstogenesis
5. aureuM
Bone destruction
Previously published (Montanaro, Testoni et al. 2011) T h i s  s t u d y
5, aureus 6 Fnßf* RANKL 0 TRADD f f  Pro caspases
f~l Osteoblast B  Fibroncctln Ü SpA q PS-phosphalldylserlnü ^
H  « A  %  TNFR'1 I I  fADD «  ikß
Gene expression 
IL-6
Nudcous
Figure 5-1 -  Model of infection.
(A)- Internalization of S. a u r e u s  by osteoblast: mediated by FnBP binding to fibronectln which 
binds to the osteoblast a5Pi integrin. This interaction promotes caspase-8 activation with 
consequent osteoblasts apoptosis. Interaction of SpA and TNFR-1 promotes the expression of 
RANKL, inducing osteoclastogenesis. Following osteoblasts apoptosis and the activation of 
osteoclasts, bone destruction ensues. Adapted from (Montanaro, Testoni et al. 2011).
(B)- TNFR-1 signalling pathway: S. aureus protein A binds to TNFR-1 on osteoblasts surface. 
Following this, two distinct pathways can be activated. The apoptotic pathway by means of 
caspase-3 activation together with membrane blebbing and finally cell death and consequent 
bone destruction; or the NFkB pathway, activated via Ikp degradation, with induction of IL-6 
release and cell inflammation.
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In th e  last d ecade, tw o  d iffe re n t th e ra p ie s  o f an ti-TN F  alpha signalling have  
becam e co m m ercia lly  availab le  and proven  to  be e ffec tive  fo r th e  tre a tm e n t o f 
rh eu m ato id  arthritis : in flix im ab, a ch im eric  TN F-a lpha m onoclonal an tib o d y  and  
e ta n e rc e p t, a soluble TNF recep to r (H u rlim an n , Forster et al. 2002 ; Jacobsson, 
Turesson et al. 2 0 0 5 ). H ow ever, TN F -a lph a  functions are n o t only regu la ted  by 
th e  TN FR -1 b u t also by TNFR -2 w hich  plays an im p o rta n t ro le  in th e  b iophylatic  
system  (G rell 1995; G rell, Douni et al. 1 9 9 5 ). T h e re fo re , co m p le te  inh ib ition  o f 
th e  TN F-a lpha signaling still com prom ises th e  risk o f in fection  as d em o n stra ted  
by B ongartz et al (B ongartz, Sutton  et al. 2 0 0 6 ).
The p resen t study shows th e  need to  d eve lo p  a n ew  tre a tm e n t fo r  osteom yelitis  
using th e  TNFR-1 as a specific th e ra p e u tic  ta rg e t. N evertheless recently , N om ura  
et al crea ted  a un ique T N F R l-se lec tive  an tagon is t capable  o f inh ib iting  TNFR-1  
fu n ctio n  w ith o u t jeo p ard iz in g  TN FR -2 fu n ctio n  in host d efen ce  (N o m u ra , A be et 
al. 2 0 1 0 ). M o re o v e r, in A ugust 2 0 1 1 , K itagaki and co-w orkers  have d em o n stra ted  
th a t th e  use o f a selective TNFR -1 an tagon is t suppressed a rte ria l in flam m atio n  by 
inh ib iting  th e  TNFR-1 signaling fo llo w in g  a cu ff in jury in m ice w ith  excessive post­
in jury  in fla m m a tio n  (K itagaki, Isoda e ta l.  2 0 1 1 ).
C om b in ed  m o d e l o f  bon e  in fe c tio n
In th is  thesis it is described th e  p rim ary  in te rac tio n  b e tw e e n  bacteria  and  
osteoblast lead ing  to  in fection  and co nseq u en t cell d e a th  and in flam m atio n . In 
ad d ition , previous studies show ed staphylococcal in te rna liza tio n  and persistence  
inside th e  host on bone cells. The ab ility  o f S. aureus and S. epidermldis to  invade  
cu ltu red  osteoblasts has been  published by several research groups (Hudson, 
Ram p et al. 1995; Ellington, Reilly et al. 1999; Jevon, Guo et al. 1999; Reilly, 
H udson et al. 20 0 0 ; Khalil, W illiam s et al. 2 0 0 7 ). The in te rna liza tio n  process in S. 
aureus b u t n o t S. epidermidis (Khalil, W illiam s et al. 2 0 0 7 ) occurs via Fnbps 
binding to  fib ro n ec tin  w hich  serves as a bridge to  th e  in tegrin  a 5Pi acting as a 
"phagocytic" recep to r (Sinha, Francois et al. 1999 ) (F igure 5 -1 ). F urtherm ore  
o th e r studies d e m o n s tra te d  th a t S. aureus- in fected  osteoblasts induce caspase- 
8 triggering  apoptosis (A lexander, R ivera et al. 2003 ; M ah a lin g am , Szegezdi et al.
Anti-TNFR-1 therapy
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2 0 0 9 ) (Figure 5 -1 ). These studies m ay  help to  explain  th e  persistence o f  
o steo m yelitis  cases w h e re  th e  bacteria  a re  p ro tec ted  inside th e  host cell, evading  
fro m  th e  im m u n e  system  and fro m  th e  action  o f an tib io tics  (H enderson  and N air
2 0 0 3 ). In addition  osteoblast apoptosis fo llo w in g  S. aureus in fections is m ost 
likely co n trib u ting  to  th e  bone loss characteris tic  o f osteom yelitis  patients  
(H en derson  and N air 2 003 ).
Even th o ug h  th e re  is still m uch w o rk  to  do to  co m p le te ly  unravel th e  
m echanism s underly ing  osteom yelitis , th is  study to g e th e r w ith  th e  recen t 
findings in th e  a n ti- TNFR -1 th e ra p y  a rea , provide an a ttra c tiv e  approach  fo r the  
d e v e lo p m e n t o f an e ffec tive  drug to  tr e a t  and p reven t osteom yelitis  and o th e r  
in fla m m a to ry  diseases.
5 . 1 .  F u t u r e  w o r k
The know led g e  o b ta in ed  in th e  p resen t study answ ers som e o f th e  questions  
a b o u t S. aureus and S. epidermidis bone infections. H ow ever, as a lready  
m e n tio n e d , add itiona l studies are  necessary to  fu lly understand  th e  m olecu lar  
m echanism s underly ing  Staphylococcal induced bone disease. T here fo re , 
suggestions to  continue  w ith  this investigation  are described below :
5. aureus  in d u ce d  o s te o m y e lit is
•  Id en tify  th e  exact b inding site on SpA in teracting  w ith  th e  TNFR -1 on 
osteoblast. Taking into  account th e  high hom ology b e tw e e n  SpA and Sbi, and th e  
fac t th a t only  SpA is invo lved  in b inding osteoblasts, exam inatio n  and  
com parison o f both  sequences m ay  be th e  key to  id en tify  th e  exact SpA binding  
site to  osteoblast;
•  S tudy o f ad d ition a l m ed ia tors  o f th e  S. aureus -  osteoblast in te rac tio n . As 
d e m o n s tra te d  in this study, SpA binding com prises 5 0  % o f th e  S. aureus 
in te rac tio n  w ith  osteoblasts. T h e re fo re  th e  rem ain ing  50  % o f this in te rac tio n
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m ay be due to  add itiona l S. aureus p ro te in s  o r specific sugars on th e  S. aureus 
cell w a ll in th e  binding to  osteoblast;
•  F u rth e r investigate  SpA and TN FR -1 in te rac tio n  using in vivo m odels o f 
o steom yelitis , in o rd er to  deve lop  a n e w  th e ra p y  fo r  osteom yelitis  patien ts .
5. ep iderm id is  in d u ce d  o s te o m y e lit is
•  Id e n tify  th e  in tegrin  re c e p to r fo r  SdrG th a t m ed ia tes  th e  binding to  
osteoblasts via fibrinogen;
•  Investigate  fu r th e r  in teractions  b e tw e e n  S. epidermidis and osteoblasts. 
Look fo r  th e  role o f o th e r  bacteria l cell w all com ponents  such as sugars and  
surface proteins;
•  Explore th e  p a th w a y  fo llo w ing  in fection  leading to  in fla m m a tio n  (looking  
fo r  cytokines release) and bone destruction ;
•  Studies using m edical im p la n t m ate ria l w ill certa in ly  co n trib u te  to  a 
b e tte r  understand ing  o f th e  S. epidermidis in fections;
•  F u rth e r investigate  th e  ro le  o f S. ep iderm id is  SdrG in bone infections  
using in vivo m odels o f disease.
192
Appendix
VI. APPENDIX
193
Appendix
i. Oral presentations
B io e n g in e e rin g  In Ire la n d  C on fe re nce , 2 2 -24  Ja nu a ry  2009
Claro T, W id aa  A ., Foster T, O 'Brien FJ and Kerrigan SW  (2 0 0 9 ). A P otentia l Drug  
T arg e t in th e  T re a tm e n t o f O steom yelitis . Proceedings of the 16th Annual 
Conference of the Section of Bioengineering of the Royal Academy of Medicine in 
Ireland, -  K.U. O 'K elly  (eds) U nivers ity  o f D ublin. PSII-8.
ISBN no. 9 7 8 -0 -9 5 4 8 5 8 3 -3 -9
R AM I B io m e d ica l Sciences S ection  M e e tin g , 2 3 -24  June 2010
Claro T, W id aa  A, M ia jlov ic  H, Foster T, O 'B rien  FJ, Kerrigan SW  (2 0 1 0 ). S. aureus 
binds to  osteoblasts and induces apoptosis. Irish Journal of Medical Science, 2 0 1 0  
A ug;179  S up p lem en t 7 :S 283 -301 .
S o c ie ty  fo r  G e ne ra l M ic ro b io lo g y , 6-9 S e p te m b e r 2010 A u tu m  C on fe rence
Claro T, W id a a  A, M ia jlov ic  H, Foster T, O 'B rien  FJ, Kerrigan SW  (2 0 1 0 ). S. aureus 
p ro te in  A binds to  osteoblasts and inhib its  p ro life ra tio n .
Research Day, 6 th A p r il 2011, Royal C ollege  o f  Surgeons in  Ire la n d
Claro T, W id a a  A, M ia jlov ic  H, Foster T, O 'B rien  FJ, Kerrigan SW  (2 0 1 0 ). N e w  
insights in to  th e  d ea th  and in fla m m a to ry  pathw ays associated w ith  bone  
in fec tio n -
R AM I B io m e d ica l Sciences S ection  M e e tin g , 2 2 nd June 2011
Claro T, M cD o n n e ll C, W id aa  A, Foster T, O 'B rien  FJ, Kerrigan SW  (2 0 1 0 ). 5. 
aureus p ro te in  A binds to  osteoblasts triggering  bone d es truction  and  
In fla m m a tio n  in bone in fection . Irish Journal of Medical Science (2 0 1 1 ) 180  
(Suppl 9 ):S 2 8 5 -S 3 0 6
V I. A P P E N D IX
194
Appendix
ii. Poster presentations
R A M I B io m e d ica l Sciences S ection  M e e tin g , 2009
Claro T, M ia jlov ic  H, Foster T, O 'B rien  FJ, Kerrigan SW  (2 0 0 9 ). A novel m echanism  
th ro u gh  w hich  S. aureus binds to  osteoblasts. Irish Journal of Medical Science 
V o lu m e  178  S u p p le m e n t 12 DOI 1 0 .1 0 0 7 /s l l8 4 5 -0 0 9 -0 4 4 1 -2
B io e n g in e e rin g  In Ire la n d  C on fe rence , 2 2 -24  January, 2010
Claro T, W id aa  A ., Foster T, O 'B rien  FJ and Kerrigan SW  (2 0 0 9 ). A  P otentia l Drug  
T arg e t in th e  T re a tm e n t o f O steom yelitis . Proceedings of the 16th Annual 
Conference of the Section of Bioengineering of the Royal Academy of Medicine in 
Ireland, -  K.U. O 'K elly  (eds) U nivers ity  o f D ublin. PSII-8.
ISBN no. 9 7 8 -0 -9 5 4 8 5 8 3 -3 -9
110 th A S M - G enera l M e e tin g , M a y  23-27 , 2010
Claro T, W id a a  A, M ia jlo v ic  H, Foster T, O 'B rien  FJ, Kerrigan SW  (2 0 1 0 ). S. aureus 
Pro te in  A Plays a Critical Role in th e  P athogenecity  o f  O steom yelitis . ISBN no. 
9 7 8 -1 -5 5 5 8 1 -6 2 3 -0
R AM I B io m e d ica l Sciences S ection  M e e tin g , 23-24  June 2010
Claro T, W id a a  A, M ia jlo v ic  H, Foster T, O 'B rien  FJ, Kerrigan SW  (2 0 1 0 ). S. aureus 
binds to  osteoblasts and induces apoptosis. Irish Journal of Medical Science, 2 0 1 0  
Aug; 179  S u p p le m e n t 7 :S 283 -301 .
R A M I B io m e d ica l Sciences S ection  M e e tin g , 2011
Claro T, M cD o n n e ll C, W id aa  A, Foster T, O 'B rien  FJ, Kerrigan SW  (2 0 1 0 ). 5. 
aureus p ro te in  A binds to  osteoblasts triggering  bone d es truction  and  
In fla m m a tio n  in bone in fection . Irish Journal of Medical Science (2 0 1 1 ) 180  
(Suppl 9 ):S 2 8 5 -S 3 0 6
195
Appendix
1. C laro T, W id aa  A, O 'Seaghdha M , M ia jlov ic  H, Foster TJ, O 'B rien  FJ, 
Kerrigan SW. 2 0 1 1  S. aureus p ro te in  A  binds to  osteoblasts and triggers signals 
th a t w ea k e n  bone in osteom yelitis . PLoS ONE, April 15;6(4):el8748
2. W id a a  A , C laro T, Foster TJ, O 'B rien  FJ, Kerrigan SW . M u lt ip le  signals 
induced by S. aureus P ro te in  A results in bone loss and bone destruction . 
Submitted PLoS ONE 2012
iii. P u b lic a t io n s
196
R eferences
VII. REFERENCES
197
R eferences
Aarden, E. M., P. J. Nijweide, et al. (1996). "Adhesive properties of isolated chick osteocytes in 
vitro." Bone 18(4): 305-313.
Abbas, S., Y. H. Zhang, et al. (2003). "Tumor necrosis factor-alpha inhibits pre-osteoblast 
differentiation through Its type-1 receptor." Cytokine 22(1-2): 33-41.
Abu-Amer, Y., J. Erdmann, et al. (2000). "Tumor necrosis factor receptors types 1 and 2 
differentially regulate osteoclastogenesis." J Biol Chem 275(35): 27307-27310.
Adler, C.-P. (2000). Bone diseases : macroscopic, histological, and radiological diagnosis of 
structural changes in the skeleton. Berlin ; New York, Springer.
Ahmed, S., S. Meghji, et al. (2001). "Staphylococcus aureus fibronectin binding proteins are 
essential for internalization by osteoblasts but do not account for differences in 
intracellular levels of bacteria." Infect Immun 69(5): 2872-2877.
Akira, S., S. Uematsu, et al. (2006). "Pathogen recognition and innate immunity." Cell 124(4): 783- 
801.
Akiyama, S. K., K. Olden, et al. (1995). "Fibronectin and integrins in invasion and metastasis." 
Cancer Metastasis Rev 14(3): 173-189.
Alexander, E. H., F. A. Rivera, et al. (2003). "Staphylococcus aureus - induced tumor necrosis 
factor - related apoptosis - inducing ligand expression mediates apoptosls and caspase-8 
activation in infected osteoblasts." BMC Microbiol 3: 5.
Arai, F., T. Miyamoto, et al. (1999). "Commitment and differentiation of osteoclast precursor cells 
by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB 
(RANK) receptors." J Exp Med 190(12): 1741-1754.
Archer, G. L. (1990). Staphylocococcus epidermidls and other coagulase-negatlve staphylococci. 
Principles of infectious diseases. G. L. Mandell and J. E. Bennett. New York, Churchill 
Livingstone: 1511-1518.
Arciola, C. R., D. Campoccia, et al. (2004). "Presence of fibrinogen-binding adhesin gene in 
Staphylococcus epidermidis Isolates from central venous catheters-associated and 
orthopaedic implant-associated infections." Biomaterials 25(19): 4825-4829.
Arrecubieta, C., M. H. Lee, et al. (2007). "SdrF, a Staphylococcus epidermidis surface protein, 
binds type I collagen." J Biol Chem 282(26): 18767-18776.
Atkins, K. L., J. D. Burman, et al. (2008). "S. aureus IgG-binding proteins SpA and Sbi: host 
specificity and mechanisms of Immune complex formation." Mol Immunol 45(6): 1600- 
1611.
Aubin, J. E. (1998). "Bone stem cells." J Cell Biochem Su p p I 30-31: 73-82.
Azuma, Y., K. Kajl, et al. (2000). "Tumor necrosis factor-alpha induces differentiation of and bone 
resorption by osteoclasts." J Biol Chem 275(7): 4858-4864.
Babich, M. and L. R. Fotl (1994). "E-cadherins identified in osteoblastic cells: effects of 
parathyroid hormone and extracellular calcium on localization." Life Sci 54(11): PL201- 
208.
Bailey, C. J., B. P. Lockhart, et al. (1995). "The epidermolytic (exfoliative) toxins of Staphylococcus 
aureus." Med Microbiol Immunol 184(2): 53-61.
Bailey, E. M., T. D. Constance, et al. (1990). "Coagulase-negative staphylococci: incidence, 
pathogenicity, and treatment in the 1990s." DICP 24(7-8): 714-720.
Bailey, E. M., M. J. Rybak, et al. (1991). "Comparative effect of protein binding on the killing 
activities of teicoplanin and vancomycin." Antimicrob Agents Chemother 35(6): 1089- 
1092.
Balows, A. (1992). The Prokaryotes : ahandbook on the biology of bacteria : ecophvsioloev. 
isolation, identification, applications. New York, N.Y., Sprlnger-Verlag.
Baltensperger, M. M. and G. K. Eyrich (2009). Osteomyelitis of the jaws. Berlin, Springer.
Banks, W. A., A. J. Kastin, et al. (1994). "Penetration of interleukin-6 across the murine blood- 
brain barrier." Neurosci Lett 179(1-2): 53-56.
Bannerman, D. D., M. J. Paape, et al. (2004). "Escherichia coli and Staphylococcus aureus elicit 
differential Innate immune responses following Intramammary infection." Clin Diagn Lab 
Immunol 11(3): 463-472.
V II. R E F E R E N C E S
198
R eferences
Barasch, A., K. M. Mosier, et al. (1993). "Postextraction osteomyelitis in a bone marrow
transplant recipient." Oral Sure Oral Med Oral Pathol 75(3): 391-396.
Baron, R., L. Neff, et al. (1990). "Selective internalization of the apical plasma membrane and 
rapid redistribution of lysosomal enzymes and mannose 6-phosphate receptors during 
osteoclast inactivation by calcitonin." J Cell Sci 97 ( Pt 3): 439-447.
Barton, L. L., L. M. Dunkle, et al. (1987). "Septic arthritis in childhood. A 13-year review." Am J Pis
Child 141(8): 898-900.
Belkin, S., M. B. Gu, et al. (2010). Whole cell sensing systems. Berlin, Springer.
Bennett, J. H., D. H. Carter, et al. (2001). "Patterns of integrin expression in a human mandibular 
explant model of osteoblast differentiation." Arch Oral Biol 46(3): 229-238.
Bennett, J. H., C. J. Joyner, et al. (1991). "Adlpocytic cells cultured from marrow have osteogenic 
potential." J Cell Sci 99 ( Pt 1): 131-139.
Berendt, T. and I. Byren (2004). "Bone and joint infection." Clin Med 4(6): 510-518.
Bernheimer, A. W. (1965). "Staphylococcal alpha toxin." Ann N Y Acad Sci 128(1): 112-123.
Bhakdi, S. and J. Tranum-Jensen (1991). "Alpha-toxin of Staphylococcus aureus." Microbiol Rev 
55(4): 733-751.
Bierbaum, G., F. Gotz, et al. (1996). "The biosynthesis of the lantibiotics epidermin, gallidermin, 
Pep5 and epilancin K7." Antonie Van Leeuwenhoek 69(2): 119-127.
Bilezikian, J. P., L. G. Raisz, et al. (2008). Principles of bone biology. Amsterdam ; London, Elsevier.
Bocchini, C. E., K. G. Hulten, et al. (2006). "Panton-Valentine leukocidin genes are associated with 
enhanced inflammatory response and local disease in acute hematogenous 
Staphylococcus aureus osteomyelitis in children." Pediatrics 117(2): 433-440.
Bonewald, L. F. (1999). "Establishment and characterization of an osteocyte-like cell line, MLO- 
Y4." J Bone Miner Metab 17(1): 61-65.
Bongartz, T., A. J. Sutton, et al. (2006). "Anti-TNF antibody therapy in rheumatoid arthritis and the 
risk of serious infections and malignancies: systematic review and meta-analysis of rare 
harmful effects In randomized controlled trials." JAMA 295(19): 2275-2285.
Bost, K. L., J. L. Bento, et al. (2001). "Monocyte chemoattractant protein-1 expression by 
osteoblasts following infection with Staphylococcus aureus or Salmonella." J Interferon 
Cytokine Res 21(5): 297-304.
Bost, K. L., W. K. Ramp, et al. (1999). "Staphylococcus aureus infection of mouse or human 
osteoblasts induces high levels of interleukin-6 and interleukin-12 production." J Infect 
Dis 180(6): 1912-1920.
Bouma, B., P. G. de Groot, et al. (1999). "Adhesion mechanism of human beta(2)-glycoproteln I to 
phospholipids based on its crystal structure." EMBO J 18(19): 5166-5174.
Bowden, M. G., W. Chen, et al. (2005). "Identification and preliminary characterization of cell- 
wall-anchored proteins of Staphylococcus epidermidis." Microbiology 151(Pt 5): 1453- 
1464.
Bozic, K. J., S. M. Kurtz, et al. (2010). "The epidemiology of revision total knee arthroplasty in the 
United States." Clin Orthop Relat Res 468(1): 45-51.
Bozic, K. J., S. M. Kurtz, et al. (2009). "The epidemiology of revision total hip arthroplasty in the 
United States." J Bone Joint Surg Am 91(1): 128-133.
Bozic, K. J. and M. D. Ries (2005). "The impact of infection after total hip arthroplasty on hospital 
and surgeon resource utilization." J Bone Joint Surg Am 87(8): 1746-1751.
Bradley, J. S., S. L. Kaplan, et al. (1998). "Pediatric pneumococcal bone and joint infections. The 
Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG)." Pediatrics 
102(6): 1376-1382.
Brady, B. A., J. G. Leid, et al. (2006). "Osteomyelitis: Clinical overview and mechanisms of 
infection persistence." Clinical Microbiology Newsletter 28(9): 65-72.
Brady, R. A., J. G. Leid, et al. (2008). "Osteomyelitis and the role of biofilms in chronic infection." 
FEMS Immunol Med Microbiol 52(1): 13-22.
Bremell, T. and A. Tarkowski (1995). "Preferential induction of septic arthritis and mortality by 
superantigen-producing staphylococci." Infect Immun 63(10): 4185-4187.
Brennan, M, P., A. Loughman, et al. (2009), "Elucidating the role of Staphylococcus epidermidis 
serine-aspartate repeat protein G in platelet activation." J Thromb Haemost 7(8): 1364- 
1372.
199
References
Brighton, C. T. and S. M. Albelda (1992). "Identification of integrin cell-substratum adhesion 
receptors on cultured rat bone cells." J Orthop Res 10(6): 766-773.
Brook, I. (2007). "Treatment of anaerobic infection." Expert Rev Anti Infect Ther 5(6): 991-1006.
Brown, D. E. M. and R. D. Neumann (2004). Orthopedic secrets. Philadelphia, Pa., Hanley & Belfus 
; [London : Elsevier Health Sciences] [distributor],
Bruzzaniti, A. and R. Baron (2006). "Molecular regulation of osteoclast activity." Rev Endocr 
Metab Disord 7(1-2): 123-139.
Bu, R., C. W. Borysenko, et al. (2003). "Expression and function of TNF-family proteins and 
receptors in human osteoblasts." Bone 33(5): 760-770.
Buckwalter, J. A., M. J. Glimcher, et al. (1996). "Bone biology. II: Formation, form, modeling, 
remodeling, and regulation of cell function." Instr Course Lect 45: 387-399.
Burger, E. H. and J. Klein-Nulend (1999). "Mechanotransduction in bone--role of the lacuno- 
canalicular network." FASEB J 13 Suppl: S101-112.
Burman, J. D., E. Leung, et al. (2008). "Interaction of human complement with Sbi, a 
staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of 
complement evasion by Staphylococcus aureus." J Biol Chem 283(25): 17579-17593.
Cadorna, E. A. and C. Watanakunakorn (1995). "Septicemic shock from urinary tract infection 
caused by Staphylococcus epidermidis." South Med J 88(8): 879-880.
Calhoun, J. H., J. Cantrell, et al. (1988). "Treatment of diabetic foot infections: Wagner 
classification, therapy, and outcome." Foot Ankle 9(3): 101-106.
Calhoun, J. H. and J. T. Mader (1997). "Treatment of osteomyelitis with a biodegradable antibiotic 
implant." Clin Orthop Relat Res(341): 206-214.
Canalis, E. (1987). "Effects of tumor necrosis factor on bone formation in vitro." Endocrinology
121(5): 1596-1604.
Caputo, G. M., P. R. Cavanagh, et al. (1994). "Assessment and management of foot disease in 
patients with diabetes." N Engl J Med 331(13): 854-860.
Carek, P. J., L. M. Dickerson, et al. (2001). "Diagnosis and management of osteomyelitis." Am Fam 
Physician 63(12): 2413-2420.
Carmody, R. J. and Y. H. Chen (2007). "Nuclear factor-kappaB: activation and regulation during 
toll-like receptor signaling." Cell Mol Immunol 4(1): 31-41.
Cartmell, T., S. Poole, et al. (2000). "Circulating interleukin-6 mediates the febrile response to 
localised inflammation in rats." J Physiol 526 Pt 3: 653-661.
Cedergren, L., R. Andersson, et al. (1993). "Mutational analysis of the interaction between
staphylococcal protein A and human IgGl." Protein Eng 6(4): 441-448.
Chamberlain, N. R. and S. A. Brueggemann (1997). "Characterisation and expression of fatty acid 
modifying enzyme produced by Staphylococcus epidermidis." J Med Microbiol 46(8): 
693-697.
Chan, B. (1999). "American Society for Microbiology-99th general meeting. 30 May-3 June 1999, 
Chicago, IL, USA." IDrugs 2(8): 745-748.
Chassaignac, E. (1852). De roste\0301o-mvelite chroniaue.
Chen, G. and D. V. Goeddel (2002). "TNF-R1 signaling: a beautiful pathway." Science 296(5573): 
1634-1635.
Cheng, S. L., F. Lecanda, et al. (1998). "Human osteoblasts express a repertoire of cadherins, 
which are critical for BMP-2-induced osteogenic differentiation." J Bone Miner Res 13(4): 
633-644.
Chiang, C. Y., G. Kyritsis, et al. (1999). "Interleukin-1 and tumor necrosis factor activities partially 
account for calvarial bone resorption induced by local injection of lipopolysaccharide." 
Infect Immun 67(8): 4231-4236.
Chonn, A., S. C. Semple, et al. (1992). "Association of blood proteins with large unilamellar 
liposomes in vivo. Relation to circulation lifetimes." J Biol Chem 267(26): 18759-18765.
Ciampolini, J. and K. G. Harding (2000). "Pathophysiology of chronic bacterial osteomyelitis. Why 
do antibiotics fail so often?" Postgrad Med J 76(898): 479-483.
Claro, T., A. Widaa, et al. (2011). "Staphylococcus aureus protein A binds to osteoblasts and 
triggers signals that weaken bone In osteomyelitis." PLoS One 6(4): el8748.
Clover, J., R. A. Dodds, et al. (1992). "Integrin subunit expression by human osteoblasts and 
osteoclasts in situ and in culture." J Cell Sci 103 ( Pt 1): 267-271.
2 0 0
References
Cohen, P. and S. Van Heyningen (1982). Molecular action of toxins and viruses. Amsterdam ; 
Oxford, Elsevier Biomedical.
Cohen, P. R. and M. E. Grossman (2004). "Management of cutaneous lesions associated with an 
emerging epidemic: community-acquired methicillin-reslstant Staphylococcus aureus 
skin infections." J Am Acad Dermatol 51(1): 132-135.
Cole, W. G., R. E. Dalziel, et al. (1982). "Treatment of acute osteomyelitis in childhood." J Bone 
Joint Sure Br 64(2): 218-223.
Colucci, S., G. Brunetti, et al. (2007). "The death receptor DR5 is involved in TRAIL-mediated 
human osteoclast apoptosis." Appptosis 12(9): 1623-1632.
Conlon, K. M., H. Humphreys, et al. (2002). "icaR encodes a transcriptional repressor involved in 
environmental regulation of ica operon expression and biofilm formation in 
Staphylococcus epidermidis." J Bacteriol 184(16): 4400-4408.
Costerton, J. W., P. S. Stewart, et al. (1999). "Bacterial biofilms: a common cause of persistent 
infections." Science 284(5418): 1318-1322.
Cramton, S. E., C. Gerke, et al. (2001). "In vitro methods to study staphylococcal biofilm 
formation." Methods Enzvmol 336: 239-255.
Cribier, B.; G. Prevost, et al. (1992). "Staphylococcus aureus leukocidin: a new virulence factor in 
cutaneous Infections? An epidemiological and experimental study." Dermatology 185(3): 
175-180.
Crossley, K. B. and G. Archer (1997). The staphylococci in human disease. New York ; Edinburgh, 
Churchill Livingstone.
Cruet-Hennequart, S., S. Maubant, et al. (2003). "alpha(v) Integrins regulate cell proliferation 
through integrin-linked kinase (ILK) in ovarian cancer cells." Oncogene 22(11): 1688- 
1702.
Darouiche, R. 0., M. D. Mansouri, et al. (2007). "In vivo efficacy of antimicrobial-coated devices." 
J Bone Joint Surg Am 89(4): 792-797.
Davis, S. L., S. Gurusiddappa, et al. (2001). "SdrG, a fibrinogen-binding bacterial adhesin of the 
microbial surface components recognizing adhesive matrix molecules subfamily from 
Staphylococcus epidermidis, targets the thrombin cleavage site in the Bbeta chain." J 
Biol Chem 276(30): 27799-27805.
De Jonghe, M. and G. Glaesener (1995). "[Type B Haemophilus influenzae infections. Experience 
at the Pediatric Hospital of Luxembourg]." Bull Soc Sci Med Grand Duche Luxemb 132(2): 
17-20.
De Wit, D., R. Mulla, et al. (1993). "Vertebral osteomyelitis due to Staphylococcus epidermidis." 
Br J Rheumatol 32(4): 339-341.
Deisenhofer, J. (1981). "Crystallographic refinement and atomic models of a human Fc fragment 
and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 
2.8-A resolution." Biochemistry 20(9): 2361-2370.
Desai, N. P., S. F. Hossalny, et al. (1992). "Surface-immobilized polyethylene oxide for bacterial 
repellence." Biomaterials 13(7): 417-420.
Domingo, P. and A. Fontanet (2001). "Management of complications associated with totally 
implantable ports in patients with AIDS." AIDS Patient Care STDS 15(1): 7-13.
Donlan, R. M. and J. W. Costerton (2002). "Biofilms: survival mechanisms of clinically relevant 
microorganisms." Clin Microbiol Rev 15(2): 167-193.
Doty, S. B. (1981). "Morphological evidence of gap junctions between bone cells." Calcif Tissue Int 
33(5): 509-512.
Dougherty, S. H. (1988). "Pathobiology of infection in prosthetic devices." Rev Infect Pis 10(6): 
1102-1117.
Dresser, L. D. and M. J. Rybak (1998). "The pharmacologic and bacteriologic properties of 
oxazolidlnones, a new class of synthetic antimicrobials." Pharmacotherapy 18(3): 456- 
462.
Ducy, P. (2000). "Cbfal: a molecular switch in osteoblast biology." Dev Dvn 219(4): 461-471.
Duong, L. T., P. Lakkakorpi, et al. (2000). "Integrins and signaling in osteoclast function." Matrix 
Biol 19(21:97-105.
Duthle, E, S. and L. L. Lorenz (1952). "Staphylococcal coagulase; mode of action and antigenicity." 
J Gen Microbiol 6(1-2): 95-107.
2 0 1
References
Dwivedi, V. K., A. Soni, et al. (2011). "Potentox Reduces Biochemical and Inflammatory Response 
in Osteomyelitis Infection." International Journal of Osteoporosis and Metabolic 
Disorders 4(1): 26-36.
Dzlewanowska, K., J. M. Patti, et al. (1999). "Fibronectin binding protein and host cell tyrosine 
kinase are required for internalization of Staphylococcus aureus by epithelial cells." 
Infect Immun 67(9): 4673-4678.
Eady, E. A. and J. H. Cove (2003). "Staphylococcal resistance revisited: community-acquired 
methicillin resistant Staphylococcus aureus-an emerging problem for the management 
of skin and soft tissue infections." Curr Qpin Infect Pis 16(2): 103-124.
Easmon, C. S. F. and C. Adlam (1983). Staphylococci and staphylococcal infections. London ; New 
York, Academic Press.
Edwards, C. J. and E. Williams (2010). "The role of interleukin-6 in rheumatoid arthritis-associated 
osteoporosis." Osteoporos Int 21(8): 1287-1293.
Ellington, J. K., S. S. Reilly, et al. (1999). "Mechanisms of Staphylococcus aureus invasion of 
cultured osteoblasts." Microb Pathos 26(6): 317-323.
Endress, C., P. R. Guyot, et al. (1990). "Cervical osteomyelitis due to i.v. heroin use: radiologic 
findings in 14 patients." AIR Am J Roentgenol 155(2): 333-335.
Evans, C. A., J. Jellis, et al. (1998). "Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 
secretion and the acute-phase response in patients with bacterial and tuberculous 
osteomyelitis." J Infect Pis 177(6): 1582-1587.
Ferrari, S. L., K. Traianedes, et al. (2000). "A role for N-cadherin in the development of the 
differentiated osteoblastic phenotype." J Bone Miner Res 15(2): 198-208.
Fischetti, V. A, (2000). Gram-positive pathogens. Washington, P.C., ASM Press.
Fischetti, V. A, (2000). Gram-positive pathogens. Washington, P.C., ASM Press.
Fitzgerald, J. R., A. Loughman, et al. (2006). "Fibronectin-binding proteins of Staphylococcus 
aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to 
integrin GPIIb/llla and IgG binding to the FcgammaRlla receptor." Mol Microbiol 59(1): 
212-230.
Fomenko, G. A. (1980). "[Quantitative determination of protein A in strains of staphylococci 
isolated in the course of different clinical states and localization of the process]." Zh 
Mikrobiol Epidemiol Immunobiol(lO): 57-61.
Forsgren, A. (1969). "Protein A from Staphylococcus aureus. 8. Production of protein A by 
bacterial and L-forms of S. aureus." Acta Pathol Microbiol Scand 75(3): 481-490.
Forsgren, A. (1970). "Significance of protein a production by staphylococci." Infect Immun 2(5): 
672-673.
Forsgren, A. and U. Forsum (1970). "Role of Protein A in Nonspecific Immunofluorescence of 
Staphylococcus aureus." Infect Immun 2(4): 387-391.
Forsgren, A. and J. Sjoquist (1966). ""Protein A" from S. aureus. I. Pseudo-immune reaction with 
human gamma-globulin." J Immunol 97(6): 822-827.
Foster, T. (1996). "Staphylococcus."
Foster, T. J. (2005). "Immune evasion by staphylococci." Nat Rev Microbiol 3(12): 948-958.
Foster, T. J. (2009). "Colonization and infection of the human host by staphylococci: adhesion, 
survival and immune evasion." Vet Permatol 20(5-6): 456-470.
Foster, T. J. and M. Hook (1998). "Surface protein adhesins of Staphylococcus aureus." Trends 
Microbiol 6(12): 484-488.
Foster, T. J. and P. McPevitt (1994). Molecular basis of adherence of staphylococci to 
biomaterials. Infections Associated with Indwelling Medical Pevices. A. L. Bisno and F. A. 
Waldvogel. Washington, P. C.
Foster, T. J. and P. McPevitt (1994). "Surface-associated proteins of Staphylococcus aureus: their 
possible roles in virulence." FEMS Microbiol Lett 118(3): 199-205.
Fournier, B. and D. J. Philpott (2005). "Recognition of Staphylococcus aureus by the innate 
immune system." Clin Microbiol Rev 18(3): 521-540.
Fowler, T., E. R. Wann, et al. (2000). "Cellular invasion by Staphylococcus aureus involves a 
fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell 
betal integrins." Eur J Cell Biol 79(10): 672-679.
2 0 2
References
Francis, S. E., K. L. Goh, et al. (2002). "Central roles of alpha5betal integrin and fibronectin in 
vascular development in mouse embryos and embryoid bodies." Arterioscler Thromb 
Vase Biol 22(6): 927-933.
Franken, N., P. H. Seidl, et al. (1984). "Specific immunoglobulin A antibodies to a peptide subunit 
sequence of bacterial cell wall peptidoglvcan." Infect Immun 44(1): 182-187.
Fraser, J. D. and T. Proft (2008). "The bacterial superantigen and superantigen-like proteins." 
Immunol Rev 225: 226-243.
Friedland, I. R., M. Paris, et al. (1993). "Evaluation of antimicrobial regimens for treatment of 
experimental penicillin- and cephalosporin-resistant pneumococcal meningitis." 
Antimicrob Aeents Chemother 37(8): 1630-1636,
Frost, H. M. (1986). Intermediary organization of the skeleton. Boca Raton, Fla., CRC Press.
Fujikawa, Y., J. M. Quinn, et al. (1996). "The human osteoclast precursor circulates in the 
monocyte fraction." Endocrinology 137(9): 4058-4060.
Gabay, C. (2006). "Interleukin-6 and chronic inflammation." Arthritis Res Ther 8 Suppl 2: S3.
Gadepalli, R., B. Dhawan, et al. (2006). "A clinico-microbiological study of diabetic foot ulcers in 
an Indian tertiary care hospital." Diabetes Care 29(8): 1727-1732.
Galliani, S., M. Viot, et al. (1994). "Early adhesion of bacteremic strains of Staphylococcus 
epidermidis to polystyrene: influence of hydrophobicity, slime production, plasma, 
albumin, fibrinogen, and fibronectin." J Lab Clin Med 123(5): 685-692.
Gallie, W. E. (1951). "First recurrence of osteomyelitis eighty years after infection." J Bone Joint 
Surg Br 33-B(l): 110-111.
Ganta, D. R., M. B. McCarthy, et al. (1997). "Ascorbic acid alters collagen integrins in bone 
culture." Endocrinology 138(9): 3606-3612.
Garcia-Alvarez, F., M, Navarro-Zorraquino, et al. (2009). "Effect of age on cytokine response in an 
experimental model of osteomyelitis." Biogerontoloev 10(5): 649-658.
Garcia-Lechuz, J. and E. Bouza (2009). "Treatment recommendations and strategies for the 
management of bone and joint infections." Expert Qpin Pharmacother 10(1): 35-55.
Garzoni, C. and W. L. Kelley (2009). "Staphylococcus aureus: new evidence for intracellular 
persistence." Trends Microbiol 17(2): 59-65.
Geiger, B. and O. Ayalon (1992). "Cadherins." Annu Rev Cell Biol 8: 307-332.
Gemmell, C. G. and M. Thelestam (1981). "Toxinogenicity of clinical isolates of coagulase- 
negative staphylococci towards various animal cells." Acta Pathol Microbiol Scand B 
89(6): 417-421.
Gemmell, C. G., R. Tree, et al. (1991). "Susceptibility to opsonophagocytosis of protein A, alpha- 
haemolysin and beta-toxin deficient mutants of Staphylococcus aureus isolated by allele 
replacement." Zentralbl Bakteriol(21): 273-277.
Gentry, L. O. (1997). "Management of osteomyelitis." Int J Antimicrob Aeents 9(1): 37-42.
George, E. L., E. N. Georges-Labouesse, et al. (1993). "Defects in mesoderm, neural tube and 
vascular development in mouse embryos lacking fibronectin." Development 119(4): 
1079-1091.
Ghosh, S. and M. Karin (2002). "Missing pieces in the NF-kappaB puzzle." CeH 109 Suppl: S81-96.
Gilbert, L., X. He, et al, (2000). "Inhibition of osteoblast differentiation by tumor necrosis factor- 
alpha." Endocrinology 141(11): 3956-3964.
Gill, S. R.( D. E. Fouts, et al. (2005). "Insights on evolution of virulence and resistance from the 
complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain 
and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain." J 
Bacteriol 187(7): 2426-2438.
Gitelis, S. and G. T. Brebach (2002). "The treatment of chronic osteomyelitis with a biodegradable 
antibiotic-impregnated implant." J Orthop Surg (Hone Kong) 10(1): 53-60.
Giuliani, N., R. Bataille, et al. (2001). "Myeloma cells induce imbalance in the 
osteoprotegerin/osteoprotegerin ligand system in the human bone marrow 
environment." Blood 98(13): 3527-3533.
Givan, A. L. (1992). Flow cytometry : first principles. Wiley-Liss.
Globus, R. K., S. B. Doty, et al. (1998). "Fibronectin is a survival factor for differentiated 
osteoblasts." J Cell Sci 111 ( Pt 10): 1385-1393.
Goldenberg, D. L. (1998). "Septic arthritis." Lancet 351(9097): 197-202.
203
References
Goldmann, D. A. and G. B. Pier (1993). "Pathogenesis of infections related to intravascular 
catheterization." Clin Microbiol Rev 6(2): 176-192.
Gomez, M. I., A. Lee, et al. (2004). "Staphylococcus aureus protein A induces airway epithelial 
inflammatory responses by activating TNFR1." Nat Med 10(8): 842-848.
Gomez, M. I., M. O'Seaghdha, et al. (2006). "Staphylococcus aureus protein A activates TNFR1 
signaling through conserved IgG binding domains." J Biol Chem 281(29): 20190-20196.
Gomez, M. I., M. O. Seaghdha, et al. (2007). "Staphylococcus aureus protein A activates TACE 
through EGFR-dependent signaling." EMBO J 26(3): 701-709.
Goodyear, C. S. and G. J. Silverman (2004). "Staphylococcal toxin induced preferential and 
prolonged in vivo deletion of innate-like B lymphocytes." Proc Natl Acad Sci U S A 
101(31): 11392-11397.
Gori, F., L. C. Hofbauer, et al. (2000). "The expression of osteoprotegerin and RANK ligand and the 
support of osteoclast formation by stromal-osteoblast lineage cells is developmental^ 
regulated." Endocrinology 141(12): 4768-4776.
Gotz, F., Bannerman, T., Schleifer, K.-H. (2006). The genera Staphylococcus and Macrococcus.. In 
The prokaryotes: an evolving electronic resource for the microbiological community. M. 
Dworkin, Springer Verlag.
Gouda, H., H. Torigoe, et al. (1992). "Three-dimensional solution structure of the B domain of 
staphylococcal protein A: comparisons of the solution and crystal structures." 
Biochemistry 31(40): 9665-9672.
Greene, C., D. McDevitt, et al. (1995). "Adhesion properties of mutants of Staphylococcus aureus 
defective in fibronectin-binding proteins and studies on the expression of fnb genes." 
Mol Microbiol 17(6): 1143-1152.
Greenwood, D. (2007). Antimicrobial chemotherapy. Oxford, Oxford University Press.
Greer, R. B„ Rosenberg A.E. (1993). "Case records of the Massachusetts General Hospital. Weekly 
clinicopathological exercises. Case 6-1993. A 69-year-old woman with a sclerotic lesion 
of the femur and pulmonary nodules." N Enel J Med 328(6): 422-428.
Grell, M. (1995). "Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and 
membrane-expressed TNF." J Inflamm 47(1-2): 8-17.
Grell, M., E. Douni, et al. (1995). "The transmembrane form of tumor necrosis factor is the prime 
activating ligand of the 80 kDa tumor necrosis factor receptor." Cell 83(5): 793-802.
Grigoriadis, A. E., J. N. Heersche, et al. (1988). "Differentiation of muscle, fat, cartilage, and bone 
from progenitor cells present in a bone-derived clonal cell population: effect of 
dexamethasone." J Cell Biol 106(6): 2139-2151.
Grundmeier, M., M. Hussain, et al. (2004). "Truncation of fibronectin-binding proteins in 
Staphylococcus aureus strain Newman leads to deficient adherence and host cell 
invasion due to loss of the cell wall anchor function." Infect Immun 72(12): 7155-7163.
Grzesik, W. J. and P. G. Robey (1994). "Bone matrix RGD glycoproteins: immunolocalization and 
interaction with human primary osteoblastic bone cells in vitro," J Bone Miner Res 9(4): 
487-496.
Guhlmann, A., D. Brecht-Krauss, et al. (1998). "Fluorine-18-FDG PET and technetium-99m 
antigranulocyte antibody scintigraphy in chronic osteomyelitis." J Nucl Med 39(12): 
2145-2152.
Guo, B., X. Zhao, et al. (2007). "Pathogenic implication of a fibrinogen-binding protein of 
Staphylococcus epidermidis in a rat model of intravascular-catheter-associated 
infection." Infect Immun 75(6): 2991-2995.
Haas, D. W. and M. P. McAndrew (1996). "Bacterial osteomyelitis in adults: evolving 
considerations in diagnosis and treatment." Am J Med 101(5): 550-561.
Harden, L. M., I. du Plessis, et al. (2006). "Interleukin-6 and leptin mediate lipopolysaccharide- 
induced fever and sickness behavior." Physiol Behav 89(2): 146-155.
Hardman, A. E. and D. J. Stensel (2009). Physical activity and health : the evidence explained. 
London, Routledge.
Harris, T. O,, D. Grossman, et al. (1993). "Lack of complete correlation between emetic and T-cell- 
stimulatory activities of staphylococcal enterotoxins." Infect Immun 61(8): 3175-3183.
Hartford, 0., L. O'Brien, et al. (2001). "The Fbe (SdrG) protein of Staphylococcus epidermidis HB 
promotes bacterial adherence to fibrinogen." Microbiology 147(Pt 9): 2545-2552.
204
References
Hartleib, J., N. Kohler, et al. (2000). "Protein A is the von Willebrand factor binding protein on 
Staphylococcus aureus." Blood 96(6): 2149-2156.
Hawiger, J. (1995). "Mechanisms involved in platelet vessel wall interaction." Thromb Haemost 
74(1): 369-372.
Hawiger, J., S. Timmons, et al. (1982). "Identification of a region of human fibrinogen interacting 
with staphylococcal clumping factor." Biochemistry 21(6): 1407-1413.
Healy, B. and A. Freedman (2006). "Infections." BMJ 332(7545): 838-841.
Helfgott, D. C., L. T. May, et al. (1987). "Bacterial lipopolysaccharide (endotoxin) enhances 
expression and secretion of beta 2 interferon by human fibroblasts." J Exp  Med 166(5): 
1300-1309.
Helfrich, M. H., S. A. Nesbitt, et al. (1996). "Beta 1 integrins and osteoclast function: involvement 
in collagen recognition and bone resorption." Bone 19(4): 317-328.
Henderson, B. and S. P. Nair (2003). "Hard labour: bacterial infection of the skeleton." Trends 
Microbiol 11(12): 570-577.
Herard, A. L., D. Pierrot, et al. (1996). "Fibronectin and its alpha 5 beta 1-integrin receptor are 
involved in the wound-repair process of airway epithelium." Am J Physiol 271(5 Pt 1): 
L726-733.
Heymann, D. and A. V. Rousselle (2000). "gpl30 Cytokine family and bone cells." Cytokine 12(10): 
1455-1468.
Hildebrand, A., M. Pohl, et al. (1991). "Staphylococcus aureus alpha-toxin. Dual mechanism of 
binding to target cells." J Biol Chem 266(26): 17195-17200.
Hillson, J. L., N. S. Karr, et al. (1993). "The structural basis of germline-encoded VH3 
immunoglobulin binding to staphylococcal protein A." J Exp Med 178(1): 331-336.
Ho, G., Jr. (1993). "How best to drain an infected joint. Will we ever know for certain?" J 
Rheumatol 20(12): 2001-2003.
Hofbauer, L. C., S. Khosla, et al. (2000). "The roles of osteoprotegerin and osteoprotegerin ligand 
in the paracrine regulation of bone resorption." J Bone Miner Res 15(1): 2-12.
Holtrop, M. E. and G. J. King (1977). "The ultrastructure of the osteoclast and its functional 
implications." Clin Orthop Relat Res(123): 177-196.
Holzman, R. S. and F. Bishko (1971). "Osteomyelitis in heroin addicts." Ann Intern Med 75(5): 
693-696.
Horne, W. C. (1995). "Toward a more complete molecular description of the osteoclast." Bone 
17(2): 107-109.
Horsburgh, M. J., J. L. Aish, et al. (2002). "sigmaB modulates virulence determinant expression 
and stress resistance: characterization of a functional rsbU strain derived from 
Staphylococcus aureus 8325-4." J Bacteriol 184(19): 5457-5467.
Horton, M. A. and G. A. Rodan (1996). Integrins as therapeutic targets in bone disease. Adhesion 
Receptors as Therapeutic targets. M. A. Horton. Boca Ranton, FL, CRC Press: 223-245.
House, R. V. and J. Descotes (2007). Cytokines in human health : immunotoxicology. pathology, 
and therapeutic applications. Totowa, N.J., Humana ; Paisley : Quantum [distributor],
Howard, C. B., M. Einhorn, et al. (1994). "Fine-needle bone biopsy to diagnose osteomyelitis." J 
Bone Joint Surg Br 76(2): 311-314.
Hoyle, B. D, and J. W. Costerton (1991). "Bacterial resistance to antibiotics: the role of biofilms." 
Pros Drug Res 37: 91-105.
Hsu, H., D. L. Lacey, et al. (1999). "Tumor necrosis factor receptor family member RANK mediates 
osteoclast differentiation and activation induced by osteoprotegerin ligand." Proc Natl 
Acad Sci U S A 96(7): 3540-3545.
Huang, S. L., I. C. Liao, et al. (2000). "Induction of apoptosis in tilapia, Oreochromis aureus 
Steindachner, and in TO-2 cells by Staphylococcus epidermidis." Journal of Fish Diseases 
23(6): 363-368.
Hudson, M. C., W. K. Ramp, et al. (1995). "Internalization of Staphylococcus aureus by cultured 
osteoblasts." Microb Pathog 19(6): 409-419.
Hurlimann, D., A. Forster, et al. (2002). "Anti-tumor necrosis factor-alpha treatment improves 
endothelial function in patients with rheumatoid arthritis." Circulation 106(17): 2184- 
2187.
Hussain, M., C. Heilmann, et al. (2001). "Teichoic acid enhances adhesion of Staphylococcus 
epidermidis to immobilized fibronectin." Microb Pathog 31(6): 261-270.
205
References
Hussain, M., M. Herrmann, et al. (1997). "A 140-kilodalton extracellular protein is essential for 
the accumulation of Staphylococcus epidermidis strains on surfaces." Infect Immun 
65(2): 519-524.
Hussain Mian, A., H. Saito, et al. (2008). "Lipopolysaccharide-induced bone resorption is 
increased in TNF type 2 receptor-deficient mice in vivo." J Bone Miner Metab 26(5): 469- 
477.
Hynes, R. O. (1992). "Integrins: versatility, modulation, and signaling in cell adhesion." Cell 69(1): 
11-25.
Ilvesaro, J. (2001). Attachment, polarity and communication characteristics of bone cells. 
University of Oulu.
Ilvesaro, J. M., P. T. Lakkakorpi, et al. (1998). "Inhibition of bone resorption in vitro by a peptide 
containing the cadherin cell adhesion recognition sequence HAV is due to prevention of 
sealing zone formation." Exp Cell Res 242(1): 75-83.
Inganas, M. (1981). "Comparison of mechanisms of interaction between protein A from 
Staphylococcus aureus and human monoclonal IgG, IgA and IgM in relation to the 
classical FC gamma and the alternative F(ab')2 epsilon protein A interactions." Scand J 
Immunol 13(4): 343-352.
Ishimi, Y., C. Miyaura, et al. (1990). "IL-6 is produced by osteoblasts and induces bone 
resorption." J Immunol 145(10): 3297-3303.
Jacobson, I. V. and W. L. Sieling (1987). "Microbiology of secondary osteomyelitis. Value of bone 
biopsy." S Afr Med J 72(7): 476-477.
Jacobsson, L. T., C. Turesson, et al. (2005). "Treatment with tumor necrosis factor blockers is 
associated with a lower incidence of first cardiovascular events in patients with 
rheumatoid arthritis." J Rheumatol 32(7): 1213-1218.
Jansson, B., M. Uhlen, et al. (1998). "All individual domains of staphylococcal protein A show Fab 
binding." FEMS Immunol Med Microbiol 20(1): 69-78.
Jauregui, L. E. f!995). Diagnosis and management of bone infections. New York, M. Dekker.
Jazayeri, J. A., G. J. Carroll, et al. (2010). "Interleukin-6 subfamily cytokines and rheumatoid 
arthritis: role of antagonists." Int Immunopharmacol 10(1): 1-8.
Jevon, M., C. Guo, et al. (1999). "Mechanisms of internalization of Staphylococcus aureus by 
cultured human osteoblasts." Infect Immun 67(5): 2677-2681.
Jirik, F. R., T. J. Podor, et al. (1989). "Bacterial lipopolysaccharide and Inflammatory mediators 
augment IL-6 secretion by human endothelial cells." J Immunol 142(1): 144-147.
Jonsson, K., C. Signas, et al. (1991). "Two different genes encode fibronectin binding proteins in 
Staphylococcus aureus. The complete nucleotide sequence and characterization of the 
second gene." Eur J Biochem 202(3): 1041-1048.
Josefsson, E., K. W. McCrea, et al. (1998). "Three new members of the serine-aspartate repeat 
protein multigene family of Staphylococcus aureus." Microbiology 144 ( Pt 12): 3387- 
3395.
Juliano, R. L. (2002). "Signal transduction by cell adhesion receptors and the cytoskeleton: 
functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members." 
Annu Rev Pharmacol Toxicol 42: 283-323.
Kaandorp, C. J., P. Krijnen, et al. (1997). "The outcome of bacterial arthritis: a prospective 
community-based study." Arthritis Rheum 40(5): 884-892.
Kaandorp, C. J., D. Van Schaardenburg, et al. (1995). "Risk factors for septic arthritis in patients 
with joint disease. A prospective study." Arthritis Rheum 38(12): 1819-1825.
Kaiser, S. and M. Rosenborg (1994). "Early detection of subperiosteal abscesses by 
ultrasonography. A means for further successful treatment in pediatric osteomyelitis." 
Pediatr Radiol 24(5): 336-339.
Kaji, R., J. Kiyoshima-Shibata, et al. (2010). "Bacterial teichoic acids reverse predominant IL-12 
production induced by certain lactobacillus strains into predominant IL-10 production 
via TLR2-dependent ERK activation in macrophages." J Immunol 184(7): 3505-3513.
Kalthoff, H. (2009). Death receptors and cognate ligands in cancer. Berlin, Springer.
Kanellakopoulou, K. and E. J. Giamarellos-Bourboulis (2000). "Carrier systems for the local 
delivery of antibiotics in bone infections." Drugs 59(6): 1223-1232.
Kanis, J. A. (2007). WHO Technical Report, University of Sheffield. Sheffiled, UK.
Kaplan, S. L. (2005). "Osteomyelitis in children." Infect Pis Clin North Am 19(4): 787-797, vii.
206
References
Karchmer, A. W. (1991). "Prosthetic valve endocarditis: a continuing challenge for infection 
control." J Hosp Infect 18 Suppl A: 355-366.
Karp, G. (2008). Cell and molecular biology : concepts and experiments. Hoboken, N.J., John 
Wiley.
Kerrigan, S. W., N. Clarke, et al. (2008). "Molecular basis for Staphylococcus aureus-mediated 
platelet aggregate formation under arterial shear in vitro." ArteriosclerThromb Vase Biol 
28(2): 335-340.
Kessler, C. M., E. Nussbaum, et al. (1991). "Disseminated intravascular coagulation associated 
with Staphylococcus aureus septicemia is mediated by peptidoglycan-induced platelet 
aggregation." J Infect Pis 164(1): 101-107.
Kessler, R. J. and P. P. Fanestil (1986). "Interference by lipids in the determination of protein 
using bicinchoninic acid." Anal Biochem 159(1): 138-142.
Khalil, H., R. J. Williams, et al. (2007). "Invasion of bone cells by Staphylococcus epidermidis."
Microbes Infect 9(4): 460-465.
Khosla, S. (2001). "Minireview: the OPG/RANKL/RANK system." Endocrinology 142(12): 5050- 
5055.
Kim, H. K., A. G. Cheng, et al. (2010). "Nontoxigenic protein A vaccine for methicillin-resistant 
Staphylococcus aureus infections in mice." J Exp Med 207(9): 1863-1870.
Kintarak, S., S. A. Whawell, et al. (2004). "Internalization of Staphylococcus aureus by human 
keratinocytes." Infect Immun 72(10): 5668-5675.
Kitagaki, M., K. Isoda, et al. (2011). "Novel TNF-alpha Receptor 1 Antagonist Treatment 
Attenuates Arterial Inflammation and Intimal Hyperplasia in Mice." J Atheroscler 
Thromb.
Klein, R. S. (1988). "Joint infection, with consideration of underlying disease and sources of
bacteremia in hematogenous infection." Clin Geriatr Med 4(2): 375-394.
Kloos, W. E. and T. L. Bannerman (1994). "Update on clinical significance of coagulase-negative 
staphylococci." Clin Microbiol Rev 7(1): 117-140.
Klosterhalfen, B., K. M. Peters, et al. (1996). "Local and systemic inflammatory mediator release 
in patients with acute and chronic posttraumatic osteomyelitis." J Trauma 40(3): 372- 
378.
Klotzbuecher, C. M., P. P. Ross, et al. (2000). "Patients with prior fractures have an increased risk 
of future fractures: a summary of the literature and statistical synthesis." J Bone Miner 
Res 15(4): 721-739.
Koch, B., P. Lemmermeier, et al. (1996). "Pemonstration of interleukin-lbeta and interleukin-6 in 
cells of synovial fluids by flow cytometry." EurJ Med Res 1(5): 244-248.
Kogianni, G. and B. S. Noble (2007). "The biology of osteocvtes." Curr Osteoporos Rep 5(2): 81-86.
Konig, C., S. Schwank, et al. (2001). "Factors compromising antibiotic activity against biofilms of 
Staphylococcus epidermidis." EurJ Clin Microbiol Infect Pis 20(1): 20-26.
Korovessis, P., A. P. Fortis, et al. (1991). "Acute osteomyelitis of the patella 50 years after a knee 
fusion for septic arthritis. A case report." Clin Orthop Relat Res(272): 205-207.
Kotake, S., K. Sato, et al. (1996). "Interleukin-6 and soluble interleukin-6 receptors in the synovial 
fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell 
formation." J Bone Miner Res 11(1): 88-95.
Kreis, T. and R. Vale (1999). Guidebook to the extracellular matrix and adhesion proteins. New 
York; Oxford, Oxford University Press.
Kriete, A. and K. L. Mayo (2009). "Atypical pathways of NF-kappaB activation and aging." Exp 
Gerontol 44(4): 250-255.
Kristinsson, K. G. (1989). "Adherence of staphylococci to intravascular catheters." J Med 
Microbiol 28(4): 249-257.
Kurihara, N., P. Bertolini, et al. (1990). "IL-6 stimulates osteoclast-like multinucleated cell 
formation in long term human marrow cultures by inducing IL-1 release." J Immunol 
144(11): 4226-4230.
Kurtz, S., K. Ong, et al. (2007). "Projections of primary and revision hip and knee arthroplasty in 
the United States from 2005 to 2030." J Bone Joint Surg Am 89(4): 780-785.
Kurtz, S. M., E. Lau, et al. (2008). "Infection burden for hip and knee arthroplasty in the United 
States." J Arthroplasty 23(7): 984-991.
207
References
Kurtz, S. M., K. L. Ong, et al. (2007). "Future clinical and economic impact of revision total hip and 
knee arthroplasty." J Bone Joint Sure Am 89 Suppl 3:144-151.
Kwan Tat, S., M. Padrines, et al. (2004). "IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone 
resorption pathophysiology." Cytokine Growth Factor Rev 15(1): 49-60.
Lacey, D. C., P. J. Simmons, et al. (2009). "Proinflammatory cytokines inhibit osteogenic 
differentiation from stem cells: implications for bone repair during inflammation." 
Osteoarthritis Cartilage 17(6): 735-742.
Lacey, D. L., E. Timms, et al. (1998). "Osteoprotegerin ligand is a cytokine that regulates 
osteoclast differentiation and activation." Cell 93(2): 165-176.
Lachica, R. V., C. A. Genigeorgis, et al. (1979). "Occurrence of protein A in Staphylococcus aureus 
and closely related Staphylococcus species." J Clin Microbiol 10(5): 752-753.
Lammers, A., P. J. Nuijten, et al. (1999). "The fibronectin binding proteins of Staphylococcus 
aureus are required for adhesion to and invasion of bovine mammary gland cells." FEMS 
Microbiol Lett 180(1): 103-109.
Langone, J. J. (1982). "Protein A of Staphylococcus aureus and related immunoglobulin receptors 
produced by streptococci and pneumonococci." Adv Immunol 32:157-252.
Lau, Y. S., W. Wang, et al. (2006). "Staphylococcus aureus capsular material promotes osteoclast 
formation." Injury 37 Suppl 2: S41-48.
Laughlin, T. J., D. G. Armstrong, et al. (1997). "Soft tissue and bone infections from puncture 
wounds in children." West J Med 166(2): 126-128.
Lazzarini, L., J. T. Mader, et al. (2004). "Osteomyelitis in long bones." J Bone Joint Sure Am 86- 
A(10): 2305-2318.
Le Dantec, L., F. Maury, et al. (1996). "Peripheral pyogenic arthritis. A study of one hundred 
seventy-nine cases." Rev Rhum Enel Ed 63(2): 103-110.
Ler, S. G., F. K. Lee, et al. (2006). "Trends in detection of warfare agents. Detection methods for 
ricin, staphylococcal enterotoxin B and T-2 toxin." J Chromatoer A 1133(1-2): 1-12.
Lew, D. P and F. A. Waldvogel (1997). "Osteomyelitis." N Enel J Med 336(14): 999-1007.
Lew, D. P. and F. A. Waldvogel (2004). "Osteomyelitis." Lancet 364(9431): 369-379.
Li, Y. P. and P. Stashenko (1992). "Proinflammatory cytokines tumor necrosis factor-alpha and IL- 
6, but not IL-1, down-regulate the osteocalcin gene promoter." J Immunol 148(3): 788- 
794.
Libermann, T. A. and D. Baltimore (1990). "Activation of interleukin-6 gene expression through 
the NF-kappa B transcription factor." Mol Cell Biol 10(5): 2327-2334.
Liou, H. C. (2002). "Regulation of the immune system by NF-kappaB and IkappaB." J Biochem Mol 
Biol 35(6): 537-546.
Lipsky, B. A. (1997). "Osteomyelitis of the foot in diabetic patients." Clin Infect Pis 25(6): 1318- 
1326.
Lipsky, P. E. (2006). "Interleukin-6 and rheumatic diseases." Arthritis ResTher8 Suppl 2: S4.
Locksley, R. M., N. Killeen, et al. (2001). "The TNF and TNF receptor superfamilies: integrating 
mammalian biology." Cell 104(4): 487-501.
Lodish, H. F. (1999). Molecular cell biology. New York ; Basingstoke, W.H. Freeman.
Longshaw, C. M., A. M. Farrell, et al. (2000). "Identification of a second lipase gene, gehP, in 
Staphylococcus epidermidis: comparison of sequence with those of other staphylococcal 
lipases." Microbiology 146 ( Pt 6): 1419-1427.
Lorenzo, J. (2000). "Interactions between immune and bone cells: new insights with many 
remaining questions." J Clin Invest 106(6): 749-752.
Lovell, W. W., R. B. Winter, et al. (2006). Lovell and Winter's pediatric orthopaedics. Philadelphia, 
Pa.; London, Lippincott Williams & Wilkins.
Lowy, F. P. (1998). "Staphylococcus aureus infections." N Engl J Med 339(8): 520-532.
Luong, T. T. and C, Y. Lee (2002). "Overproduction of type 8 capsular polysaccharide augments 
Staphylococcus aureus virulence." Infect Immun 70(7): 3389-3395.
Mack, D. (1999). "Molecular mechanisms of Staphylococcus epidermidis biofilm formation." J 
Hosp Infect 43 Suppl: S113-125.
Mack, D,, K. Bartscht, et al. (2000). Staphylococcal factors involved in adhesion and biofilm 
formation on biomaterials. Handbook for studying bacterial adhesion: principles, 
methods, and applications. Y. H. a. F. R. J. An. Totowa, Humana Press: 307-330.
208
References
Mack, D., M. Nedelmann, et al. (1994). "Characterization of transposon mutants of biofilm- 
producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm 
production: genetic identification of a hexosamine-containing polysaccharide 
intercellular adhesin." Infect Immun 62(8): 3244-3253.
Mack, D., N. Siemssen, et al. (1992). "Parallel induction by glucose of adherence and a 
polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: 
evidence for functional relation to intercellular adhesion." Infect Immun 60(5): 2048- 
2057.
Mader, J. T., D. Mohan, et al. (1997). "A practical guide to the diagnosis and management of bone 
and joint infections." Drugs 54(2): 253-264.
Mader, J. T., M. Ortiz, et al. (1996). "Update on the diagnosis and management of osteomyelitis." 
Clin Podiatr Med Surg 13(4): 701-724.
Mader, J. T., M. E. Shirtliff, et al. (1999). "Antimicrobial treatment of chronic osteomyelitis." Clin 
Orthop Relat Res(360): 47-65.
Magnusson, M. K. and D. F. Mosher (1998). "Fibronectin: structure, assembly, and cardiovascular 
implications." Arterioscler Thromb Vase Biol 18(9): 1363-1370.
Mah, E. T., G. W. LeQuesne, et al. (1994). "Ultrasonic features of acute osteomyelitis in children." 
J Bone Joint Surg Br 76(6): 969-974.
Mahalingam, D., E. Szegezdi, et al. (2009). "TRAIL receptor signalling and modulation: Are we on 
the right TRAIL?" Cancer Treat Rev 35(3): 280-288.
Malani, P. N., S. A. McNeil, et al. (2002). "Candida albicans sternal wound infections: a chronic 
and recurrent complication of median sternotomy." Clin Infect Pis 35(11): 1316-1320.
Marriott, I., D. L. Gray, et al. (2005). "Osteoblasts produce monocyte chemoattractant protein-1 
in a murine model of Staphylococcus aureus osteomyelitis and infected human bone 
tissue." Bone 37(4): 504-512.
Marriott, I., D. L. Gray, et al. (2004). "Osteoblasts express the inflammatory cytokine interleukin-6 
in a murine model of Staphylococcus aureus osteomyelitis and infected human bone 
tissue." Am J Pathol 164(4): 1399-1406.
Martini, F. and E. F. Bartholomew (2003). Essentials of anatomy & physiology. San Francisco ; 
London, Pearson.
Masters, B. R. (2006). Confocal microscopy and multiphoton excitation microscopy : the genesis 
of live cell imaging. Bellingham, Wash., SPIE Press.
Mathews, C. J., G. Kingsley, et al. (2008). "Management of septic arthritis: a systematic review." 
Postgrad Med J 84(991): 265-270.
Matsuo, K. and N. Irie (2008). "Osteoclast-osteoblast communication." Arch Biochem Biophvs 
473(2): 201-209.
Mattsson, E., H. Herwald, et al. (2002). "Peptidoglycan from Staphylococcus aureus induces tissue 
factor expression and procoagulant activity in human monocytes." Infect Immun 70(6): 
3033-3039.
May, M. J. and S. Ghosh (1997). "Rel/NF-kappa B and I kappa B proteins: an overview." Semin 
Cancer Biol 8(2): 63-73.
Mbalaviele, G., H. Chen, et al. (1995). "The role of cadherin in the generation of multinucleated 
osteoclasts from mononuclear precursors in murine marrow." J Clin Invest 95(6): 2757- 
2765.
Mbalaviele, G., R. Nishimura, et al. (1998). "Cadherin-6 mediates the heterotypic interactions 
between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of 
osteoclast differentiation." J Cell Biol 141(6): 1467-1476.
McCrea, K. W., O. Hartford, et al. (2000). "The serine-aspartate repeat (Sdr) protein family in 
Staphylococcus epidermidis." Microbiology 146 ( Pt 7): 1535-1546.
McDevitt, D., P. Francois, et al. (1994). "Molecular characterization of the clumping factor 
(fibrinogen receptor) of Staphylococcus aureus." Mol Microbiol 11(2): 237-248.
McKevitt, A. I., G. L. Bjornson, et al. (1990). "Amino acid sequence of a deltalike toxin from 
Staphylococcus epidermidis." Infect Immun 58(5): 1473-1475.
Meghji, S., S. J. Crean, et al. (1998). "Surface-associated protein from Staphylococcus aureus 
stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology." Br J 
Rheumatol 37(10): 1095-1101.
209
References
Meghji, S., S. J. Crean, et al. (1997). "Staphylococcus epidermidis produces a cell-associated 
proteinaceous fraction which causes bone resorption by a prostanoid-independent 
mechanism: relevance to the treatment of infected orthopaedic implants." Br J 
Rheumatol 36(9): 957-963.
Mehlin, C., C. M. Headley, et al. (1999). "An inflammatory polypeptide complex from 
Staphylococcus epidermidis: isolation and characterization." J Exp Med 189(6): 907-918.
Melamed, M. R., T. Lindmo, et al. (1990). Flow cytometry and sorting. New York, A.R. Liss.
Menton, D. N., D. J. Simmons, et al. (1984). "From bone lining cell to osteocyte--an SEM study." 
Anat Rec 209(1): 29-39.
Menzies, B. E. and I. Kourteva (2000). "Staphylococcus aureus alpha-toxin induces apoptosis in 
endothelial cells." FEMS Immunol Med Microbiol 29(1): 39-45.
Menzies, R., D. MacCulloch, et al. (1991). "Investigation of nosocomial prosthetic valve 
endocarditis due to antibiotic-resistant Staphylococcus epidermidis." J Hosp Infect 19(2): 
107-114.
Meunier, P. J. (1998). Osteoporosis: diagnosis and management. London, Martin Dunitz.
Mlkuni-Takagaki, Y. (1999). "Mechanical responses and signal transduction pathways in stretched 
osteocytes." J Bone Miner Metab 17(1): 57-60.
Miller, D. J. and G. C. Mejicano (2001). "Vertebral osteomyelitis due to Candida species: case 
report and literature review." Clin Infect Pis 33(4): 523-530.
Montanaro, L., F. Testoni, et al. (2011). "Emerging pathogenetic mechanisms of the implant- 
related osteomyelitis by Staphylococcus aureus." IntJ Artif Organs 34(9): 781-788.
Morgan, P. S.( P. Fisher, et al. (1996). "An 18 year clinical review of septic arthritis from tropical 
Australia." Epidemiol Infect 117(3): 423-428.
Morrissy, R. T. and P. W. Haynes (1989). "Acute hematogenous osteomyelitis: a model with 
trauma as an etiology." J Pediatr Orthop 9(4): 447-456.
Moursi, A. M., R. K. Globus, et al. (1997). "Interactions between integrin receptors and 
fibronectin are required for calvarial osteoblast differentiation in vitro." J Cell Sci 110 ( Pt 
18): 2187-2196.
Nade, S. (2003). "Septic arthritis." Best Pract Res Clin Rheumatol 17(2): 183-200.
Nalr, S., Y. Song, et al. (1995). "Surface-associated proteins from Staphylococcus aureus 
demonstrate potent bone resorbing activity." J Bone Miner Res 10(5): 726-734.
Nakamura, I., N. Takahashi, et al. (1996). "Chemical and physical properties of the extracellular 
matrix are required for the actin ring formation in osteoclasts." J Bone Miner Res 11(12): 
1873-1879.
Naktin, J. and J. PeSimone (1999). "Lumbar vertebral osteomyelitis with mycotic abdominal aortic 
aneurysm caused by highly penicillin-resistant Streptococcus pneumoniae." J Clin 
Microbiol 37(12): 4198-4200.
Nanes, M. S. (2003). "Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal 
pathology." Gene 321:1-15.
Navarre, W. W. and O. Schneewind (1994). "Proteolytic cleavage and cell wall anchoring at the 
LPXTG motif of surface proteins in gram-positive bacteria." Mol Microbiol 14(1): 115- 
121.
Navarre, W. W., H. Ton-That, et al. (1998). "Anchor structure of staphylococcal surface proteins. 
II. Cooh-terminal structure of muramidase and amidase-solubilized surface protein." J 
Biol Chem 273(44): 29135-29142.
Nelson, J. P. and W. C. Koontz (1966). "Septic arthritis in infants and children: a review of 117 
cases." Pediatrics 38(6): 966-971.
Nesbitt, S., A. Nesbit, et al. (1993). "Biochemical characterization of human osteoclast integrins. 
Osteoclasts express alpha v beta 3, alpha 2 beta 1, and alpha v beta 1 integrins." J Biol 
Chem 268(22): 16737-16745.
Nesbitt, S. A. and M. A. Horton (1997). "Trafficking of matrix collagens through bone-resorbing 
osteoclasts." Science 276(5310): 266-269.
Ni Eidhin, P., S. Perkins, et al. (1998). "Clumping factor B (ClfB), a new surface-located fibrinogen- 
binding adhesin of Staphylococcus aureus." Mol Microbiol 30(2): 245-257.
Nielsen, C. H. and R. G. Leslie (2002). "Complement's participation in acquired immunity." J 
Leukoc Biol 72(2): 249-261.
2 1 0
References
Nilsdotter-Augustinsson, A., A. Wilsson, et al. (2004). "Staphylococcus aureus, but not 
Staphylococcus epidermidis, modulates the oxidative response and induces apoptosis in 
human neutrophils." APMIS 112(2): 109-118.
Nilsson, I, M., J. C. Lee, et al. (1997). "The role of staphylococcal polysaccharide microcapsule 
expression in septicemia and septic arthritis." Infect Immun 65(10): 4216-4221.
Nilsson, M., L. Frykberg, et al. (1998). "A fibrinogen-binding protein of Staphylococcus 
epidermidis." Infect Immun 66(6): 2666-2673.
Nimpf, J., E. M. Bevers, et al. (1986). "Prothrombinase activity of human platelets is inhibited by 
beta 2-elvcoprotein-l." Biochim Biophvs Acta 884(1): 142-149.
Ning, R., X. Zhang, et al. (2010). "Attachment of Staphylococcus aureus is required for activation 
of nuclear factor kappa B in human osteoblasts." Acta Biochim Biophvs Sin (Shanghai) 
42(12): 883-892.
Ning, R., X. Zhang, et al. (2011). "Staphylococcus aureus regulates secretion of interleukin-6 and 
monocyte chemoattractant protein-1 through activation of nuclear factor kappaB 
signaling pathway in human osteoblasts." Braz J Infect Pis 15(3): 189-194.
Nishimoto, N. and T. Kishimoto (2004). "Inhibition of IL-6 for the treatment of inflammatory 
diseases." Curr Qpin Pharmacol 4(4): 386-391.
Nomura, T., Y. Abe, et al. (2010). "Creation of TNFRl-selective Antagonist and Its Therapeutic 
Effects." YAKUGAKU ZASSHI130: 63-68.
Norden, C., J. P. Nelson, et al. (1992). "Evaluation of new anti-infective drugs for the treatment of 
infections of prosthetic hip joints. Infectious Piseases Society of America and the Food 
and Drug Administration." Clin Infect Pis 15 Suppl 1: S177-181.
Norden, C. W., R. Bryant, et al. (1986). "Chronic osteomyelitis caused by Staphylococcus aureus: 
controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy." South Med J 
79(8): 947-951.
Novick, R. (1967). "Properties of a cryptic high-frequency transducing phage in Staphylococcus 
aureus." Virology 33(1): 155-166.
Novick, R. P. (1990). Molecular biology of the staphylococci. New York, N.Y., VCH.
O'Brien, L., S. W. Kerrigan, et al. (2002). "Multiple mechanisms for the activation of human 
platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and 
ClfB, the serine-aspartate repeat protein SdrE and protein A." Mol Microbiol 44(4): 1033- 
1044.
O'Gara, J. P. and H. Humphreys (2001). "Staphylococcus epidermidis biofilms: importance and 
implications." J Med Microbiol 50(7): 582-587.
O'Riordan, K. and J. C. Lee (2004). "Staphylococcus aureus capsular polysaccharides." Clin 
Microbiol Rev 17(1): 218-234.
O'Seaghdha, M., C. J. van Schooten, et al. (2006). "Staphylococcus aureus protein A binding to 
von Willebrand factor Al domain is mediated by conserved IgG binding regions." FEBS J 
273(21): 4831-4841.
O'Toole, G., H. B. Kaplan, et al. (2000). "Biofilm formation as microbial development." Annu Rev 
Microbiol 54: 49-79.
Ochi, H., Y. Hara, et al. (2010). "The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual 
effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival." J 
Orthop Res 28(5): 657-663.
Ogawa, S. K., E. R. Yurberg, et al. (1985). "Bacterial adherence to human endothelial cells in 
vitro." Infect Immun 50(1): 218-224.
Okazaki, M., S. Takeshita, et al. (1994). "Molecular cloning and characterization of OB-cadherin, a 
new member of cadherin family expressed in osteoblasts." J Biol Chem 269(16): 12092- 
12098.
Otto, M. (2009). "Staphylococcus epidermidis--the 'accidental' pathogen." Nat Rev Microbiol 7(8): 
555-567.
Ozawa, T., J. Kaneko, et al. (1995). "Essential binding of LukF of staphylococcal gamma-hemolysin 
followed by the binding of H gamma II for the hemolysis of human erythrocytes." Biosci 
Biotechnol Biochem 59(6): 1181-1183.
Paget, S. A., A. Gibofsky, et al. (2005). Hospital for Special Surgery manual of rheumatology and 
outpatient orthopedic disorders : diagnosis and therapy. Philadelphia, Pa. ; London, 
Lippincott Williams & Wilkins.
2 1 1
References
Palmqvist, N., T. Foster, et al. (2005). "Fibronectin-binding proteins and fibrinogen-binding 
clumping factors play distinct roles in staphylococcal arthritis and systemic 
inflammation." J Infect Pis 191(5): 791-798.
Palmqvist, N., T. Foster, et al. (2002). "Protein A is a virulence factor In Staphylococcus aureus 
arthritis and septic death." Microb Pathos 33(5): 239-249.
Paniccia, R., S. Colucci, et al. (1993). "Immediate cell signal by bone-related peptides in human 
osteoclast-like cells." Am J Physiol 265(5 Pt 1): C1289-1297.
Panzer, U., O. M. Steinmetz, et al. (2009). "Resolution of renal inflammation: a new role for NF- 
kappaBl (p50) in inflammatory kidney diseases." Am J Physiol Renal Phvsiol 297(2): 
F429-439.
Parfitt, A. M. (1977). "The cellular basis of bone turnover and bone loss: a rebuttal of the 
osteocytic resorption—bone flow theory." Clin Orthop Relat Res(127): 236-247.
Patel, A. H., J. Kornblum, et al. (1992). "Regulation of the protein A-encoding gene in 
Staphylococcus aureus." Gene 114(1): 25-34.
Patel, A. H., P. Nowlan, et al. (1987). "Virulence of protein A-deficient and alpha-toxin-deficient 
mutants of Staphylococcus aureus isolated by allele replacement." Infect Immun 55(12): 
3103-3110.
Patti, J. M., B. L. Allen, et al. (1994). "MSCRAMM-mediated adherence of microorganisms to host 
tissues." Annu Rev Microbiol 48: 585-617.
Patti, J. M., T. Bremell, et al. (1994). "The Staphylococcus aureus collagen adhesin is a virulence 
determinant in experimental septic arthritis." Infect Immun 62(1): 152-161.
Patti, J. M., K. House-Pompeo, et al. (1995). "Critical residues in the ligand-binding site of the 
Staphylococcus aureus collagen-binding adhesin (MSCRAMM)." J Biol Chem 270(20): 
12005-12011.
Patti, J. M., H. Jonsson, et al. (1992). "Molecular characterization and expression of a gene 
encoding a Staphylococcus aureus collagen adhesin." J Biol Chem 267(7): 4766-4772.
Patzakis, M. J., J. Wilkins, et al. (1994). "Comparison of the results of bacterial cultures from 
multiple sites in chronic osteomyelitis of long bones. A prospective study." J Bone Joint 
Sure Am 76(5): 664-666.
Pawley, J. B. (2006). Handbook of biolosical confocal microscopy. New York, NY, Springer.
Peacock, S. J., T. J. Foster, et al. (1999). "Bacterial fibronectin-binding proteins and endothelial 
cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human 
endothelial cells." Microbiology 145 ( Pt 12): 3477-3486.
Peacock, S. J., C. E. Moore, et al. (2002). "Virulent combinations of adhesin and toxin genes in 
natural populations of Staphylococcus aureus." Infect Immun 70(9): 4987-4996.
Pei, L., M. Palma, et al. (1999). "Functional studies of a fibrinogen binding protein from 
Staphylococcus epidermidis." Infect Immun 67(9): 4525-4530.
Perry, M. (1996). "Erythrocyte sedimentation rate and C reactive protein in the assessment of 
suspected bone infection-are they reliable indices?" J R Coll Sure Edinb 41(2): 116-118.
Petersen, O. H. (2007). Human phvsioloev. Oxford, Blackwell.
Pharmakakis, N. M., I. K. Petropoulos, et al. (2009). "Apoptotic mechanisms within the retina in 
Staphylococcus epidermidis experimental endophthalmitis." Graefes Arch Clin Exp 
Ophthalmol 247(5): 667-674.
Pietrzak, W. S. (2008). Musculoskeletal tissue reeeneration : bioloeical materials and methods. 
Totowa, NJ, Humana Press.
Pohlmann-Pietze, P., M. Ulrich, et al. (2000). "Adherence of Staphylococcus aureus to endothelial 
cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth 
phase." Infect Immun 68(9): 4865-4871.
Pollard, A. J., G. H. McCracken, et al. (2004). Hot topics in infection and immunity in children. 
Pordrecht; London, Kluwer Academic/Plenum.
Poltorak, A., X. He, et al. (1998). "Pefective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: 
mutations in Tlr4 gene." Science 282(5396): 2085-2088.
Ponnuraj, K., M. G. Bowden, et al. (2003). "A "dock, lock, and latch" structural model for a 
staphylococcal adhesin binding to fibrinogen." Cell 115(2): 217-228.
Prevost, G., B. Cribier, et al. (1995). "Panton-Valentine leucocidin and gamma-hemolysin from 
Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have 
different biological activities." Infect Immun 63(10): 4121-4129.
2 1 2
References
Provenza, G., M. Provenzano, et al. (2010). "Functional analysis of a murine monoclonal antibody 
against the repetitive region of the fibronectin-binding adhesins fibronectin-binding 
protein A and fibronectin-binding protein B from Staphylococcus aureus." FEBS J 
277(21): 4490-4505.
Qaseem, A., V. Snow, et al. (2008). "Screening for osteoporosis in men: a clinical practice 
guideline from the American College of Physicians." Ann Intern Med 148(9): 680-684.
Raad, I., A. Alrahwan, et al. (1998). "Staphylococcus epidermidis: emerging resistance and need 
for alternative agents." Clin Infect Pis 26(5): 1182-1187.
Ramsey, S. P., K. Newton, et al. (1999). "Incidence, outcomes, and cost of foot ulcers in patients 
with diabetes." Piabetes Care 22(3): 382-387.
Rao, N. and B. A. Lipsky (2007). "Optimising antimicrobial therapy in diabetic foot infections." 
Prues 67(2): 195-214.
Rawlings, N. D. and A. J. Barrett (1994). "Families of serine peptidases." Methods Enzvmol 244: 
19-61.
Reilly, S. S., M. C. Hudson, et al. (2000). "In vivo internalization of Staphylococcus aureus by 
embryonic chick osteoblasts." Bone 26(1): 63-70.
Rickert, R. C. (2005). "Regulation of B lymphocyte activation by complement C3 and the B cell 
coreceptor complex." Curr Opin Immunol 17(3): 237-243.
Riikonen, T., J. Westermarck, et al. (1995). "Integrin alpha 2 beta 1 is a positive regulator of 
collagenase (MMP-1) and collagen alpha 1(1) gene expression." J Biol Chem 270(22): 
13548-13552.
Rivera, J., G. Vannakambadi, et al. (2007). "Fibrinogen-binding proteins of Gram-positive 
bacteria." Thromb Haemost 98(3): 503-511.
Robiller, F. C., K. D. Stumpe, et al. (2000). "Chronic osteomyelitis of the femur: value of PET 
imaging." Eur Radiol 10(5): 855-858.
Rogers, A. and R. Eastell (2005). "Circulating osteoprotegerin and receptor activator for nuclear 
factor kappaB ligand: clinical utility in metabolic bone disease assessment." J Clin 
Endocrinol Metab 90(11): 6323-6331.
Rogers, K. (2010). Bone and muscle : structure, force, and motion. New York, NY, Britannica 
Educational Pub. in association with Rosen Education Services.
Roodman, G. P. (2001). "Biology of osteoclast activation in cancer." J Clin Oncol 19(15): 3562- 
3571.
Ruoslahti, E. (1996). "RGP and other recognition sequences for integrins." Annu Rev Cell Pev Biol 
12: 697-715.
Ruoslahti, E. and J. C. Reed (1994). "Anchorage dependence, integrins, and apoptosis." Cell 77(4): 
477-478.
Rupp, M. E. and G. L. Archer (1994). "Coagulase-negative staphylococci: pathogens associated 
with medical progress." Clin Infect Pis 19(2): 231-243; quiz 244-235.
Ryan, M. J., R. Kavanagh, et al. (1997). "Bacterial joint infections in England and Wales: analysis of 
bacterial isolates over a four year period." Br J Rheumatol 36(3): 370-373.
Ryden, C., H. S. Tung, et al. (1997). "Staphylococcus aureus causing osteomyelitis binds to a 
nonapeptide sequence in bone sialoprotein." Biochem J 327 ( Pt 3): 825-829.
Saadeh, C. (1998). "The erythrocyte sedimentation rate: old and new clinical applications." South 
Med J 91(3): 220-225.
Sabat, A., P. C. Melles, et al. (2006). "Pistribution of the serine-aspartate repeat protein-encoding 
sdr genes among nasal-carriage and invasive Staphylococcus aureus strains." J Clin 
Microbiol 44(3): 1135-1138.
Sadat-Ali, M. (1998). "The status of acute osteomyelitis in sickle cell disease. A 15-year review." 
IntSurg 83(1): 84-87.
Salo, J., P. Lehenkari, et al. (1997). "Removal of osteoclast bone resorption products by 
transcvtosis." Science 276(5310): 270-273.
Salter, P. M., J. E. Robb, et al. (1997). "Electrophysiological responses of human bone cells to
mechanical stimulation: evidence for specific integrin function in mechanotransduction." 
J Bone Miner Res 12(7): 1133-1141.
Sammak, B., M. Abd El Bagi, et al. (1999). "Osteomyelitis: a review of currently used imaging
techniques." Eur Radiol 9(5): 894-900.
213
References
Sanford, B. A., V. L. Thomas, et al. (1986). "Characterization of clinical strains of Staphylococcus 
aureus associated with pneumonia." J Clin Microbiol 24(1): 131-136.
Santiago Restrepo, C., C. R. Gimenez, et al. (2003). "Imaging of osteomyelitis and musculoskeletal 
soft tissue infections: current concepts." Rheum Pis Clin North Am 29(1): 89-109.
Sapico, F. L. (1996). "Microbiology and antimicrobial therapy of spinal infections." Orthop Clin 
North Am 27(1): 9-13.
Saravia-Otten, P., H. P. Muller, et al. (1997). "Transcription of Staphylococcus aureus fibronectin 
binding protein genes is negatively regulated by agr and an agr-independent 
mechanism." J Bacteriol 179(17): 5259-5263.
Sasso, E. H., G. J. Silverman, et al. (1989). "Human IgM molecules that bind staphylococcal protein 
A contain VHIII H chains." J Immunol 142(8): 2778-2783.
Sasso, E. H., G. J. Silverman, et al. (1991). "Human IgA and IgG F(ab')2 that bind to staphylococcal 
protein A belong to the VHIII subgroup." J Immunol 147(6): 1877-1883.
Sax, H. and P. Lew (1999). "Osteomyelitis." Curr Infect Pis Rep 1(3): 261-266.
Schattner, A. and K. L. Vosti (1998). "Bacterial arthritis due to beta-hemolytic streptococci of 
serogroups A, B, C, F, and G. Analysis of 23 cases and a review of the literature." 
Medicine (Baltimore) 77(2): 122-139.
Schleifer, K. H. (1973). "Chemical composition of staphylococcal cell walls." Contrib Microbiol 
Immunol 1: 13-23.
Schleifer, K. H. and O. Kandler (1972). "Peptidoglycan types of bacterial cell walls and their 
taxonomic implications." Bacteriol Rev 36(4): 407-477.
Schmitz, A., T. Kalicke, et al. (2000). "Use of fluorine-18 fluoro-2-deoxy-P-glucose positron 
emission tomography in assessing the process of tuberculous spondylitis." J Spinal 
Pisord 13(6): 541-544.
Seibold, R. and A. Betz (1991). "Treatment of posttraumatic osteitis with intravenous ofloxacin." 
Clin Ther 13(4): 457-459.
Sellman, B. R., Y. Timofeyeva, et al. (2008). "Expression of Staphylococcus epidermidis SdrG 
increases following exposure to an in vivo environment." Infect Immun 76(7): 2950- 
2957.
Senneville, E., Y. Yazdanpanah, et al. (2001). "Rifampicin-ofloxacin oral regimen for the treatment 
of mild to moderate diabetic foot osteomyelitis." J Antimicrob Chemother 48(6): 927- 
930.
Shankar, G., I. Pavison, et al. (1993). "Integrin receptor-mediated mobilisation of intranuclear 
calcium in rat osteoclasts." J Cell Sci 105 ( Pt 1): 61-68.
Shapiro, H. M. (1995). Practical flow cytometry. New York; Chichester, Wiley-Liss.
Sheftel, T. G. and J. T. Mader (1986). "Randomized evaluation of ceftazidime or ticarcillin and 
tobramycin for the treatment of osteomyelitis caused by gram-negative bacilli." 
Antimicrob Aeents Chemother 29(1): 112-115.
Shirtliff, M. E., J. H. Calhoun, et al. (2002). "Gatifloxacin efficacy in treatment of experimental 
methicillin-sensitive Staphylococcus aureus-induced osteomyelitis in rabbits." 
Antimicrob Agents Chemother 46(1): 231-233.
shirtliff m e , c. m . m . j . (1999). Abstracts of the 99th general meeting of the American Society for 
Microbiology. Chicago, ASM.
Sibbald, M. J., T. Winter, et al. (2010). "Synthetic effects of secG and secY2 mutations on 
exoproteome biogenesis in Staphylococcus aureus." J Bacteriol 192(14): 3788-3800.
Siegel, G. J. and B. W. Agranoff (1999). Basic neurochemistrv : molecular, cellular, and medical 
aspects. Philadelphia, Lippincott-Raven Publishers.
Signas, C., G. Raucci, et al. (1989). "Nucleotide sequence of the gene for a fibronectin-binding 
protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of 
biologically active peptides." Proc Natl Acad Sci U S A 86(2): 699-703.
Silver, I. A., R. J. Murrills, et al. (1988). "Microelectrode studies on the acid microenvironment 
beneath adherent macrophages and osteoclasts." Exp Cell Res 175(2): 266-276.
Simonet, W. S., P. L. Lacey, et al. (1997). "Osteoprotegerin: a novel secreted protein involved in 
the regulation of bone density." Cell 89(2): 309-319.
Sinha, B., P. P. Francois, et al. (1999). "Fibronectin-binding protein acts as Staphylococcus aureus 
invasin via fibronectin bridging to integrin alpha5betal." Cell Microbiol 1(2): 101-117.
214
References
Sironi, M., F. Breviario, et al. (1989). "IL-1 stimulates IL-6 production in endothelial cells." J 
Immunol 142(2): 549-553.
Sloot, N., M. Thomas, et al. (1992). "Purification and characterisation of elastase from 
Staphylococcus epidermidis." J Med Microbiol 37(3): 201-205.
Smith, P. K., R. I. Krohn, et al. (1985). "Measurement of protein using bicinchoninic acid." Anal 
Biochem 150(1): 76-85.
Snyder, R. J., M. M. Cohen, et al. (2001). "Osteomyelitis in the diabetic patient: diagnosis and 
treatment. Part 2: Medical, surgical, and alternative treatments." Ostomv Wound 
Manage 47(3): 24-30, 32-41; quiz 42-23.
Sommerfeldt, D. W. and C. T. Rubin (2001). "Biology of bone and how it orchestrates the form 
and function of the skeleton." Eur Spine J 10 Suppl 2: S86-95.
Sompolinsky, D., Z. Samra, et al. (1985). "Encapsulation and capsular types in isolates of 
Staphylococcus aureus from different sources and relationship to phage types." J Clin 
Microbiol 22(5): 828-834.
Song, K. M. and J. F. Sloboda (2001). "Acute hematogenous osteomyelitis in children." J Am Acad 
Orthop Surg 9(3): 166-175.
Southwick, F. S. (2003). Infectious disease in 30 days. New York, N.Y.; London, McGraw-Hill.
Southwick, F. S. (2008). Infectious diseases : a clinical short course. New York, McGraw-Hill 
Medical; London : McGraw-Hill [distributor],
Srivastava, R. (2007). Apoptosis. cell signaling, and human diseases : molecular mechanisms. 
Totowa, N.J., Humana Press.
Stewart, P. S. and J. W. Costerton (2001). "Antibiotic resistance of bacteria in biofilms." Lancet 
358(9276): 135-138.
Stott, N. S. (2001). "Review article: Paediatric bone and joint infection." J Orthop Surg (Hong 
Kong) 9(1): 83-90.
Swoboda, J. G., J. Campbell, et al. (2010). "Wall teichoic acid function, biosynthesis, and 
inhibition." Chembiochem 11(1): 35-45.
Tak, P. P. and G. S. Firestein (2001). "NF-kappaB: a key role in inflammatory diseases." J Clin 
Invest 107(1): 7-11.
Takeichi, M. (1991). "Cadherin cell adhesion receptors as a morphogenetic regulator." Science 
251(5000): 1451-1455.
Takeichi, M. (1993). "Cadherins in cancer: implications for invasion and metastasis." Curr Opin 
Cell Biol 5(5): 806-811.
Takeshita, S., N. Namba, et al. (2002). "SHIP-deficient mice are severely osteoporotic due to 
increased numbers of hyper-resorptive osteoclasts." Nat Med 8(9): 943-949.
Tamura, M., J. Gu, et al. (1998). "Inhibition of cell migration, spreading, and focal adhesions by 
tumor suppressor PTEN." Science 280(5369): 1614-1617.
Tanaka, S., T. Miyazaki, et al. (2006). "Molecular mechanism of the life and death of the 
osteoclast." Ann N Y Acad Sci 1068:180-186.
Tanaka, Y., I. Morimoto, et al. (1995). "Osteoblasts are regulated by the cellular adhesion through 
I CAM-1 and VCAM-1." J Bone Miner Res 10(10): 1462-1469.
Teitelbaum, S. L. (2000). "Bone resorption by osteoclasts." Science 289(5484): 1504-1508.
Teitelbaum, S. L. (2007). "Osteoclasts: what do they do and how do they do it?" Am J Pathol 
170(2): 427-435.
Tetzlaff, T. R., G. H. McCracken, Jr., et al. (1978). "Oral antibiotic therapy for skeletal infections of 
children. II. Therapy of osteomyelitis and suppurative arthritis." J Pediatr 92(3): 485-490.
Till, M., R. L. Wixson, et al. (2002). "Linezolid treatment for osteomyelitis due to vancomycin- 
resistant Enterococcus faecium." Clin Infect Pis 34(10): 1412-1414.
Ton-That, H. and O. Schneewind (1999). "Anchor structure of staphylococcal surface proteins. IV. 
Inhibitors of the cell wall sorting reaction." J Biol Chem 274(34): 24316-24320.
Topazian, R. G. and M. H. Goldberg (1994). Oral and maxillofacial infections. Philadelphia ; 
London, W.B. Saunders Co.
Trad, S., J. Allignet, et al. (2004). "PNA macroarray for identification and typing of Staphylococcus 
aureus isolates." J Clin Microbiol 42(5): 2054-2064.
Tucker, K. A., S. S. Reilly, et al. (2000). "Intracellular Staphylococcus aureus induces apoptosis in 
mouse osteoblasts." FEMS Microbiol Lett 186(2): 151-156.
215
References
Udagawa, N., N.Takahashi, et al. (1995). "Interleukin (IL)-6 induction of osteoclast differentiation 
depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast 
progenitors." J Exp Med 182(5): 1461-1468.
Uhlen, M., B. Guss, et al. (1984). "Complete sequence of the staphylococcal gene encoding 
protein A. A gene evolved through multiple duplications." J Biol Chem 259(3): 1695- 
1702.
Uhlen, M., B. Guss, et al. (1984). "Expression of the gene encoding protein A in Staphylococcus 
aureus and coagulase-negative staphylococci." J Bacteriol 159(2): 713-719.
Ulrich, R. G., S. Bavari, et al. (1995). "Bacterial superantigens in human disease: structure, 
function and diversity." Trends Microbiol 3(12): 463-468.
Unkila-Kallio, L., M. J. Kallio, et al. (1994). "Serum C-reactive protein, erythrocyte sedimentation 
rate, and white blood cell count in acute hematogenous osteomyelitis of children." 
Pediatrics 93(1): 59-62.
Urquhart, D. M., F. S. Hanna, et al. (2010). "Incidence and risk factors for deep surgical site 
infection after primary total hip arthroplasty: a systematic review." J Arthroplasty 25(8): 
1216-1222 el211-1213.
Usui, A., M. Murai, et al. (1992). "Conspicuous ingestion of Staphylococcus aureus organisms by 
murine fibroblasts in vitro." Microbiol Immunol 36(5): 545-550.
Vaananen, H. K. and M. Horton (1995). "The osteoclast clear zone is a specialized cell- 
extracellular matrix adhesion structure." J Cell Sei 108 ( Pt 8): 2729-2732.
Valeva, A., A. Weisser, et al. (1996). "Molecular architecture of a toxin pore: a 15-residue 
sequence lines the transmembrane channel of staphylococcal alpha-toxin." EMBO J 
15(8): 1857-1864.
van der Mee-Marquet, N., A. Achard, et al. (2003). "Staphylococcus lugdunensis infections: high 
frequency of inguinal area carriage." J Clin Microbiol 41(4): 1404-1409.
Vaudaux, P. E., P. Francois, et al. (1995). "Use of adhesion-defective mutants of Staphylococcus 
aureus to define the role of specific plasma proteins in promoting bacterial adhesion to 
canine arteriovenous shunts." Infect Immun 63(2): 585-590.
Vernachio, J., A. S. Bayer, et al. (2003). "Anti-clumping factor A immunoglobulin reduces the 
duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental 
model of infective endocarditis." Antimicrob Agents Chemother 47(11): 3400-3406.
Viau, M., N. S. Longo, et al. (2005). "Staphylococcal protein a deletes B-la and marginal zone B 
lymphocytes expressing human immunoglobulins: an immune evasion mechanism." J 
Immunol 175(11): 7719-7727.
Vleminckx, K. (2011). Adhesive Specificity and the Evolution of Multicellularity. eLS.
Vuong, C. and M. Otto (2002). "Staphylococcus epidermidis infections." Microbes Infect 4(4): 481- 
489.
Wada, T., T. Nakashima, et al. (2006). "RANKL-RANK signaling in osteoclastogenesis and bone 
disease." Trends Mol Med 12(1): 17-25.
Waldvogel, F. A. (2000). "Infections associated with Indwelling Medical Devices." ASM Press 
Second edition: 173-209.
Wallace, W. C., M. Cinat, et al. (1999). "Nosocomial infections in the surgical intensive care unit: a 
difference between trauma and surgical patients." Am Surg 65(10): 987-990.
Wann, E. R., B. Dassy, et al. (1999). "Genetic analysis of the cap5 locus of Staphylococcus aureus." 
FEMS Microbiol Lett 170(1): 97-103.
Wann, E. R., S. Gurusiddappa, et al. (2000). "The fibronectin-binding MSCRAMM FnbpA of 
Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen." J Biol 
Chem 275(18): 13863-13871.
Weichert, S., M. Sharland, et al. (2008). "Acute haematogenous osteomyelitis in children: is there 
any evidence for how long we should treat?" Curr Qpin Infect Pis 21(3): 258-262.
Weidenmaier, C., J. F. Kokai-Kun, et al. (2004). "Role of teichoic acids in Staphylococcus aureus 
nasal colonization, a major risk factor in nosocomial infections." Nat Med 10(3): 243- 
245.
Weidenmaier, C., J. F. Kokai-Kun, et al. (2008). "Differential roles of sortase-anchored surface 
proteins and wall teichoic acid in Staphylococcus aureus nasal colonization." Int J Med 
Microbiol 298(5-6): 505-513.
216
References
Weidenmaier, C. and A. Peschel (2008). "Teichoic acids and related cell-wall glycopolymers in 
Gram-positive physiology and host interactions." Nat Rev Microbiol 6(4): 276-287.
Weidenmaier, C., A. Peschel, et al. (2005). "Lack of wall teichoic acids in Staphylococcus aureus 
leads to reduced interactions with endothelial cells and to attenuated virulence in a 
rabbit model of endocarditis." J Infect Pis 191(10): 1771-1777.
Weinstein, S. L. and J. A. Buckwalter (2005). Turek's orthopaedics : principles and their 
application. Philadelphia, Pa.; London, Lippincott Williams & Wilkins.
Wells, J. M., P. W. Wilson, et al. (1993). "Improved cloning vectors and transformation procedure 
for Lactococcus lactis." J AdpI Bacteriol 74(6): 629-636.
Wesson, C. A., J. Peringer, et al. (2000). "Apoptosis induced by Staphylococcus aureus in 
epithelial cells utilizes a mechanism involving caspases 8 and 3." Infect Immun 68(5): 
2998-3001.
Wong, G. G. and S. C. Clark (1988). "Multiple actions of interleukin 6 within a cytokine network." 
Immunol Today 9(5): 137-139.
Wright, J. A. and S. P. Nair (2010). "Interaction of staphylococci with bone." Int J Med Microbiol 
300(2-3): 193-204.
Wright, K. M. and J. S. Friedland (2004). "Regulation of chemokine gene expression and secretion 
in Staphylococcus aureus-infected osteoblasts." Microbes Infect 6(9): 844-852.
Xiao, G., P. Wang, et al. (1998). "Role of the alpha2-integrin in osteoblast-specific gene 
expression and activation of the Osf2 transcription factor." J Biol Chem 273(49): 32988- 
32994.
Yamada, K. M. and K. Olden (1978). "Fibronectins-adhesive glycoproteins of cell surface and 
blood." Nature 275(5677): 179-184.
Yamaguchi, A. and A. J. Kahn (1991). "Clonal osteogenic cell lines express myogenic and 
adipocytic developmental potential." Calcif Tissue Int 49(3): 221-225.
Yao, Y., P. E. Sturdevant, et al. (2005). "Genomewide analysis of gene expression in 
Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis 
biofilms and the role of phenol-soluble modulins in formation of biofilms." J Infect Pis 
191(2): 289-298.
Yasuda, H., N. Shima, et al. (1998). "Osteoclast differentiation factor is a ligand for 
osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to 
TRANCE/RANKL." Proc Natl Acad Sci U S A 95(7): 3597-3602.
Yoshii, T., S. Magara, et al. (2002). "Local levels of interleukin-lbeta, -4, -6 and tumor necrosis 
factor alpha in an experimental model of murine osteomyelitis due to staphylococcus 
aureus." Cytokine 19(2): 59-65.
Yu, L. P., J. P. Bradley, et al. (1992). "Predictors of mortality in non-post-operative patients with 
septic arthritis." Scand J Rheumatol 21(3): 142-144.
Zamir, E. and B. Geiger (2001). "Molecular complexity and dynamics of cell-matrix adhesions." J 
Cell Sci 114(Pt 20): 3583-3590.
Zauli, G., E. Rimondi, et al. (2004). "TNF-related apoptosis-inducing ligand (TRAIL) blocks 
osteoclastic differentiation induced by RANKL plus M-CSF." Blood 104(7): 2044-2050.
Zhang, L., K. Jacobsson, et al. (1999). "Staphylococcus aureus expresses a cell surface protein that 
binds both IgG and beta2-glycoprotein I." Microbiology 145 ( Pt 1): 177-183.
Zhang, L., K. Jacobsson, et al. (1998). "A second IgG-binding protein in Staphylococcus aureus." 
Microbiology 144 ( Pt 4): 985-991.
Zhou, Y. and M. Karplus (1999). "Folding of a model three-helix bundle protein: a thermodynamic 
and kinetic analysis." J Mol Biol 293(4): 917-951.
Zhou, Y. and M. Karplus (1999). "Interpreting the folding kinetics of helical proteins." Nature 
401(6751): 400-403.
Zhu, J., E. Shimizu, et al. (2011). "EGFR signaling suppresses osteoblast differentiation and inhibits 
expression of master osteoblastic transcription factors Runx2 and Osterix." J Cell 
Biochem 112(7): 1749-1760.
Zhuang, H., P. S. Puarte, et al. (2000). "Exclusion of chronic osteomyelitis with F-18 
fluorodeoxyglucose positron emission tomographic imaging." Clin Nucl Med 25(4): 281- 
284.
Ziebuhr, W. (2001). "Staphylococcus aureus and Staphylococcus epidermidis: emerging 
pathogens in nosocomial infections." Contrib Microbiol 8:102-107.
217
References
Zimmerli, W. (2010). "Clinical practice. Vertebral osteomyelitis." N Enel J Med 362(11): 1022- 
1029.
Zimmerli, W., A. F. Widmer, etal. (1998). "Role of rifampin for treatment of orthopedic implant- 
related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection 
(FBI) Study Group." JAMA 279(19): 1537-1541.
Zimolo, Z., G. Wesolowski, et al. (1994). "Soluble alpha v beta 3-integrin ligands raise [Ca2+]i in 
rat osteoclasts and mouse-derived osteoclast-like cells." Am J Phvsiol 266(2 Pt 1): C376- 
381.
2 1 8
